	<rdf:RDF xmlns:admin="http://webns.net/mvcb/" xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://purl.org/rss/1.0/modules/prism/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/">
	<channel rdf:about="https://biorxiv.org">
	<admin:errorReportsTo rdf:resource="mailto:biorxiv@cshlpress.edu"/>
	<title>bioRxiv Channel: European Molecular Biology Laboratory (EMBL)</title>
	<link>https://biorxiv.org</link>
	<description>
	This feed contains articles for bioRxiv Channel "European Molecular Biology Laboratory (EMBL)"
	</description>

		<items>
	<rdf:Seq>
		</rdf:Seq>
	</items>
	<prism:eIssn/>
	<prism:publicationName>bioRxiv</prism:publicationName>
	<prism:issn/>

	<image rdf:resource=""/>
	</channel>
	<image rdf:about="">
	<title>bioRxiv</title>
	<url/>
	<link>https://biorxiv.org</link>
	</image>
	<item rdf:about="https://biorxiv.org/content/10.1101/575282?rss=1">
<title>
<![CDATA[
Lumen expansion facilitates epiblast-primitive endoderm fate specification in the mouse blastocyst formation. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/575282?rss=1</link>
<description><![CDATA[
Mouse blastocyst formation involves lumen formation and cell fate specification. While many studies have investigated how the blastocyst cell lineages are specified through genetics and signaling, studies into the potential role of the fluid lumen have yet to be conducted. We discover that blastocyst fluid emerges by secretion of cytoplasmic vesicles to intercellular space in addition to trans-epithelial flow. We observe that the beginning of epiblast and primitive endoderm spatial segregation directly follows lumen coalescence. Notably, we show that perturbing lumen expansion by pharmacological and biophysical means impair the specification and spatial segregation of primitive endoderm cells within the blastocyst. Combined, our results suggest that blastocyst lumen expansion plays a critical role in guiding cell fate specification and positioning. As epithelial tissues typically form lumina, lumen expansion may provide a general mechanism of cell fate control in many tissues.
]]></description>
<dc:creator>Ryan, A. Q.</dc:creator>
<dc:creator>Chan, C. J.</dc:creator>
<dc:creator>Graner, F.</dc:creator>
<dc:creator>Hiiragi, T.</dc:creator>
<dc:date>2019-03-12</dc:date>
<dc:identifier>doi:10.1101/575282</dc:identifier>
<dc:title><![CDATA[Lumen expansion facilitates epiblast-primitive endoderm fate specification in the mouse blastocyst formation.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2019-03-12</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/462978?rss=1">
<title>
<![CDATA[
Iron deficiency affects early stages of embryonic hematopoiesis but not the endothelial to hematopoietic transition 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/462978?rss=1</link>
<description><![CDATA[
Iron is an essential micronutrient for hematopoiesis and previous research suggested that iron deficiency in the pregnant female could cause anemia in the offspring. Since the development of all embryonic and adult blood cells begins in the embryo, we aimed to resolve the role of iron in embryonic hematopoiesis. For this purpose, we used an experimental system of mouse embryonic stem cells differentiation into embryonic hematopoietic progenitors. We modulated the iron status in cultures by adding either an iron chelator DFO for iron deficiency, or ferric ammonium citrate for iron excess, and followed the emergence of developing hematopoietic progenitors by flow cytometry. We found interestingly that iron deficiency by DFO did not block the endothelial to hematopoietic transition, the first step of hematopoiesis. However, it had a differential effect on the proliferation, survival and clonogenic capacity of hematopoietic progenitors. Surprisingly, iron deficiency affected erythro-myeloid Kitpos CD41+ progenitors significantly more than the primitive erythroid Kitneg CD41+. The Kitpos progenitors paradoxically died more, proliferated less and had more reduction in colony formation than Kitneg after 24 hours of DFO treatment. Kitpos progenitors expressed less transferrin-receptor on the cell surface and had less labile iron compared to Kitneg, which could reduce their capacity to compete for scarce iron and survive iron deficiency. We suggest that iron deficiency could disturb hematopoiesis already at an early embryonic stage by compromising survival, proliferation and differentiation of definitive hematopoietic progenitors.
]]></description>
<dc:creator>Shvartsman, M.</dc:creator>
<dc:creator>Bilican, S.</dc:creator>
<dc:creator>Lancrin, C.</dc:creator>
<dc:date>2018-11-05</dc:date>
<dc:identifier>doi:10.1101/462978</dc:identifier>
<dc:title><![CDATA[Iron deficiency affects early stages of embryonic hematopoiesis but not the endothelial to hematopoietic transition]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/459354?rss=1">
<title>
<![CDATA[
The transcriptome-wide landscape and modalities of EJC binding in adult Drosophila 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/459354?rss=1</link>
<description><![CDATA[
Splicing-dependent assembly of the exon junction complex (EJC) at canonical sites -20 to -24 nucleotides upstream of exon-exon junctions in mRNAs occurs in all higher eukaryotes and affects most major regulatory events in the life of a transcript. In mammalian cell cytoplasm, EJC is essential for efficient RNA surveillance, while in Drosophila the most essential cytoplasmic EJC function is in localization of oskar mRNA. Here we developed a method for isolation of protein complexes and associated RNA-targets (ipaRt), which provides a transcriptome-wide view of RNA binding sites of the fully assembled EJC in adult Drosophila. We find that EJC binds at canonical positions, with highest occupancy on mRNAs from genes comprising multiple splice sites and long introns. Moreover, the occupancy is highest at junctions adjacent to strong splice sites, CG-rich hexamers and RNA structures. These modalities have not been identified by previous studies in mammals, where more binding was seen at non-canonical positions. The most highly occupied transcripts in Drosophila have increased tendency to be maternally localized, and are more likely to derive from genes involved in differentiation or development. Taken together, we identify the RNA modalities that specify EJC assembly in Drosophila on a biologically coherent set of transcripts.
]]></description>
<dc:creator>Obrdlik, A.</dc:creator>
<dc:creator>Lin, G.</dc:creator>
<dc:creator>Haberman, N.</dc:creator>
<dc:creator>Ule, J.</dc:creator>
<dc:creator>Ephrussi, A.</dc:creator>
<dc:date>2018-11-04</dc:date>
<dc:identifier>doi:10.1101/459354</dc:identifier>
<dc:title><![CDATA[The transcriptome-wide landscape and modalities of EJC binding in adult Drosophila]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-11-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/447367?rss=1">
<title>
<![CDATA[
Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/447367?rss=1</link>
<description><![CDATA[
SummaryWhile many disease-associated variants have been identified through genome-wide association studies, their downstream molecular consequences remain unclear.nnTo identify these effects, we performed cis- and trans-expression quantitative trait locus (eQTL) analysis in blood from 31,684 individuals through the eQTLGen Consortium.nnWe observed that cis-eQTLs can be detected for 88% of the studied genes, but that they have a different genetic architecture compared to disease-associated variants, limiting our ability to use cis-eQTLs to pinpoint causal genes within susceptibility loci.nnIn contrast, trans-eQTLs (detected for 37% of 10,317 studied trait-associated variants) were more informative. Multiple unlinked variants, associated to the same complex trait, often converged on trans-genes that are known to play central roles in disease etiology.nnWe observed the same when ascertaining the effect of polygenic scores calculated for 1,263 genome-wide association study (GWAS) traits. Expression levels of 13% of the studied genes correlated with polygenic scores, and many resulting genes are known to drive these traits.
]]></description>
<dc:creator>Vosa, U.</dc:creator>
<dc:creator>Claringbould, A.</dc:creator>
<dc:creator>Westra, H.-J.</dc:creator>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:creator>Deelen, P.</dc:creator>
<dc:creator>Zeng, B.</dc:creator>
<dc:creator>Kirsten, H.</dc:creator>
<dc:creator>Saha, A.</dc:creator>
<dc:creator>Kreuzhuber, R.</dc:creator>
<dc:creator>Kasela, S.</dc:creator>
<dc:creator>Pervjakova, N.</dc:creator>
<dc:creator>Alvaes, I.</dc:creator>
<dc:creator>Fave, M.-J.</dc:creator>
<dc:creator>Agbessi, M.</dc:creator>
<dc:creator>Christiansen, M.</dc:creator>
<dc:creator>Jansen, R.</dc:creator>
<dc:creator>Seppälä, I.</dc:creator>
<dc:creator>Tong, L.</dc:creator>
<dc:creator>Teumer, A.</dc:creator>
<dc:creator>Schramm, K.</dc:creator>
<dc:creator>Hemani, G.</dc:creator>
<dc:creator>Verlouw, J.</dc:creator>
<dc:creator>Yaghootkar, H.</dc:creator>
<dc:creator>Sönmez, R.</dc:creator>
<dc:creator>Andrew, A. A.</dc:creator>
<dc:creator>Kukushkina, V.</dc:creator>
<dc:creator>Kalnapenkis, A.</dc:creator>
<dc:creator>Rüeger, S.</dc:creator>
<dc:creator>Porcu, E.</dc:creator>
<dc:creator>Kronberg-Guzman, J.</dc:creator>
<dc:creator>Kettunen, J.</dc:creator>
<dc:creator>Powell, J.</dc:creator>
<dc:creator>Lee, B.</dc:creator>
<dc:creator>Zhang, F.</dc:creator>
<dc:creator>Arindrarto, W.</dc:creator>
<dc:creator>Beutner, F.</dc:creator>
<dc:creator>BIOS Consortium,</dc:creator>
<dc:creator>Brugge, H.</dc:creator>
<dc:creator>i2QTL Consortium,</dc:creator>
<dc:creator>Dmitrieva, J.</dc:creator>
<dc:creator>Elansary, M.</dc:creator>
<dc:creator>Fairfax, B. P.</dc:creator>
<dc:creator>Georges, M.</dc:creator>
<dc:creator>He</dc:creator>
<dc:date>2018-10-19</dc:date>
<dc:identifier>doi:10.1101/447367</dc:identifier>
<dc:title><![CDATA[Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/446492?rss=1">
<title>
<![CDATA[
Reverse GWAS: Using Genetics to Identify and Model Phenotypic Subtypes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/446492?rss=1</link>
<description><![CDATA[
Recent and classical work has revealed biologically and medically significant subtypes in complex diseases and traits. However, relevant subtypes are often unknown, unmeasured, or actively debated, making automatic statistical approaches to subtype definition particularly valuable. We propose reverse GWAS (RGWAS) to identify and validate subtypes using genetics and multiple traits: while GWAS seeks the genetic basis of a given trait, RGWAS seeks to define trait subtypes with distinct genetic bases. Unlike existing approaches relying on off-the-shelf clustering methods, RGWAS uses a bespoke decomposition, MFMR, to model covariates, binary traits, and population structure. We use extensive simulations to show these features can be crucial for power and calibration. We validate RGWAS in practice by recovering known stress subtypes in major depressive disorder. We then show the utility of RGWAS by identifying three novel subtypes of metabolic traits. We biologically validate these metabolic subtypes with SNP-level tests and a novel polygenic test: the former recover known metabolic GxE SNPs; the latter suggests genetic heterogeneity may explain substantial missing heritability. Crucially, statins, which are widely prescribed and theorized to increase diabetes risk, have opposing effects on blood glucose across metabolic subtypes, suggesting potential have potential translational value.nnAuthor summaryComplex diseases depend on interactions between many known and unknown genetic and environmental factors. However, most studies aggregate these strata and test for associations on average across samples, though biological factors and medical interventions can have dramatically different effects on different people. Further, more-sophisticated models are often infeasible because relevant sources of heterogeneity are not generally known a priori. We introduce Reverse GWAS to simultaneously split samples into homogeneoues subtypes and to learn differences in genetic or treatment effects between subtypes. Unlike existing approaches to computational subtype identification using high-dimensional trait data, RGWAS accounts for covariates, binary disease traits and, especially, population structure; these features are each invaluable in extensive simulations. We validate RGWAS by recovering known genetic subtypes of major depression. We demonstrate RGWAS is practically useful in a metabolic study, finding three novel subtypes with both SNP- and polygenic-level heterogeneity. Importantly, RGWAS can uncover differential treatment response: for example, we show that statin, a common drug and potential type 2 diabetes risk factor, may have opposing subtype-specific effects on blood glucose.
]]></description>
<dc:creator>Dahl, A.</dc:creator>
<dc:creator>Cai, N.</dc:creator>
<dc:creator>Ko, A.</dc:creator>
<dc:creator>Laakso, M.</dc:creator>
<dc:creator>Pajukanta, P.</dc:creator>
<dc:creator>Flint, J.</dc:creator>
<dc:creator>Zaitlen, N.</dc:creator>
<dc:date>2018-10-17</dc:date>
<dc:identifier>doi:10.1101/446492</dc:identifier>
<dc:title><![CDATA[Reverse GWAS: Using Genetics to Identify and Model Phenotypic Subtypes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/446070?rss=1">
<title>
<![CDATA[
IsoProt: A fully reproducible one-stop-shop for the analysis of iTRAQ/TMT data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/446070?rss=1</link>
<description><![CDATA[
Reproducibility has become a major concern in biomedical research. In proteomics, bioinformatic workflows can quickly consist of multiple software tools each with its own set of parameters. Their usage involves the definition of often hundreds of parameters as well as data operations to ensure tool interoperability. Hence a manuscripts methods section is often insufficient to completely describe and reproduce a data analysis workflow. Here we present IsoProt: A complete and reproducible bioinformatic workflow deployed on a portable container environment to analyse data from isobarically-labeled, quantitative proteomics experiments. The workflow uses only open source tools and provides a user-friendly and interactive browser interface to configure and execute the different operations. Once the workflow is executed, the results including the R code to perform statistical analyses can be downloaded as an HTML or PDF document providing a complete record of the performed analyses. IsoProt therefore represents a reproducible bioinformatics workflow that will yield identical results on any computer platform.
]]></description>
<dc:creator>Griss, J.</dc:creator>
<dc:creator>Vinterhalter, G.</dc:creator>
<dc:creator>Schwaemmle, V.</dc:creator>
<dc:date>2018-10-17</dc:date>
<dc:identifier>doi:10.1101/446070</dc:identifier>
<dc:title><![CDATA[IsoProt: A fully reproducible one-stop-shop for the analysis of iTRAQ/TMT data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/443945?rss=1">
<title>
<![CDATA[
Evolution of protein kinase substrate recognition at the active site 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/443945?rss=1</link>
<description><![CDATA[
Protein kinases catalyse the phosphorylation of target proteins, controlling most cellular processes. The specificity of serine/threonine kinases is partly determined by interactions with a few residues near the phospho-acceptor residue, forming the so-called kinase substrate motif. Kinases have been extensively duplicated throughout evolution but little is known about when in time new target motifs have arisen. Here we show that sequence variation occurring early in the evolution of kinases is dominated by changes in specificity determining residues. We then analysed kinase specificity models, based on known target sites, observing that specificity has remained mostly unchanged for recent kinase duplications. Finally, analysis of phosphorylation data from a taxonomically broad set of 48 eukaryotic species indicates that most phosphorylation motifs are broadly distributed in eukaryotes but not present in prokaryotes. Overall, our results suggest that the set of eukaryotes kinase motifs present today was acquired soon after the eukaryotic last common ancestor and that early expansions of the protein kinase fold rapidly explored the space of possible target motifs.
]]></description>
<dc:creator>Bradley, D.</dc:creator>
<dc:creator>Beltrao, P.</dc:creator>
<dc:date>2018-10-16</dc:date>
<dc:identifier>doi:10.1101/443945</dc:identifier>
<dc:title><![CDATA[Evolution of protein kinase substrate recognition at the active site]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/440735?rss=1">
<title>
<![CDATA[
Minimal phenotyping yields GWAS hits of low specificity for major depression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/440735?rss=1</link>
<description><![CDATA[
Minimal phenotyping refers to the reliance on the use of a small number of self-report items for disease case identification. This strategy has been applied to genome-wide association studies (GWAS) of major depressive disorder (MDD). Here we report that the genotype derived heritability (h2SNP) of depression defined by minimal phenotyping (14%, SE = 0.8%) is lower than strictly defined MDD (26%, SE = 2.2%). This cannot be explained by differences in prevalence between definitions or including cases of lower liability to MDD in minimal phenotyping definitions of depression, but can be explained by misdiagnosis of those without depression or with related conditions as cases of depression. Depression defined by minimal phenotyping is as genetically correlated with strictly defined MDD (rG = 0.81, SE = 0.03) as it is with the personality trait neuroticism (rG = 0.84, SE = 0.05), a trait not defined by the cardinal symptoms of depression. While they both show similar shared genetic liability with neuroticism, a greater proportion of the genome contributes to the minimal phenotyping definitions of depression (80.2%, SE = 0.6%) than to strictly defined MDD (65.8%, SE = 0.6%). We find that GWAS loci identified in minimal phenotyping definitions of depression are not specific to MDD: they also predispose to other psychiatric conditions. Finally, while highly predictive polygenic risk scores can be generated from minimal phenotyping definitions of MDD, the predictive power can be explained entirely by the sample size used to generate the polygenic risk score, rather than specificity for MDD. Our results reveal that genetic analysis of minimal phenotyping definitions of depression identifies non-specific genetic factors shared between MDD and other psychiatric conditions. Reliance on results from minimal phenotyping for MDD may thus bias views of the genetic architecture of MDD and may impede our ability to identify pathways specific to MDD.
]]></description>
<dc:creator>Cai, N.</dc:creator>
<dc:creator>Kendler, K.</dc:creator>
<dc:creator>Flint, J.</dc:creator>
<dc:date>2018-10-11</dc:date>
<dc:identifier>doi:10.1101/440735</dc:identifier>
<dc:title><![CDATA[Minimal phenotyping yields GWAS hits of low specificity for major depression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-11</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/438234?rss=1">
<title>
<![CDATA[
Using the drug-protein interactome to identify anti-ageing compounds for humans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/438234?rss=1</link>
<description><![CDATA[
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p < 0.001). Using the targets of each drug, we established its association with ageing at multiple levels of biological actions including pathways, functions and protein interactions. Finally, combining all the data, we calculated a comprehensive ranked list of drugs that predicted tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in Caenorhabditis elegans.nnAuthor SummaryHuman life expectancy is continuing to increase worldwide, as a result of successive improvements in living conditions and medical care. Although this trend is to be celebrated, advancing age is the major risk factor for multiple impairments and chronic diseases. As a result, the later years of life are often spent in poor health and lowered quality of life. However, these effects of ageing are not inevitable, because very long-lived people often suffer rather little ill-health at the end of their lives. Furthermore, laboratory experiments have shown that animals fed with specific drugs can live longer and with fewer age-related diseases than their untreated companions. We therefore need to identify drugs with anti-ageing properties for humans. We have therefore used computers to search for drugs that affect components and processes known to be important in human ageing. This approach worked, because it was able to re-discover several drugs known to increase lifespan in animal models, plus some new ones, including one that we tested experimentally and validated in this study. These drugs are now a high priority for animal testing and for exploring effects on human ageing.
]]></description>
<dc:creator>Fuentealba Valenzuela, M.</dc:creator>
<dc:creator>Donertas, H. M.</dc:creator>
<dc:creator>Williams, R.</dc:creator>
<dc:creator>Labbadia, J.</dc:creator>
<dc:creator>Thornton, J.</dc:creator>
<dc:creator>Partridge, L.</dc:creator>
<dc:date>2018-10-08</dc:date>
<dc:identifier>doi:10.1101/438234</dc:identifier>
<dc:title><![CDATA[Using the drug-protein interactome to identify anti-ageing compounds for humans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/437947?rss=1">
<title>
<![CDATA[
The Hox Transcription Factor Ubx stabilizes Lineage Commitment by Suppressing Cellular Plasticity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/437947?rss=1</link>
<description><![CDATA[
During development cells become gradually restricted in their differentiation potential by the repression of alternative cell fates. While we know that the Polycomb complex plays a crucial role in this process, it still remains unclear how alternative fate genes are specifically targeted for silencing in different cell lineages. We address this question by studying Ultrabithorax (Ubx), a multi-lineage transcription factor (TF) of the Hox class, in the mesodermal and neuronal lineages using sorted nuclei of Drosophila embryos and by interfering with Ubx in mesodermal cells that have already initiated differentiation. We find that Ubx is a key regulator of lineage development, as its mesoderm-specific depletion leads to the de-repression of many genes normally expressed in other lineages. Ubx silences expression of alternative fate genes by interacting with and retaining the Polycomb Group (PcG) protein Pleiohomeotic (Pho) at Ubx targeted genomic regions, thereby setting repressive chromatin marks in a lineage-dependent manner. In sum, our study demonstrates that Ubx stabilizes lineage choice by suppressing the multi-potency encoded in the genome in a lineage-specific manner via its interaction with Pho. This mechanism may explain why the Hox code is maintained throughout the lifecycle, since it seems to set a block to transdifferentiation in many adult cells.
]]></description>
<dc:creator>Domsch, K.</dc:creator>
<dc:creator>Carnesecchi, J.</dc:creator>
<dc:creator>Disela, V.</dc:creator>
<dc:creator>Friedrich, J.</dc:creator>
<dc:creator>Trost, N.</dc:creator>
<dc:creator>Ermakova, O.</dc:creator>
<dc:creator>Polychronidou, M.</dc:creator>
<dc:creator>Lohmann, I.</dc:creator>
<dc:date>2018-10-08</dc:date>
<dc:identifier>doi:10.1101/437947</dc:identifier>
<dc:title><![CDATA[The Hox Transcription Factor Ubx stabilizes Lineage Commitment by Suppressing Cellular Plasticity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-08</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/437459?rss=1">
<title>
<![CDATA[
Condensin II inactivation in interphase does not affect chromatin folding or gene expression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/437459?rss=1</link>
<description><![CDATA[
Condensin complexes have been proposed to play a prominent role in interphase chromatin organization and control of gene expression. Here, we report that the deletion of the central condensin II kleisin subunit Ncaph2 in differentiated mouse hepatocytes does not lead to significant changes in chromosome organization or in gene expression. Both observations challenge current views that implicate condensin in interphase chromosomal domain formation and in enhancer-promoter interactions. Instead, we suggest that the previously reported effects of condensin perturbation may result from their structural role during mitosis, which might indirectly impact the re-establishment of interphase chromosomal architecture after cell division.
]]></description>
<dc:creator>Abdennur, N.</dc:creator>
<dc:creator>Schwarzer, W.</dc:creator>
<dc:creator>Pekowska, A.</dc:creator>
<dc:creator>Shaltiel, I. A.</dc:creator>
<dc:creator>Huber, W.</dc:creator>
<dc:creator>Haering, C. H.</dc:creator>
<dc:creator>Mirny, L.</dc:creator>
<dc:creator>Spitz, F.</dc:creator>
<dc:date>2018-10-07</dc:date>
<dc:identifier>doi:10.1101/437459</dc:identifier>
<dc:title><![CDATA[Condensin II inactivation in interphase does not affect chromatin folding or gene expression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/434720?rss=1">
<title>
<![CDATA[
Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates, and humans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/434720?rss=1</link>
<description><![CDATA[
Targeting genes to specific neuronal or glial cell types is valuable both for understanding and for repairing brain circuits. Adeno-associated viral vectors (AAVs) are frequently used for gene delivery, but targeting expression to specific cell types is a challenge. We created a library of 230 AAVs, each with a different synthetic promoter designed using four independent strategies. We show that ~11% of these AAVs specifically target expression to neuronal and glial cell types in the mouse retina, mouse brain, non-human primate retina in vivo, and in the human retina in vitro. We demonstrate applications for recording, stimulation, and molecular characterization, as well as the intersectional and combinatorial labeling of cell types. These resources and approaches allow economic, fast, and efficient cell-type targeting in a variety of species, both for fundamental science and for gene therapy.
]]></description>
<dc:creator>Juettner, J.</dc:creator>
<dc:creator>Szabo, A.</dc:creator>
<dc:creator>Gross-Scherf, B.</dc:creator>
<dc:creator>Morikawa, R.</dc:creator>
<dc:creator>Rompani, S.</dc:creator>
<dc:creator>Teixeira, M.</dc:creator>
<dc:creator>Hantz, P.</dc:creator>
<dc:creator>Szikra, T.</dc:creator>
<dc:creator>Esposti, F.</dc:creator>
<dc:creator>Cowan, C.</dc:creator>
<dc:creator>Bharioke, A.</dc:creator>
<dc:creator>Patino, C.</dc:creator>
<dc:creator>Keles, O.</dc:creator>
<dc:creator>Roth, C.</dc:creator>
<dc:creator>Kusnyerik, A.</dc:creator>
<dc:creator>Gerber-Hollbach, N.</dc:creator>
<dc:creator>Azoulay, T.</dc:creator>
<dc:creator>Hartl, D.</dc:creator>
<dc:creator>Krebs, A.</dc:creator>
<dc:creator>Schuebeler, D.</dc:creator>
<dc:creator>Hajdu, R.</dc:creator>
<dc:creator>Lukats, A.</dc:creator>
<dc:creator>Nemeth, J.</dc:creator>
<dc:creator>Nagy, Z.</dc:creator>
<dc:creator>Wu, K.-C.</dc:creator>
<dc:creator>Wu, R.-H.</dc:creator>
<dc:creator>Xiang, L.</dc:creator>
<dc:creator>Fang, X.-L.</dc:creator>
<dc:creator>Jin, Z.-B.</dc:creator>
<dc:creator>Goldblum, D.</dc:creator>
<dc:creator>Hasler, P.</dc:creator>
<dc:creator>Scholl, H.</dc:creator>
<dc:creator>Krol, J.</dc:creator>
<dc:creator>Roska, B.</dc:creator>
<dc:date>2018-10-04</dc:date>
<dc:identifier>doi:10.1101/434720</dc:identifier>
<dc:title><![CDATA[Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates, and humans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/431890?rss=1">
<title>
<![CDATA[
Dppa2 and Dppa4 directly regulate the Dux driven zygotic transcriptional programme 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/431890?rss=1</link>
<description><![CDATA[
The molecular regulation of zygotic genome activation (ZGA) in mammals remains poorly understood. Primed mouse embryonic stem cells contain a rare subset of "2C-like" cells that are epigenetically and transcriptionally similar to the two cell embryo and thus represent an ideal system for studying ZGA transcription regulation. Recently, the transcription factor Dux, expressed exclusively in the minor wave of ZGA, was described to activate many downstream ZGA transcripts. However, it remains unknown what upstream maternal factors initiate ZGA either in a Dux dependent or independent manner. Here we performed a candidate-based overexpression screen, identifying, amongst others, Developmental Pluripotency Associated 2 (Dppa2) and 4 (Dppa4) as positive regulators of 2C-like cells and ZGA transcription. In the germ line, promoter DNA demethylation coincides with upregulation of Dppa2 and Dppa4 which remain expressed until E7.5 when their promoters are remethylated. Furthermore, Dppa2 and Dppa4 are also expressed during iPSC reprogramming at the time 2C-like ZGA transcription transiently peaks. Through a combination of overexpression, knockdown, knockout and rescue experiments, together with transcriptional analyses, we show that Dppa2 and Dppa4 directly regulate the 2C-like cell population and associated transcripts, including Dux and the Zscan4 cluster. Importantly, we tease apart the molecular hierarchy in which the 2C-like transcriptional programme is initiated and stabilised. Dppa2 and Dppa4 require Dux to initiate 2C-like ZGA transcription, suggesting they act upstream by directly regulating Dux. Supporting this, ChIP-seq analysis revealed Dppa2 and Dppa4 bind to the Dux promoter and gene body and drive its expression. Zscan4c is also able to induce 2C-like cells in wild type cells, but, in contrast to Dux, can no longer do so in Dppa2/4 double knockout cells, suggesting it may act to stabilise rather than drive the transcriptional network. Our findings suggest a model in which Dppa2/4 binding to the Dux promoter leads to Dux upregulation and activation of the 2C-like transcriptional programme which is subsequently reinforced by Zscan4c.
]]></description>
<dc:creator>Eckersley-Maslin, M. A.</dc:creator>
<dc:creator>Alda-Catalinas, C.</dc:creator>
<dc:creator>Blotenburg, M.</dc:creator>
<dc:creator>Kreibich, E.</dc:creator>
<dc:creator>Krueger, C.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2018-10-01</dc:date>
<dc:identifier>doi:10.1101/431890</dc:identifier>
<dc:title><![CDATA[Dppa2 and Dppa4 directly regulate the Dux driven zygotic transcriptional programme]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-10-01</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/425041?rss=1">
<title>
<![CDATA[
Tunneling nanotubes contribute to the stroma-mediated imatinib resistance of leukemic cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/425041?rss=1</link>
<description><![CDATA[
Intercellular communication within the bone marrow niche significantly influences leukemogenesis and the sensitivity of leukemic cells to therapy. Tunneling nanotubes (TNTs) are a novel mode of intercellular cross-talk. They are long, thin membranous protrusions that enable the direct transfer of various cargo between cells. Here we show that TNTs are formed between leukemic and bone marrow stromal cells. Fluorescence confocal microscopy with 3D reconstructions, correlative light-electron microscopy and electron tomography provided evidence that TNTs transfer cellular vesicles between cells. The quantitative analysis demonstrated that the stromal cells stimulate TNT-mediated vesicle transfer towards leukemic cells. Transfer of vesicular cargo from stromal cells correlated with increased resistance to anti-leukemic treatment. Moreover, specific sets of proteins with a potential role in survival and the drug response were transferred within these vesicles. Altogether, we found that TNTs are involved in the leukemia-stroma cross-talk and the stroma-mediated cytoprotection of leukemic cells. Our findings implicate TNT connections as a possible target for therapeutic interventions within the leukemia microenvironment to attenuate stroma-conferred protection.
]]></description>
<dc:creator>Kolba, M. D.</dc:creator>
<dc:creator>Dudka, W.</dc:creator>
<dc:creator>Zareba-Koziol, M.</dc:creator>
<dc:creator>Kominek, A.</dc:creator>
<dc:creator>Ronchi, P.</dc:creator>
<dc:creator>Turos, L.</dc:creator>
<dc:creator>Wlodarczyk, J.</dc:creator>
<dc:creator>Schwab, Y.</dc:creator>
<dc:creator>Cysewski, D.</dc:creator>
<dc:creator>Srpan, K.</dc:creator>
<dc:creator>Davis, D. M.</dc:creator>
<dc:creator>Piwocka, K.</dc:creator>
<dc:date>2018-09-25</dc:date>
<dc:identifier>doi:10.1101/425041</dc:identifier>
<dc:title><![CDATA[Tunneling nanotubes contribute to the stroma-mediated imatinib resistance of leukemic cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/424473?rss=1">
<title>
<![CDATA[
Protein inference using PIA workflows and PSI standard file formats 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/424473?rss=1</link>
<description><![CDATA[
Proteomics using LC-MS/MS has become one of the main methods to analyze the proteins in biological samples in high-throughput. But the existing mass spectrometry instruments are still limited with respect to resolution and measurable mass ranges, which is one of the main reasons why shotgun proteomics is the major approach. Here, proteins are digested, which leads to the identification and quantification of peptides instead. While often neglected, the important step of protein inference needs to be conducted to infer from the identified peptides to the actual proteins in the original sample.nnIn this work, we highlight some of the previously published and newly added features of the tool PIA - Protein Inference Algorithms, which helps the user with the protein inference of measured samples. We also highlight the importance of the usage of PSI standard file formats, as PIA is the only current software supporting all available standards used for spectrum identification and protein inference. Additionally, we briefly describe the benefits of working with workflow environments for proteomics analyses and show the new features of the PIA nodes for the KNIME Analytics Platform. Finally, we benchmark PIA against a recently published dataset for isoform detection.nnPIA is open source and available for download on GitHub (https://github.com/mpc-bioinformatics/pia) or directly via the community extensions inside the KNIME analytics platform.
]]></description>
<dc:creator>Uszkoreit, J.</dc:creator>
<dc:creator>Perez-Riverol, Y.</dc:creator>
<dc:creator>Eggers, B.</dc:creator>
<dc:creator>Marcus, K.</dc:creator>
<dc:creator>Eisenacher, M.</dc:creator>
<dc:date>2018-09-23</dc:date>
<dc:identifier>doi:10.1101/424473</dc:identifier>
<dc:title><![CDATA[Protein inference using PIA workflows and PSI standard file formats]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/422998?rss=1">
<title>
<![CDATA[
Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/422998?rss=1</link>
<description><![CDATA[
Mechanistic modeling of signaling pathways mediating patient-specific response to therapy can help to unveil resistance mechanisms and improve therapeutic strategies. Yet, creating such models for patients, in particular for solid malignancies, is challenging. A major hurdle to build these models is the limited material available, that precludes the generation of large-scale perturbation data. Here, we present an approach that couples ex vivo high-throughput screenings of cancer biopsies using microfluidics with logic-based modeling to generate patient-specific dynamic models of extrinsic and intrinsic apoptosis signaling pathways. We used the resulting models to investigate heterogeneity in pancreatic cancer patients, showing dissimilarities especially in the PI3K-Akt pathway. Variation in model parameters reflected well the different tumor stages. Finally, we used our dynamic models to efficaciously predict new personalized combinatorial treatments. Our results suggest our combination of microfluidic experiments and mathematical model can be a novel tool toward cancer precision medicine.
]]></description>
<dc:creator>Eduati, F.</dc:creator>
<dc:creator>Jaaks, P.</dc:creator>
<dc:creator>Merten, C. A.</dc:creator>
<dc:creator>Garnett, M. J.</dc:creator>
<dc:creator>Saez-Rodriguez, J.</dc:creator>
<dc:date>2018-09-21</dc:date>
<dc:identifier>doi:10.1101/422998</dc:identifier>
<dc:title><![CDATA[Patient-specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/421123?rss=1">
<title>
<![CDATA[
RELION-3: new tools for automated high-resolution cryo-EM structure determination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/421123?rss=1</link>
<description><![CDATA[
Here, we describe the third major release of relion. CPU-based vector acceleration has been added in addition to GPU support, which provides flexibility in use of resources and avoids memory limitations. Reference-free autopicking with Laplacian-of-Gaussian filtering and execution of jobs from python allows non-interactive processing during acquisition, including 2D-classification, de novo model generation and 3D-classification. Perparticle refinement of CTF parameters and correction of estimated beam tilt provides higher-resolution reconstructions when particles are at different heights in the ice, and/or coma-free alignment has not been optimal. Ewald sphere curvature correction improves resolution for large particles. We illustrate these developments with publicly available data sets: together with a Bayesian approach to beam-induced motion correction it leads to resolution improvements of 0.2-0.7 [A] compared to previous relion versions.
]]></description>
<dc:creator>Zivanov, J.</dc:creator>
<dc:creator>Nakane, T.</dc:creator>
<dc:creator>Forsberg, B.</dc:creator>
<dc:creator>Kimanius, D.</dc:creator>
<dc:creator>Hagen, W. J. H.</dc:creator>
<dc:creator>Lindahl, E.</dc:creator>
<dc:creator>Scheres, S. H. W.</dc:creator>
<dc:date>2018-09-19</dc:date>
<dc:identifier>doi:10.1101/421123</dc:identifier>
<dc:title><![CDATA[RELION-3: new tools for automated high-resolution cryo-EM structure determination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-19</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/420638?rss=1">
<title>
<![CDATA[
Bleaching-independent, whole-cell, 3D and multi-color STED imaging with exchangeable fluorophores 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/420638?rss=1</link>
<description><![CDATA[
We demonstrate bleaching-independent STED microscopy using fluorogenic labels that reversibly bind to their target structure. A constant exchange of labels guarantees the removal of photobleached fluorophores and their replacement by intact fluorophores, thereby circumventing bleaching-related limitations of STED super-resolution imaging in fixed and living cells. Foremost, we achieve a constant labeling density and demonstrate a fluorescence signal for long and theoretically unlimited acquisition times. Using this concept, we demonstrate whole-cell, 3D, multi-color and live cell STED microscopy with up to 100 min acquisition time.
]]></description>
<dc:creator>Spahn, C.</dc:creator>
<dc:creator>Grimm, J. B.</dc:creator>
<dc:creator>Lavis, L. D.</dc:creator>
<dc:creator>Lampe, M.</dc:creator>
<dc:creator>Heilemann, M.</dc:creator>
<dc:date>2018-09-18</dc:date>
<dc:identifier>doi:10.1101/420638</dc:identifier>
<dc:title><![CDATA[Bleaching-independent, whole-cell, 3D and multi-color STED imaging with exchangeable fluorophores]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/418988?rss=1">
<title>
<![CDATA[
Nodal and Eph signalling relay drives the transition between apical constriction and apico-basal shortening during ascidian endoderm invagination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/418988?rss=1</link>
<description><![CDATA[
Gastrulation is the first major morphogenetic event during animal embryogenesis. Ascidian gastrulation starts with the invagination of 10 endodermal precursor cells between the 64- and late 112-cell stages. This process occurs in the absence of endodermal cell division and in two steps, driven by myosin-dependent contractions of the acto-myosin network. First, endoderm precursors constrict their apex. Second, they shorten apico-basally, while retaining small apical surfaces, thereby causing invagination. The mechanisms controlling the endoderm mitotic delay, the step 1 to step 2 transition, and apico-basal shortening have remained elusive. Here, we demonstrate the conserved role during invagination of Nodal and Eph signalling in two distantly related ascidian species (Phallusia mammillata and Ciona intestinalis). We show that the transition to step 2 is controlled by Nodal relayed by Eph signalling and that Eph signalling has a Nodal-independent role in mitotic delay. Interestingly, both Nodal and Eph signals are dispensable for endodermal germ layer fate specification.

Summary statementIdentification of a regulatory developmental signalling sub-network driving endoderm cell shape changes during ascidian endoderm invagination, not involved in cell fate specification.
]]></description>
<dc:creator>Fiuza, U.-M.</dc:creator>
<dc:creator>Negishi, T.</dc:creator>
<dc:creator>Rouan, A.</dc:creator>
<dc:creator>Yasuo, H.</dc:creator>
<dc:creator>Lemaire, P.</dc:creator>
<dc:date>2018-09-15</dc:date>
<dc:identifier>doi:10.1101/418988</dc:identifier>
<dc:title><![CDATA[Nodal and Eph signalling relay drives the transition between apical constriction and apico-basal shortening during ascidian endoderm invagination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-15</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/413047?rss=1">
<title>
<![CDATA[
Cardelino: Integrating whole exomes and single-cell transcriptomes to reveal phenotypic impact of somatic variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/413047?rss=1</link>
<description><![CDATA[
Decoding the clonal substructures of somatic tissues sheds light on cell growth, development and differentiation in health, ageing and disease. DNA-sequencing, either using bulk or using single-cell assays, has enabled the reconstruction of clonal trees from frequency and co-occurrence patterns of somatic variants. However, approaches to systematically characterize phenotypic and functional variations between individual clones are not established. Here we present cardelino (https://github.com/PMBio/cardelino), a computational method for inferring the clone of origin of individual cells that have been assayed using single-cell RNA-seq (scRNA-seq). After validating our model using simulations, we apply cardelino to matched scRNA-seq and exome sequencing data from 32 human dermal fibroblast lines, identifying hundreds of differentially expressed genes between cells from different somatic clones. These genes are frequently enriched for cell cycle and proliferation pathways, indicating a key role for cell division genes in non-neutral somatic evolution.nnKey findingsO_LIA novel approach for integrating DNA-seq and single-cell RNA-seq data to reconstruct clonal substructure for single-cell transcriptomes.nC_LIO_LIEvidence for non-neutral evolution of clonal populations in human fibroblasts.nC_LIO_LIProliferation and cell cycle pathways are commonly distorted in mutated clonal populations.nC_LI
]]></description>
<dc:creator>McCarthy, D. J.</dc:creator>
<dc:creator>Rostom, R.</dc:creator>
<dc:creator>Huang, Y.</dc:creator>
<dc:creator>Kunz, D. J.</dc:creator>
<dc:creator>Danecek, P.</dc:creator>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:creator>Hagai, T.</dc:creator>
<dc:creator>HipSci Consortium,</dc:creator>
<dc:creator>Wang, W.</dc:creator>
<dc:creator>Gaffney, D. J.</dc:creator>
<dc:creator>Simons, B. D.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Teichmann, S. A.</dc:creator>
<dc:date>2018-09-10</dc:date>
<dc:identifier>doi:10.1101/413047</dc:identifier>
<dc:title><![CDATA[Cardelino: Integrating whole exomes and single-cell transcriptomes to reveal phenotypic impact of somatic variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/413377?rss=1">
<title>
<![CDATA[
Cytoskeleton mechanics determine resting size and activation dynamics of platelets. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/413377?rss=1</link>
<description><![CDATA[
Platelets are cell fragments of various size that help maintain hemostasis. The way platelets respond during a clotting process is known to depend on their size, with important physiological consequences. We characterized the cytoskeleton of platelets as a function of their size. In resting Human and Mice platelets, we find a quadradic law between the size of a platelet and the amount of microtubule polymer it contains. We further estimate the length and number of microtubules in the marginal band using Electron and Super-resolution microscopy. In platelets activated with ADP, the marginal band coils as a consequence of cortical contraction driven by actin. We observe that this elastic coiling response is accompanied by a reversible shortening of the marginal band. Moreover, larger platelets have a higher propensity to coil. These results establish the dynamic equilibrium that is responsible for platelet size and differential response on a more quantitative level.nnHighlightsO_LIPlatelet size scales consistently with amount of polymerized tubulin in both mouse and human.nC_LIO_LIPolymerized actin is required for ADP-induced marginal band coiling.nC_LIO_LIUpon activation, the marginal band exhibits a reversible visco-elastic response involving shortening.nC_LIO_LILarger marginal bands have a higher propensity to coil than shorter ones.nC_LInnIn briefThe cytoskeleton is adapted to platelet size and its mechanical properties determine propensity of a platelet to undergo morphological changes in response to agonists.
]]></description>
<dc:creator>Mathur, A.</dc:creator>
<dc:creator>Correia, S. R.</dc:creator>
<dc:creator>Dmitrieff, S.</dc:creator>
<dc:creator>Gibeaux, R.</dc:creator>
<dc:creator>Kalinina, I.</dc:creator>
<dc:creator>Quidwai, T.</dc:creator>
<dc:creator>Ries, J.</dc:creator>
<dc:creator>Nedelec, F.</dc:creator>
<dc:date>2018-09-10</dc:date>
<dc:identifier>doi:10.1101/413377</dc:identifier>
<dc:title><![CDATA[Cytoskeleton mechanics determine resting size and activation dynamics of platelets.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/413211?rss=1">
<title>
<![CDATA[
Modularity, criticality and evolvability of a developmental gene regulatory network 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/413211?rss=1</link>
<description><![CDATA[
The existence of discrete phenotypic traits suggests that the complex regulatory processes which produce them are functionally modular. These processes are usually represented by networks. Only modular networks can be partitioned into intelligible subcircuits able to evolve relatively independently. Traditionally, functional modularity is approximated by detection of modularity in network structure. However, the correlation between structure and function is loose. Many regulatory networks exhibit modular behaviour without structural modularity. Here we partition an experimentally tractable regulatory network--the gap gene system of dipteran insects--using an alternative approach. We show that this system, although not structurally modular, is composed of dynamical modules driving different aspects of whole-network behaviour. All these subcircuits share the same regulatory structure, but differ in components and sensitivity to regulatory interactions. Some subcircuits are in a state of criticality while others are not, which explains the observed differential evolvability of the various expression features in the system.
]]></description>
<dc:creator>Verd, B.</dc:creator>
<dc:creator>Monk, N. A.</dc:creator>
<dc:creator>Jaeger, J.</dc:creator>
<dc:date>2018-09-10</dc:date>
<dc:identifier>doi:10.1101/413211</dc:identifier>
<dc:title><![CDATA[Modularity, criticality and evolvability of a developmental gene regulatory network]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/413294?rss=1">
<title>
<![CDATA[
Utilisation of staphylococcal immune evasion protein Sbi as a novel vaccine adjuvant 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/413294?rss=1</link>
<description><![CDATA[
Co-ligation of the B cell antigen receptor with complement receptor 2 on B-cells via a C3d-opsonised antigen complex significantly lowers the threshold required for B cell activation. Consequently, fusions of antigens with C3d polymers have shown great potential in vaccine design. However, these linear arrays of C3d multimers do not mimic the natural opsonisation of antigens with C3d. Here we investigate the potential of using the unique complement activating characteristics of Staphylococcal immune-evasion protein Sbi to develop a pro-vaccine approach that spontaneously coats antigens with C3 degradation products in a natural way. We show that Sbi rapidly triggers the alternative complement pathway through recruitment of complement regulators, forming a tripartite complex that acts as a competitive antagonist of factor H, resulting in enhanced complement consumption. These functional results are corroborated by the structure of this complement activating Sbi-III-IV:C3d:FHR-1 complex. Finally, we demonstrate that Sbi, fused with Mycobacterium tuberculosis antigen Ag85b, causes efficient opsonisation with C3 fragments, thereby enhancing the immune response significantly beyond that of Ag85b alone, providing proof of concept for our pro-vaccine approach.
]]></description>
<dc:creator>Yang, Y.</dc:creator>
<dc:creator>Back, C.</dc:creator>
<dc:creator>Graewert, M.</dc:creator>
<dc:creator>Wahid, A.</dc:creator>
<dc:creator>Denton, H.</dc:creator>
<dc:creator>Kildani, R.</dc:creator>
<dc:creator>Paulin, J.</dc:creator>
<dc:creator>Woerner, K.</dc:creator>
<dc:creator>Kaiser, W.</dc:creator>
<dc:creator>Svergun, D. I.</dc:creator>
<dc:creator>Sartbaeva, A.</dc:creator>
<dc:creator>Watts, A.</dc:creator>
<dc:creator>Marchbank, K.</dc:creator>
<dc:creator>van den Elsen, J. M.</dc:creator>
<dc:date>2018-09-10</dc:date>
<dc:identifier>doi:10.1101/413294</dc:identifier>
<dc:title><![CDATA[Utilisation of staphylococcal immune evasion protein Sbi as a novel vaccine adjuvant]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/411173?rss=1">
<title>
<![CDATA[
Effect of Sec61 interaction with Mpd1 on Endoplasmic Reticulum-Associated Degradation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/411173?rss=1</link>
<description><![CDATA[
Proteins that misfold in the endoplasmic reticulum (ER) are transported back to the cytosol for ER-associated degradation (ERAD). The Sec61 channel is one of the candidates for the retrograde transport conduit. Channel opening from the ER lumen must be triggered by ERAD factors and substrates. Here we identified new lumenal interaction partners of Sec61 by chemical crosslinking and mass spectrometry. In addition to known Sec61 interactors we detected ERAD factors including Cue1, Ubc6, Ubc7, Asi3, and Mpd1. We show that the CPY* ERAD factor Mpd1 binds to the lumenal Sec61 hinge region. Deletion of the Mpd1 binding site reduced the interaction between both proteins and caused an ERAD defect specific for CPY* without affecting protein import into the ER or ERAD of other substrates. Our data suggest that Mpd1 binding to Sec61 is a prerequisite for CPY* ERAD and confirm a role of Sec61 in ERAD of misfolded secretory proteins.
]]></description>
<dc:creator>Pereira, F.</dc:creator>
<dc:creator>Rettel, M.</dc:creator>
<dc:creator>Stein, F.</dc:creator>
<dc:creator>Savitski, M. M.</dc:creator>
<dc:creator>Collinson, I.</dc:creator>
<dc:creator>Romisch, K.</dc:creator>
<dc:date>2018-09-07</dc:date>
<dc:identifier>doi:10.1101/411173</dc:identifier>
<dc:title><![CDATA[Effect of Sec61 interaction with Mpd1 on Endoplasmic Reticulum-Associated Degradation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/409151?rss=1">
<title>
<![CDATA[
PhenoMeNal: Processing and analysis of Metabolomics data in the Cloud 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/409151?rss=1</link>
<description><![CDATA[
BackgroundMetabolomics is the comprehensive study of a multitude of small molecules to gain insight into an organisms metabolism. The research field is dynamic and expanding with applications across biomedical, biotechnological and many other applied biological domains. Its computationally-intensive nature has driven requirements for open data formats, data repositories and data analysis tools. However, the rapid progress has resulted in a mosaic of independent - and sometimes incompatible - analysis methods that are difficult to connect into a useful and complete data analysis solution.nnFindingsThe PhenoMeNal (Phenome and Metabolome aNalysis) e-infrastructure provides a complete, workflow-oriented, interoperable metabolomics data analysis solution for a modern infrastructure-as-a-service (IaaS) cloud platform. PhenoMeNal seamlessly integrates a wide array of existing open source tools which are tested and packaged as Docker containers through the projects continuous integration process and deployed based on a kubernetes orchestration framework. It also provides a number of standardized, automated and published analysis workflows in the user interfaces Galaxy, Jupyter, Luigi and Pachyderm.nnConclusionsPhenoMeNal constitutes a keystone solution in cloud infrastructures available for metabolomics. It provides scientists with a ready-to-use, workflow-driven, reproducible and shareable data analysis platform harmonizing the software installation and configuration through user-friendly web interfaces. The deployed cloud environments can be dynamically scaled to enable large-scale analyses which are interfaced through standard data formats, versioned, and have been tested for reproducibility and interoperability. The flexible implementation of PhenoMeNal allows easy adaptation of the infrastructure to other application areas and  omics research domains.
]]></description>
<dc:creator>Peters, K.</dc:creator>
<dc:creator>Bradbury, J.</dc:creator>
<dc:creator>Bergmann, S.</dc:creator>
<dc:creator>Capuccini, M.</dc:creator>
<dc:creator>Cascante, M.</dc:creator>
<dc:creator>de Atauri, P.</dc:creator>
<dc:creator>Ebbels, T.</dc:creator>
<dc:creator>Foguet, C.</dc:creator>
<dc:creator>Glen, R.</dc:creator>
<dc:creator>Gonzalez-Beltran, A.</dc:creator>
<dc:creator>Handakas, E.</dc:creator>
<dc:creator>Hankemeier, T.</dc:creator>
<dc:creator>Herman, S.</dc:creator>
<dc:creator>Haug, K.</dc:creator>
<dc:creator>Holub, P.</dc:creator>
<dc:creator>Izzo, M.</dc:creator>
<dc:creator>Jacob, D.</dc:creator>
<dc:creator>Johnson, D.</dc:creator>
<dc:creator>Jourdan, F.</dc:creator>
<dc:creator>Kale, N.</dc:creator>
<dc:creator>Karaman, I.</dc:creator>
<dc:creator>Khalili, B.</dc:creator>
<dc:creator>Emami Khoonsari, P.</dc:creator>
<dc:creator>Kultima, K.</dc:creator>
<dc:creator>Lampa, S.</dc:creator>
<dc:creator>Larsson, A.</dc:creator>
<dc:creator>Moreno, P.</dc:creator>
<dc:creator>Neumann, S.</dc:creator>
<dc:creator>Novella, J. A.</dc:creator>
<dc:creator>O'Donovan, C.</dc:creator>
<dc:creator>Pearce, J. T.</dc:creator>
<dc:creator>Peluso, A.</dc:creator>
<dc:creator>Pireddu, L.</dc:creator>
<dc:creator>Piras, M. E.</dc:creator>
<dc:creator>Reed, M. A.</dc:creator>
<dc:creator>Rocca-Serra, P.</dc:creator>
<dc:creator>Roger, P.</dc:creator>
<dc:creator>Rosato, A.</dc:creator>
<dc:creator>Rueedi, R.</dc:creator>
<dc:creator>Ruttkies, C.</dc:creator>
<dc:creator>Sadawi, N.</dc:creator>
<dc:creator>Salek, R.</dc:creator>
<dc:creator>Sansone, S.-A.</dc:creator>
<dc:creator>Selivanov, V.</dc:creator>
<dc:creator>Spjuth, O.</dc:creator>
<dc:creator></dc:creator>
<dc:date>2018-09-06</dc:date>
<dc:identifier>doi:10.1101/409151</dc:identifier>
<dc:title><![CDATA[PhenoMeNal: Processing and analysis of Metabolomics data in the Cloud]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/407031?rss=1">
<title>
<![CDATA[
Modeling of DNA methylation in cis reveals principles of chromatin folding in vivo in the absence of crosslinking and ligation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/407031?rss=1</link>
<description><![CDATA[
Mammalian chromosomes are folded into an intricate hierarchy of structural domains, within which topologically associating domains (TADs) and CTCF-associated loops partition the physical interactions between regulatory sequences. Current understanding of chromosome folding largely relies on chromosome conformation capture (3C)-based experiments, where chromosomal interactions are detected as ligation products after crosslinking of chromatin. To measure chromosome structure in vivo, quantitatively and without relying on crosslinking and ligation, we have implemented a new method named damC. DamC combines DNA-methylation based detection of chromosomal interactions with next-generation sequencing and a biophysical model of methylation kinetics. DamC performed in mouse embryonic stem cells provides the first in vivo validation of the existence of TADs and CTCF loops, confirms 3C-based measurements of the scaling of contact probabilities within TADs, and provides evidence that mammalian chromatin in vivo is essentially rigid below 5 kilobases. Combining damC with transposon-mediated genomic engineering shows that new loops can be formed between ectopically introduced and endogenous CTCF sites, which alters the partitioning of physical interactions within TADs. This establishes damC as a crosslinking-and ligation-free framework to measure and modify chromosome interactions combined with a solid theoretical background for rigorous data interpretation. This orthogonal approach to 3C validates the existence of key structural features of mammalian chromosomes and provides novel insights into how chromosome structure within TADs can be manipulated.
]]></description>
<dc:creator>Redolfi, J.</dc:creator>
<dc:creator>Zhan, Y.</dc:creator>
<dc:creator>Valdes, C.</dc:creator>
<dc:creator>Kryzhanovska, M.</dc:creator>
<dc:creator>Misteli Guerreiro, I.</dc:creator>
<dc:creator>Iesmantavicius, V.</dc:creator>
<dc:creator>Tiana, G.</dc:creator>
<dc:creator>Pollex, T.</dc:creator>
<dc:creator>Kind, J.</dc:creator>
<dc:creator>Smallwood, S.</dc:creator>
<dc:creator>de Laat, W.</dc:creator>
<dc:creator>Giorgetti, L.</dc:creator>
<dc:date>2018-09-03</dc:date>
<dc:identifier>doi:10.1101/407031</dc:identifier>
<dc:title><![CDATA[Modeling of DNA methylation in cis reveals principles of chromatin folding in vivo in the absence of crosslinking and ligation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-09-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/403543?rss=1">
<title>
<![CDATA[
Chromatin-dependent cryptic promoters encode alternative protein isoforms in yeast. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/403543?rss=1</link>
<description><![CDATA[
Cryptic transcription is widespread and generates a heterogeneous group of RNA molecules of unknown function. To improve our understanding of cryptic transcription, we investigated their transcription start site usage, chromatin organization and post-transcriptional consequences in Saccharomyces cerevisiae. We show that transcription start sites (TSSs) of chromatin-sensitive internal cryptic transcripts retain comparable features of canonical TSSs in terms of DNA sequence, directionality and chromatin accessibility. We degine the 5 and 3 boundaries of cryptic transcripts and show that, contrary to RNA degradation-sensitive ones, they often overlap with the end of the gene thereby using the canonical polyadenylation site and associate to polyribosomes. We show that chromatin-sensitive cryptic transcripts can be recognized by ribosomes and may produce truncated polypeptides from downstream, in-frame start codons. Finally, we congirm the presence of the predicted polypeptides by reanalyzing N-terminal proteomic datasets. Our work suggests that a fraction of chromatin-sensitive internal cryptic promoters are in fact alternative truncated mRNA isoforms. The expression of these chromatin-sensitive isoforms is conserved from yeast to human expanding the functional consequences of cryptic transcription and proteome complexity.
]]></description>
<dc:creator>Wei, W.</dc:creator>
<dc:creator>Hennig, B.</dc:creator>
<dc:creator>Wang, J.</dc:creator>
<dc:creator>Zhang, Y.</dc:creator>
<dc:creator>Chabbert, C. D.</dc:creator>
<dc:creator>Adjalley, S. H.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:creator>Pelechano, V.</dc:creator>
<dc:date>2018-08-29</dc:date>
<dc:identifier>doi:10.1101/403543</dc:identifier>
<dc:title><![CDATA[Chromatin-dependent cryptic promoters encode alternative protein isoforms in yeast.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-29</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/400275?rss=1">
<title>
<![CDATA[
Topological data analysis quantifies biological nano-structure from single molecule localization microscopy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/400275?rss=1</link>
<description><![CDATA[
The study of complex molecular organisation and nano-structure by localization based microscopy is limited by the available analysis tools. We present a segmentation protocol which, through the application of persistence based clustering, is capable of probing densely packed structures which vary in scale. An increase in segmentation performance over state-of-the-art methods is demonstrated. Moreover we employ persistent homology to move beyond clustering, and quantify the topological structure within data. This provides new information about the preserved shapes formed by molecular architecture. Our methods are flexible and we demonstrate this by applying them to receptor clustering in platelets, nuclear pore components and endocytic proteins. Both 2D and 3D implementations are provided within RSMLM, an R package for pointillist based analysis and batch processing of localization microscopy data.
]]></description>
<dc:creator>Pike, J. A.</dc:creator>
<dc:creator>Khan, A. O.</dc:creator>
<dc:creator>Pallini, C.</dc:creator>
<dc:creator>Thomas, S. G.</dc:creator>
<dc:creator>Mund, M.</dc:creator>
<dc:creator>Ries, J.</dc:creator>
<dc:creator>Poulter, N. S.</dc:creator>
<dc:creator>Styles, I. B.</dc:creator>
<dc:date>2018-08-26</dc:date>
<dc:identifier>doi:10.1101/400275</dc:identifier>
<dc:title><![CDATA[Topological data analysis quantifies biological nano-structure from single molecule localization microscopy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/396994?rss=1">
<title>
<![CDATA[
All four double-stranded RNA binding domains of Staufen2 contribute to efficient mRNA recognition and transcript localization 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/396994?rss=1</link>
<description><![CDATA[
Throughout metazoans, Staufen (Stau) proteins are core factors of mRNA localization particles. They consist of three to four double-stranded RNA binding domains (dsRBDs) and a C-terminal dsRBD-like domain. Mouse Staufen2 (mStau2) like Drosophila Stau (dmStau) contains four dsRBDs. Existing data suggest that only dsRBDs 3-4 are necessary and sufficient for mRNA binding. Here, we show that dsRBDs 1 and 2 of mStau2 bind RNA with similar affinities and kinetics as dsRBDs 3 and 4. While RNA binding by these tandem domains is transient, all four dsRBDs recognize their target RNAs with high stability. Rescue experiments in Drosophila oocytes demonstrate that mStau2 partially rescues dmStau-dependent mRNA localization. In contrast, a rescue with mStau2 bearing RNA-binding mutations in dsRBD1-2 fails, confirming the physiological relevance of our findings. In summary, our data show that the dsRBDs 1-2 play essential roles in the mRNA recognition and function of Stau- family proteins of different species.
]]></description>
<dc:creator>Heber, S.</dc:creator>
<dc:creator>Gaspar, I.</dc:creator>
<dc:creator>Tants, J.-N.</dc:creator>
<dc:creator>Günther, J.</dc:creator>
<dc:creator>Fernandez Moya, S. M.</dc:creator>
<dc:creator>Janowski, R.</dc:creator>
<dc:creator>Ephrussi, A.</dc:creator>
<dc:creator>Sattler, M.</dc:creator>
<dc:creator>Niessing, D.</dc:creator>
<dc:date>2018-08-21</dc:date>
<dc:identifier>doi:10.1101/396994</dc:identifier>
<dc:title><![CDATA[All four double-stranded RNA binding domains of Staufen2 contribute to efficient mRNA recognition and transcript localization]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/391920?rss=1">
<title>
<![CDATA[
Whole-head recording of chemosensory activity in the marine annelid Platynereis dumerilii 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/391920?rss=1</link>
<description><![CDATA[
Chemical detection is key to various behaviours in both marine and terrestrial animals. Marine species, though highly diverse, have been underrepresented so far in studies on chemosensory systems, and our knowledge mostly concerns the detection of airborne cues. A broader comparative approach is therefore desirable. Marine annelid worms with their rich behavioural repertoire represent attractive models for chemosensory studies. Here, we study the marine worm Platynereis dumerilii to provide the first comprehensive study of head chemosensory organ physiology in an annelid. By combining microfluidics and calcium imaging, we record neuronal activity in the entire head of early juveniles upon chemical stimulation. We find that Platynereis uses four types of organs to detect stimuli such as alcohols, esters, amino acids and sugars. Antennae, but not nuchal organs or palps as generally hypothesised in annelids, are the main chemosensory organs. We report chemically-evoked activity in possible downstream brain regions including the mushroom bodies, which are anatomically and molecularly similar to insect mushroom bodies. We conclude that chemosensation is a major sensory modality for marine annelids, and propose early Platynereis juveniles as a model to study annelid chemosensory systems.nnnnO_FIG O_LINKSMALLFIG WIDTH=184 HEIGHT=200 SRC="FIGDIR/small/391920_ufig1.gif" ALT="Figure 1">nView larger version (74K):norg.highwire.dtl.DTLVardef@4384corg.highwire.dtl.DTLVardef@10c2563org.highwire.dtl.DTLVardef@6a8a32org.highwire.dtl.DTLVardef@96f06c_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Chartier, T. F.</dc:creator>
<dc:creator>Deschamps, J.</dc:creator>
<dc:creator>Duerichen, W.</dc:creator>
<dc:creator>Jekely, G.</dc:creator>
<dc:creator>Arendt, D.</dc:creator>
<dc:date>2018-08-14</dc:date>
<dc:identifier>doi:10.1101/391920</dc:identifier>
<dc:title><![CDATA[Whole-head recording of chemosensory activity in the marine annelid Platynereis dumerilii]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/389619?rss=1">
<title>
<![CDATA[
Hydraulic control of embryo size, tissue shape and cell fate 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/389619?rss=1</link>
<description><![CDATA[
Size control is fundamental in tissue development and homeostasis1,2. While the role of cell proliferation in this process has been widely studied3, the mechanisms of organ size control and how it impacts cell fates remain elusive. Here, we use mouse blastocyst development as a model to unravel a key role of fluid-filled lumen in embryonic size control and cell fate specification. We find that during blastocyst expansion, there is a two-fold increase in the pressure of the lumen that translates into a concomitant increase in the cortical tension of trophectoderm (TE) cells lining the lumen. Increased cortical tension leads to vinculin mechanosensing and maturation of the functional tight junctions, thereby establishing a positive feedback loop to accommodate lumenal growth. However, when the cortical tension reaches a critical threshold, cell-cell adhesion cannot be sustained, and mitotic entry leads to a rupture of TE epithelium, fluid leakage and collapse of the blastocyst cavity. A simple theory of hydraulically-gated oscillations that integrates these feedback interactions recapitulates the evolution of cavity size and predicts the scaling of embryonic size with the tissue volume. Our theory further predicts that reduced cortical tension or disrupted tight junctions, and increased tissue stiffness lead to smaller embryonic size. These predictions are verified experimentally by embryological, pharmacological and genetic manipulations of the embryos. Remarkably, these changes to lumenal size, without a change in the tissue volume, lead to alteration of tissue architecture and cell fate. Overall, our study reveals how lumenal pressure and tissue mechanics control embryonic size at the tissue scale, that in turn couples to cell position and fate at the cellular scale.
]]></description>
<dc:creator>Chan, C. J.</dc:creator>
<dc:creator>Costanzo, M.</dc:creator>
<dc:creator>Ruiz-Herrero, T.</dc:creator>
<dc:creator>Monke, G.</dc:creator>
<dc:creator>Petrie, R.</dc:creator>
<dc:creator>Mahadevan, L.</dc:creator>
<dc:creator>Hiiragi, T.</dc:creator>
<dc:date>2018-08-10</dc:date>
<dc:identifier>doi:10.1101/389619</dc:identifier>
<dc:title><![CDATA[Hydraulic control of embryo size, tissue shape and cell fate]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/388579?rss=1">
<title>
<![CDATA[
Fluorescence-Based Detection of Fusion State on a Cryo-EM Grid using Correlated Cryo-Fluorescence and Cryo-Electron Microscopy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/388579?rss=1</link>
<description><![CDATA[
Correlated light and electron microscopy (CLEM) has become a popular technique for combining the protein-specific labeling of fluorescence with electron microscopy, both at room and cryogenic temperatures. Fluorescence applications at cryo-temperature have typically been limited to localization of tagged protein oligomers due to known issues of extended triplet state duration, spectral shifts, and reduced photon capture through cryo-CLEM objectives. Here, we consider fluorophore characteristics and behaviors that could enable more extended applications. We describe how dialkylcarbocanine DiD and its autoquenching by resonant energy transfer can be used to distinguish the fusion state of a lipid bilayer at cryo-temperatures. By adapting an established fusion assay to work under cryo-CLEM conditions, we identified areas of fusion between influenza virus-like particles and fluorescently labeled lipid vesicles on a cryo-EM grid. This result demonstrates that cryo-CLEM can be used to localize functions in addition to tagged proteins, and that fluorescence autoquenching by resonant energy transfer can be incorporated successfully into cryo-CLEM approaches. In the case of membrane fusion applications, this method provides both an orthogonal confirmation of functional state independent of the morphological description from cryo-EM and a way to bridge room-temperature kinetic assays and the cryo-EM images.
]]></description>
<dc:creator>Metskas, L. A.</dc:creator>
<dc:creator>Briggs, J. A. G.</dc:creator>
<dc:date>2018-08-10</dc:date>
<dc:identifier>doi:10.1101/388579</dc:identifier>
<dc:title><![CDATA[Fluorescence-Based Detection of Fusion State on a Cryo-EM Grid using Correlated Cryo-Fluorescence and Cryo-Electron Microscopy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/389502?rss=1">
<title>
<![CDATA[
Software tools for automated transmission electron microscopy 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/389502?rss=1</link>
<description><![CDATA[
In the recent years, electron microscopy in the life sciences has witnessed increasing demand for high-throughput data collection in both structural and cellular biology. We present a combination of software tools that enable automated acquisition guided by image analysis for a wide variety of Transmission Electron Microscopy applications. Using these tools, we demonstrate dose-reduction in single particle cryo-EM experiments, fully automated acquisition of every single cell in a plastic section and automated targeting of features on serial sections for 3D volume imaging even across multiple grids.
]]></description>
<dc:creator>Schorb, M.</dc:creator>
<dc:creator>Haberbosch, I.</dc:creator>
<dc:creator>Hagen, W.</dc:creator>
<dc:creator>Schwab, Y.</dc:creator>
<dc:creator>Mastronarde, D.</dc:creator>
<dc:date>2018-08-10</dc:date>
<dc:identifier>doi:10.1101/389502</dc:identifier>
<dc:title><![CDATA[Software tools for automated transmission electron microscopy]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/388538?rss=1">
<title>
<![CDATA[
Three-dimensional nanostructure of an intact microglia cell 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/388538?rss=1</link>
<description><![CDATA[
Microglia are non-neuronal cells of the myeloid lineage that invade and take up long-term residence in the brain during development (Ginhoux et al. 2010) and are increasingly implicated in neuronal maturation, homeostasis, and pathology (Bessis et al. 2007; Paolicelli et al. 2011; Li et al. 2012; Aguzzi et al. 2013, Cunningham 2013, Cunningham et al. 2013). Since the early twentieth century several methods for staining and visualizing microglia have been developed. Scientists in Ramon y Cajals group (Achucarro 1913, Rio-Hortega 1919) pioneered these methods and their work led to the christening of microglia as the third element of the nervous system, distinct from astrocytes and neurons. More recently, a combination of imaging, genetic, and immunological tools has been used to visualize microglia in living brain (Davalos et al. 2005; Nimmerjahn et al. 2005). It was found that microglia are highly motile under resting conditions and rapidly respond to injuries (Kettenmann et al. 2011) suggesting a role for microglia in both brain homeostasis and pathology. Transmission Electron microscopy (TEM) has provided crucial complementary information on microglia morphology and physiology but until recently EM analyses have been limited to single or limited serial section studies (Tremblay et al. 2010; Paolicelli et al. 2011; Schafer et al. 2012; Tremblay et al. 2012; Sipe et al. 2016). TEM studies were successful in defining a set of morphological criteria for microglia: a polygonal nucleus with peripheral condensed chromatin, a relatively small cytoplasm with abundant presence of rough endoplasmic reticulum (RER), and a large volume of lysosomes and inclusions in the perikaryon. Recent advances in volumetric electron microscopy techniques allow for 3D reconstruction of large samples at nanometer-resolution, thus opening up new avenues for the understanding of cell biology and architecture in intact tissues. At the same time, correlative light and electron microscopy (CLEM) techniques have been extended to 3D brain samples to help navigate and identify critical molecular landmarks within large EM volumes (Briggman and Denk 2006; Maco et al. 2013; Blazquez-Llorca et al. 2015, Bosch et al. 2015). Here we present the first volumetric ultrastructural reconstruction of an entire mouse hippocampal microglia using serial block face scanning electron microscopy (SBEM). Using CLEM we have ensured the inclusion of both large, small, and filopodial microglia processes. Segmentation of the dataset allowed us to carry out a comprehensive inventory of microglia cell structures, including vesicles, organelles, membrane protrusions, and processes. This study provides a reference that can serve as a data mining resource for investigating microglia cell biology.
]]></description>
<dc:creator>Bolasco, G.</dc:creator>
<dc:creator>Weinhard, L.</dc:creator>
<dc:creator>Boissonnet, T.</dc:creator>
<dc:creator>Neujahr, R.</dc:creator>
<dc:creator>Gross, C. T.</dc:creator>
<dc:date>2018-08-09</dc:date>
<dc:identifier>doi:10.1101/388538</dc:identifier>
<dc:title><![CDATA[Three-dimensional nanostructure of an intact microglia cell]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/386268?rss=1">
<title>
<![CDATA[
iProteinDB: an integrative database of Drosophila post-translational modifications 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/386268?rss=1</link>
<description><![CDATA[
Post-translational modification (PTM) serves as a regulatory mechanism for protein function, influencing stability, protein interactions, activity and localization, and is critical in many signaling pathways. The best characterized PTM is phosphorylation, whereby a phosphate is added to an acceptor residue, commonly serine, threonine and tyrosine. As proteins are often phosphorylated at multiple sites, identifying those sites that are important for function is a challenging problem. Considering that many phosphorylation sites may be non-functional, prioritizing evolutionarily conserved phosphosites provides a general strategy to identify the putative functional sites with regards to regulation and function. To facilitate the identification of conserved phosphosites, we generated a large-scale phosphoproteomics dataset from Drosophila embryos collected from six closely-related species. We built iProteinDB (https://www.flyrnai.org/tools/iproteindb/), a resource integrating these data with other high-throughput PTM datasets, including vertebrates, and manually curated information for Drosophila. At iProteinDB, scientists can view the PTM landscape for any Drosophila protein and identify predicted functional phosphosites based on a comparative analysis of data from closely-related Drosophila species. Further, iProteinDB enables comparison of PTM data from Drosophila to that of orthologous proteins from other model organisms, including human, mouse, rat, Xenopus laevis, Danio rerio, and Caenorhabditis elegans.
]]></description>
<dc:creator>Hu, Y.</dc:creator>
<dc:creator>Sopko, R.</dc:creator>
<dc:creator>Chung, V.</dc:creator>
<dc:creator>Studer, R. A.</dc:creator>
<dc:creator>Landry, S. D.</dc:creator>
<dc:creator>Liu, D.</dc:creator>
<dc:creator>Rabinow, L.</dc:creator>
<dc:creator>Gnad, F.</dc:creator>
<dc:creator>Beltrao, P.</dc:creator>
<dc:creator>Perrimon, N.</dc:creator>
<dc:date>2018-08-07</dc:date>
<dc:identifier>doi:10.1101/386268</dc:identifier>
<dc:title><![CDATA[iProteinDB: an integrative database of Drosophila post-translational modifications]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/385773?rss=1">
<title>
<![CDATA[
CausalTab: PSI-MITAB 2.8 updated format for signaling data representation and dissemination 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/385773?rss=1</link>
<description><![CDATA[
Combining multiple layers of information underlying biological complexity into a structured framework, and in particular deciphering the molecular mechanisms behind cellular phenotypes, represent two challenges in systems biology. A key task is the formalisation of such information in models describing how biological entities interact to mediate the response to external and internal signals. Several databases with signaling information, such as SIGNOR, SignaLink and IntAct, focus on capturing, organising and displaying signaling interactions by representing them as binary, causal relationships between biological entities. The curation efforts that build these individual databases demand a concerted effort to ensure interoperability among resources, through the development of a standardized exchange format, ontologies and controlled vocabularies supporting the domain of causal interactions. Aware of the enormous benefits of standardization efforts in the molecular interaction research field, representatives of the signalling network community agreed to extend the PSI-MI controlled vocabulary to include additional terms representing aspects of causal interactions. Here, we present a common standard for the representation and dissemination of signaling information: the PSI Causal Interaction tabular format (CausalTAB) which is an extension of the existing PSI-MI tab-delimited format, now designated MITAB2.8. We define the new term "causal interaction", and related child terms, which are children of the PSI-MI "molecular interaction" term. The new vocabulary terms in this extended PSI-MI format will enable systems biologists to model large-scale signaling networks more precisely and with higher coverage than before.
]]></description>
<dc:creator>Perfetto, L.</dc:creator>
<dc:creator>Acencio, M. L.</dc:creator>
<dc:creator>Bradley, G.</dc:creator>
<dc:creator>Cesareni, G.</dc:creator>
<dc:creator>del Toro, N.</dc:creator>
<dc:creator>Fazekas, D.</dc:creator>
<dc:creator>Hermjakob, H.</dc:creator>
<dc:creator>Korcsmaros, T.</dc:creator>
<dc:creator>Kuiper, M.</dc:creator>
<dc:creator>laegreid, A.</dc:creator>
<dc:creator>Lo Surdo, P.</dc:creator>
<dc:creator>Lovering, R. C.</dc:creator>
<dc:creator>Orchard, S.</dc:creator>
<dc:creator>Porras, P.</dc:creator>
<dc:creator>Thomas, P. D.</dc:creator>
<dc:creator>Toure, V.</dc:creator>
<dc:creator>Zobolas, J.</dc:creator>
<dc:creator>Licata, L.</dc:creator>
<dc:date>2018-08-06</dc:date>
<dc:identifier>doi:10.1101/385773</dc:identifier>
<dc:title><![CDATA[CausalTab: PSI-MITAB 2.8 updated format for signaling data representation and dissemination]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-08-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/381335?rss=1">
<title>
<![CDATA[
In silico prioritization of transporter-drug relationships from drug sensitivity screens 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/381335?rss=1</link>
<description><![CDATA[
The interplay between drugs and cell metabolism is a key factor in determining both compound potency and toxicity. In particular, how and to what extent transmembrane transporters affect drug uptake and disposition is currently only partially understood. Most transporter proteins belong to two protein families: the ATP-Binding Cassette (ABC) transporter family, whose members are often involved in xenobiotic efflux and drug resistance, and the large and heterogeneous family of Solute carriers (SLCs). We recently argued that SLCs are collectively a rather neglected gene group, with most of its members still poorly characterized, and thus likely to include many yet-to-be-discovered associations with drugs. We searched publicly available resources and literature to define the currently known set of drugs transported by ABCs or SLCs, which involved ~500 drugs and more than 100 transporters. In order to extend this set, we then mined the largest publicly available pharmacogenomics dataset, which involves approximately 1000 molecularly annotated cancer cell lines and their response to 265 chemical compounds, and used regularized linear regression models (Elastic Net, LASSO) to predict drug responses based on SLC and ABC data (expression levels, SNVs, CNVs). The most predictive models included both known and previously unidentified associations between drugs and transporters. To our knowledge, this represents the first application of regularized linear regression to this set of genes, providing an extensive prioritization of potentially pharmacologically interesting interactions.
]]></description>
<dc:creator>Cesar-Razquin, A.</dc:creator>
<dc:creator>Girardi, E.</dc:creator>
<dc:creator>Yang, M.</dc:creator>
<dc:creator>Brehme, M.</dc:creator>
<dc:creator>Saez-Rodriguez, J.</dc:creator>
<dc:creator>Superti-Furga, G.</dc:creator>
<dc:date>2018-07-31</dc:date>
<dc:identifier>doi:10.1101/381335</dc:identifier>
<dc:title><![CDATA[In silico prioritization of transporter-drug relationships from drug sensitivity screens]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/381830?rss=1">
<title>
<![CDATA[
The Integrated Rapid Infectious Disease Analysis (IRIDA) Platform 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/381830?rss=1</link>
<description><![CDATA[
Whole genome sequencing (WGS) is a powerful tool for public health infectious disease investigations owing to its higher resolution, greater efficiency, and cost-effectiveness over traditional genotyping methods. Implementation of WGS in routine public health microbiology laboratories is impeded by a lack of user-friendly automated and semi-automated pipelines, restrictive jurisdictional data sharing policies, and the proliferation of non-interoperable analytical and reporting systems. To address these issues, we developed the Integrated Rapid Infectious Disease Analysis (IRIDA) platform (irida.ca), a user-friendly, decentralized, open-source bioinformatics and analytical web platform to support real-time infectious disease outbreak investigations using WGS data. Instances can be independently installed on local high-performance computing infrastructure, enabling private and secure data management and analyses according to organizational policies and governance. IRIDAs data management capabilities enable secure upload, storage and sharing of all WGS data and metadata. The core platform currently includes pipelines for quality control, assembly, annotation, variant detection, phylogenetic analysis, in silico serotyping, multi-locus sequence typing, and genome distance calculation. Analysis pipeline results can be visualized within the platform through dynamic line lists and integrated phylogenomic clustering for research and discovery, and for enhancing decision-making support and hypothesis generation in epidemiological investigations. Communication and data exchange between instances are provided through customizable access controls. IRIDA complements centralized systems, empowering local analytics and visualizations for genomics-based microbial pathogen investigations. IRIDA is currently transforming the Canadian public health ecosystem and is freely available at https://github.com/phac-nml/irida and www.irida.ca.nnImpact StatementWhole genome sequencing (WGS) is revolutionizing infectious disease analysis and surveillance due to its cost effectiveness, utility, and improved analytical power. To date, no "one-size-fits-all" genomics platform has been universally adopted, owing to differences in national (and regional) health information systems, data sharing policies, computational infrastructures, lack of interoperability and prohibitive costs. The Integrated Rapid Infectious Disease Analysis (IRIDA) platform is a user-friendly, decentralized, open-source bioinformatics and analytical web platform developed to support real-time infectious disease outbreak investigations using WGS data. IRIDA empowers public health, regulatory and clinical microbiology laboratory personnel to better incorporate WGS technology into routine operations by shielding them from the computational and analytical complexities of big data genomics. IRIDA is now routinely used as part of a validated suite of tools to support outbreak investigations in Canada. While IRIDA was designed to serve the needs of the Canadian public health system, it is generally applicable to any public health and multi-jurisdictional environment. IRIDA enables localized analyses but provides mechanisms and standard outputs to enable data sharing. This approach can help overcome pervasive challenges in real-time global infectious disease surveillance, investigation and control, resulting in faster responses, and ultimately, better public health outcomes.nnDATA SUMMARYO_LIData used to generate some of the figures in this manuscript can be found in the NCBI BioProject PRJNA305824.nC_LI
]]></description>
<dc:creator>Matthews, T. C.</dc:creator>
<dc:creator>Bristow, F. R.</dc:creator>
<dc:creator>Griffiths, E. J.</dc:creator>
<dc:creator>Petkau, A.</dc:creator>
<dc:creator>Adam, J.</dc:creator>
<dc:creator>Dooley, D.</dc:creator>
<dc:creator>Kruczkiewicz, P.</dc:creator>
<dc:creator>Curatcha, J.</dc:creator>
<dc:creator>Cabral, J.</dc:creator>
<dc:creator>Fornika, D.</dc:creator>
<dc:creator>Winsor, G. L.</dc:creator>
<dc:creator>Courtot, M.</dc:creator>
<dc:creator>Bertelli, C.</dc:creator>
<dc:creator>Roudgar, A.</dc:creator>
<dc:creator>Feijao, P.</dc:creator>
<dc:creator>Mabon, P.</dc:creator>
<dc:creator>Enns, E.</dc:creator>
<dc:creator>Thiessen, J.</dc:creator>
<dc:creator>Keddy, A.</dc:creator>
<dc:creator>Isaac-Renton, J.</dc:creator>
<dc:creator>Gardy, J. L.</dc:creator>
<dc:creator>Tang, P.</dc:creator>
<dc:creator>The IRIDA Consortium,</dc:creator>
<dc:creator>Carrico, J. A.</dc:creator>
<dc:creator>Chindelevitch, L.</dc:creator>
<dc:creator>Chauve, C.</dc:creator>
<dc:creator>Graham, M. R.</dc:creator>
<dc:creator>McArthur, A. G.</dc:creator>
<dc:creator>Taboada, E. N.</dc:creator>
<dc:creator>Beiko, R. G.</dc:creator>
<dc:creator>Brinkman, F. S.</dc:creator>
<dc:creator>Hsiao, W. W.</dc:creator>
<dc:creator>Van Domselaar, G.</dc:creator>
<dc:date>2018-07-31</dc:date>
<dc:identifier>doi:10.1101/381830</dc:identifier>
<dc:title><![CDATA[The Integrated Rapid Infectious Disease Analysis (IRIDA) Platform]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/380907?rss=1">
<title>
<![CDATA[
A positive feedback loop drives centrosome maturation in flies 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/380907?rss=1</link>
<description><![CDATA[
Centrosomes are formed when mother centrioles recruit pericentriolar material (PCM) around themselves. The PCM expands dramatically as cells prepare to enter mitosis (a process termed centrosome maturation), but it is unclear how this expansion is achieved. In flies, Spd-2 and Cnn form an extensive scaffold around the mother centriole that recruits other components of the mitotic PCM, and the Polo-dependent phosphorylation of Cnn at the centrosome is crucial for scaffold assembly. Here we show that, like Cnn, Spd-2 is specifically phosphorylated at centrosomes. This phosphorylation appears to create multiple phosphorylated S-S/T(p) motifs that allow Spd-2 to recruit Polo to the expanding scaffold. If Spd-2 cannot recruit Polo to the expanding scaffold, the scaffold is initially assembled around the mother centriole, but it cannot expand outwards, and centrosome maturation fails. We conclude that Spd-2, Polo and Cnn cooperate to form a positive feedback loop that drives the dramatic expansion of the mitotic centrosome in flies.
]]></description>
<dc:creator>Alvarez Rodrigo, I.</dc:creator>
<dc:creator>Conduit, P. T.</dc:creator>
<dc:creator>Baumbach, J.</dc:creator>
<dc:creator>Novak, Z. A.</dc:creator>
<dc:creator>Aydogan, M. G.</dc:creator>
<dc:creator>Wainman, A.</dc:creator>
<dc:creator>Raff, J. W.</dc:creator>
<dc:date>2018-07-31</dc:date>
<dc:identifier>doi:10.1101/380907</dc:identifier>
<dc:title><![CDATA[A positive feedback loop drives centrosome maturation in flies]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/380238?rss=1">
<title>
<![CDATA[
Studying the fate of tumor extracellular vesicles at high spatio-temporal resolution using the zebrafish embryo 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/380238?rss=1</link>
<description><![CDATA[
Tumor extracellular vesicles (tumor EVs) mediate the communication between tumor and stromal cells mostly to the benefit of tumor progression. Notably, tumor EVs have been reported to travel in the blood circulation, reach specific distant organs and locally modify the microenvironment. However, visualizing these events in vivo still faces major hurdles. Here, we show a new method for tracking individual circulating tumor EVs in a living organism: we combine novel, bright and specific fluorescent membrane probes, MemBright, with the transparent zebrafish embryo as an animal model. We provide the first description of tumor EVs hemodynamic behavior and document their arrest before internalization. Using transgenic lines, we show that circulating tumor EVs are uptaken by endothelial cells and blood patrolling macrophages, but not by leukocytes, and subsequently stored in acidic degradative compartments. Finally, we prove that the MemBright can be used to follow naturally released tumor EVs in vivo. Overall, our study demonstrates the usefulness and prospects of zebrafish embryo to track tumor EVs in vivo.nnHighlightsO_LIMemBright, a new family of membrane probes, allows for bright and specific staining of EVsnC_LIO_LIZebrafish melanoma EVs are very similar to human and mouse melanoma EVs in morphology and protein contentnC_LIO_LIThe zebrafish embryo is an adapted model to precisely track tumor EVs dynamics and fate in a living organism from light to electron microscopynC_LIO_LICirculating tumor EVs are rapidly uptaken by endothelial cells and patrolling macrophagesnC_LIO_LICorrelated light and electron microscopy can be used in zebrafish to identify cells and compartments uptaking tumor EVsnC_LInnBlurbDispersion of tumor extracellular vesicles (EVs) throughout the body promotes tumor progression. However the behavior of tumor EVs in body fluids remains mysterious due to their small size and the absence of adapted animal model. Here we show that the zebrafish embryo can be used to track circulating tumor EVs in vivo and provide the first high-resolution description of their dissemination and uptake.
]]></description>
<dc:creator>Hyenne, V.</dc:creator>
<dc:creator>Ghoroghi, S.</dc:creator>
<dc:creator>Collot, M.</dc:creator>
<dc:creator>Harlepp, S.</dc:creator>
<dc:creator>Bauer, J.</dc:creator>
<dc:creator>Mercier, L.</dc:creator>
<dc:creator>Busnelli, I.</dc:creator>
<dc:creator>Lefebvre, O.</dc:creator>
<dc:creator>Fekonja, N.</dc:creator>
<dc:creator>Machado, P.</dc:creator>
<dc:creator>Bons, J.</dc:creator>
<dc:creator>Delalande, F.</dc:creator>
<dc:creator>Amor, A. I.</dc:creator>
<dc:creator>Silva, S. G.</dc:creator>
<dc:creator>Verweij, F. J.</dc:creator>
<dc:creator>Van Niel, G.</dc:creator>
<dc:creator>Schwab, Y.</dc:creator>
<dc:creator>Peinado, H.</dc:creator>
<dc:creator>Carapito, C.</dc:creator>
<dc:creator>Klymchenko, A. S.</dc:creator>
<dc:creator>Goetz, J. G.</dc:creator>
<dc:date>2018-07-30</dc:date>
<dc:identifier>doi:10.1101/380238</dc:identifier>
<dc:title><![CDATA[Studying the fate of tumor extracellular vesicles at high spatio-temporal resolution using the zebrafish embryo]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/372995?rss=1">
<title>
<![CDATA[
Identifying alternative splicing isoforms in the human proteome with small proteotranscriptomic databases 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/372995?rss=1</link>
<description><![CDATA[
RNA sequencing has led to the discovery of many transcript isoforms created by alternative splicing, but the translational status and functional significance of most alternative splicing events remain unknown. Here we applied a splice junction-centric approach to survey the landscape of protein alternative isoform expression in the human proteome. We focused on alternative splice events where pairs of splice junctions corresponding to included and excluded exons with appreciable read counts are translated together into selective protein sequence databases. Using this approach, we constructed tissue-specific FASTA databases from ENCODE RNA sequencing data, then reanalyzed splice junction peptides in existing mass spectrometry datasets across 10 human tissues (heart, lung, liver, pancreas, ovary, testis, colon, prostate, adrenal gland, and esophagus). Our analysis reidentified 1,108 non-canonical isoforms annotated in SwissProt. We further found 253 novel splice junction peptides in 212 genes that are not documented in the comprehensive Uniprot TrEMBL or Ensembl RefSeq databases. On a proteome scale, non-canonical isoforms differ from canonical sequences preferentially at sequences with heightened protein disorder, suggesting a functional consequence of alternative splicing on the proteome is the regulation of intrinsically disordered regions. We further observed examples where isoform-specific regions intersect with important cardiac protein phosphorylation sites. Our results reveal previously unidentified protein isoforms and may avail efforts to elucidate the functions of splicing events and expand the pool of observable biomarkers in profiling studies.

Acronyms and Abbreviations
]]></description>
<dc:creator>Lau, E.</dc:creator>
<dc:creator>Lam, M. P. Y.</dc:creator>
<dc:date>2018-07-27</dc:date>
<dc:identifier>doi:10.1101/372995</dc:identifier>
<dc:title><![CDATA[Identifying alternative splicing isoforms in the human proteome with small proteotranscriptomic databases]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/377358?rss=1">
<title>
<![CDATA[
Subdivision of ancestral scale genetic program underlies origin of feathers and avian scutate scales 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/377358?rss=1</link>
<description><![CDATA[
Birds and other reptiles possess a diversity of feather and scale-like skin appendages. Feathers are commonly assumed to have originated from ancestral scales in theropod dinosaurs. However, most birds also have scaled feet, indicating birds evolved the capacity to grow both ancestral and derived morphologies. This suggests a more complex evolutionary history than a simple linear transition between feathers and scales. We set out to investigate the evolution of feathers via the comparison of transcriptomes assembled from diverse skin appendages in chicken, emu, and alligator. Our data reveal that feathers and the overlapping  scutate scales of birds share more similar gene expression to each other, and to two types of alligator scales, than they do to the tuberculate  reticulate scales on bird footpads. Accordingly, we propose a history of skin appendage diversification, in which feathers and bird scutate scales arose from ancestral archosaur body scales, whereas reticulate scales arose earlier in tetrapod evolution. We also show that many "feather-specific genes" are also expressed in alligator scales. In-situ hybridization results in feather buds suggest that these genes represent ancestral scale genes that acquired novel roles in feather morphogenesis and were repressed in bird scales. Our findings suggest that the differential reuse, in feathers, and suppression, in bird scales, of genes ancestrally expressed in archosaur scales has been a key factor in the origin of feathers - and may represent an important mechanism for the origin of evolutionary novelties.
]]></description>
<dc:creator>Musser, J. M.</dc:creator>
<dc:creator>Wagner, G. P.</dc:creator>
<dc:creator>Liang, C.</dc:creator>
<dc:creator>Stabile, F. A.</dc:creator>
<dc:creator>Cloutier, A.</dc:creator>
<dc:creator>Baker, A. J.</dc:creator>
<dc:creator>Prum, R. O.</dc:creator>
<dc:date>2018-07-25</dc:date>
<dc:identifier>doi:10.1101/377358</dc:identifier>
<dc:title><![CDATA[Subdivision of ancestral scale genetic program underlies origin of feathers and avian scutate scales]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/377390?rss=1">
<title>
<![CDATA[
The USTC complex co-opts an ancient machinery to drive piRNA transcription in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/377390?rss=1</link>
<description><![CDATA[
Piwi-interacting RNAs (piRNAs) engage Piwi proteins to suppress transposons and non-self nucleic acids, maintain genome integrity, and are essential for fertility in a variety of organisms. In C. elegans most piRNA precursors are transcribed from two genomic clusters that contain thousands of individual piRNA transcription units. While a few genes have been shown to be required for piRNA biogenesis the mechanism of piRNA transcription remains elusive. Here we used functional proteomics approaches to identify an upstream sequence transcription complex (USTC) that is essential for piRNA biogenesis. The USTC complex contains PRDE-1, TOFU-4, TOFU-5 and SNPC-4. The USTC complex form a unique piRNA foci in germline nuclei and coat the piRNA cluster genomic loci. USTC factors associate with the Ruby motif just upstream of type I piRNA genes. USTC factors are also mutually dependent for binding to the piRNA clusters and to form the piRNA foci. Interestingly, USTC components bind differentially to piRNAs in the clusters and other non-coding RNA genes. These results reveal USTC as a striking example of the repurposing of a general transcription factor complex to aid in genome defence against transposons.
]]></description>
<dc:creator>Weng, C.</dc:creator>
<dc:creator>Kosalka, A.</dc:creator>
<dc:creator>Berkyurek, A. C.</dc:creator>
<dc:creator>Stempor, P.</dc:creator>
<dc:creator>Feng, X.</dc:creator>
<dc:creator>Mao, H.</dc:creator>
<dc:creator>Zeng, C.</dc:creator>
<dc:creator>Li, W.-J.</dc:creator>
<dc:creator>Yan, Y.-H.</dc:creator>
<dc:creator>Dong, M.-Q.</dc:creator>
<dc:creator>Zuliani, C.</dc:creator>
<dc:creator>Barabas, O.</dc:creator>
<dc:creator>Ahringer, J.</dc:creator>
<dc:creator>Guang, S.</dc:creator>
<dc:creator>Miska, E.</dc:creator>
<dc:date>2018-07-25</dc:date>
<dc:identifier>doi:10.1101/377390</dc:identifier>
<dc:title><![CDATA[The USTC complex co-opts an ancient machinery to drive piRNA transcription in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/375345?rss=1">
<title>
<![CDATA[
Kipoi: accelerating the community exchange and reuse of predictive models for genomics 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/375345?rss=1</link>
<description><![CDATA[
Advanced machine learning models applied to large-scale genomics datasets hold the promise to be major drivers for genome science. Once trained, such models can serve as a tool to probe the relationships between data modalities, including the effect of genetic variants on phenotype. However, lack of standardization and limited accessibility of trained models have hampered their impact in practice. To address this, we present Kipoi, a collaborative initiative to define standards and to foster reuse of trained models in genomics. Already, the Kipoi repository contains over 2,000 trained models that cover canonical prediction tasks in transcriptional and post-transcriptional gene regulation. The Kipoi model standard grants automated software installation and provides unified interfaces to apply and interpret models. We illustrate Kipoi through canonical use cases, including model benchmarking, transfer learning, variant effect prediction, and building new models from existing ones. By providing a unified framework to archive, share, access, use, and build on models developed by the community, Kipoi will foster the dissemination and use of machine learning models in genomics.
]]></description>
<dc:creator>Avsec, Z.</dc:creator>
<dc:creator>Kreuzhuber, R.</dc:creator>
<dc:creator>Israeli, J.</dc:creator>
<dc:creator>Xu, N.</dc:creator>
<dc:creator>Cheng, J.</dc:creator>
<dc:creator>Shrikumar, A.</dc:creator>
<dc:creator>Banerjee, A.</dc:creator>
<dc:creator>Kim, D. S.</dc:creator>
<dc:creator>Urban, L.</dc:creator>
<dc:creator>Kundaje, A.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Gagneur, J.</dc:creator>
<dc:date>2018-07-24</dc:date>
<dc:identifier>doi:10.1101/375345</dc:identifier>
<dc:title><![CDATA[Kipoi: accelerating the community exchange and reuse of predictive models for genomics]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/374546?rss=1">
<title>
<![CDATA[
Thresholding of cryo-EM density maps by false discovery rate control 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/374546?rss=1</link>
<description><![CDATA[
Cryo-EM now commonly generates close-to-atomic resolution as well as intermediate resolution maps from macromolecules observed in isolation and in situ. Interpreting these maps remains a challenging task due to poor signal in the highest resolution shells and the necessity to select a threshold for density analysis. In order to facilitate this process, we developed a statistical framework for the generation of confidence maps by multiple hypothesis testing and false discovery rate (FDR) control. In this way, 3D confidence maps contain separated signal from background noise in the form of local detection rates of EM density values. We demonstrate that confidence maps and FDR-based thresholding can be used for the interpretation of near-atomic resolution single-particle structures as well as lower resolution maps determined by subtomogram averaging. Confidence maps represent a conservative way of interpreting molecular structures due to minimized noise. At the same time they provide a detection error with respect to background noise, which is associated with the density and particularly beneficial for the interpretation of weaker cryo-EM densities in cases of conformational flexibility and lower occupancy of bound molecules and ions to the structure.
]]></description>
<dc:creator>Beckers, M.</dc:creator>
<dc:creator>Jakobi, A.</dc:creator>
<dc:creator>Sachse, C.</dc:creator>
<dc:date>2018-07-23</dc:date>
<dc:identifier>doi:10.1101/374546</dc:identifier>
<dc:title><![CDATA[Thresholding of cryo-EM density maps by false discovery rate control]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/375097?rss=1">
<title>
<![CDATA[
PathwayMatcher: multi-omics pathway mapping and proteoform network generation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/375097?rss=1</link>
<description><![CDATA[
BackgroundMapping biomedical data to functional knowledge is an essential task in bioinformatics and can be achieved by querying identifiers, e.g. gene sets, in pathway knowledgebases. However, the isoform and post-translational modification states of proteins are lost when converting input and pathways into gene-centric lists.nnFindingsBased on the Reactome knowledgebase, we built a network of protein-protein interactions accounting for the documented isoform and modification statuses of proteins. We then implemented a command line application called PathwayMatcher (github.com/PathwayAnalysisPlatform/PathwayMatcher) to query this network. PathwayMatcher supports multiple types of omics data as input, and outputs the possibly affected biochemical reactions, subnetworks, and pathways.nnConclusionsPathwayMatcher enables refining the network-representation of pathways by including isoform and post-translational modifications. The specificity of pathway analyses is hence adapted to different levels of granularity and it becomes possible to distinguish interactions between different forms of the same protein.
]]></description>
<dc:creator>Hernandez Sanchez, L. F.</dc:creator>
<dc:creator>Burger, B.</dc:creator>
<dc:creator>Horro, C.</dc:creator>
<dc:creator>Fabregat, A.</dc:creator>
<dc:creator>Johansson, S.</dc:creator>
<dc:creator>Njolstad, P. R.</dc:creator>
<dc:creator>Barsnes, H.</dc:creator>
<dc:creator>Hermjakob, H.</dc:creator>
<dc:creator>Vaudel, M.</dc:creator>
<dc:date>2018-07-23</dc:date>
<dc:identifier>doi:10.1101/375097</dc:identifier>
<dc:title><![CDATA[PathwayMatcher: multi-omics pathway mapping and proteoform network generation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-23</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/373845?rss=1">
<title>
<![CDATA[
Non-Parametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-Binding Proteins 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/373845?rss=1</link>
<description><![CDATA[
Detecting the targets of drugs and other molecules in intact cellular contexts is a major objective in drug discovery and in biology more broadly. Thermal proteome profiling (TPP) pursues this aim at proteome-wide scale by inferring target engagement from its effects on temperature-dependent protein denaturation. However, a key challenge of TPP is the statistical analysis of the measured melting curves with controlled false discovery rates at high proteome coverage and detection power. We present non-parametric analysis of response curves (NPARC), a statistical method for TPP based on functional data analysis and nonlinear regression. We evaluate NPARC on five independent TPP datasets and observe that it is able to detect subtle changes in any region of the melting curves, reliably detects the known targets, and outperforms a melting point-centric, single-parameter fitting approach in terms of specificity and sensitivity. NPARC can be combined with established analysis of variance (ANOVA) statistics and enables flexible, factorial experimental designs and replication levels. To facilitate access to a wide range of users, a freely available software implementation of NPARC is provided.
]]></description>
<dc:creator>Childs, D.</dc:creator>
<dc:creator>Bach, K.</dc:creator>
<dc:creator>Franken, H.</dc:creator>
<dc:creator>Anders, S.</dc:creator>
<dc:creator>Kurzawa, N.</dc:creator>
<dc:creator>Bantscheff, M.</dc:creator>
<dc:creator>Mikhail, S.</dc:creator>
<dc:creator>Huber, W.</dc:creator>
<dc:date>2018-07-22</dc:date>
<dc:identifier>doi:10.1101/373845</dc:identifier>
<dc:title><![CDATA[Non-Parametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-Binding Proteins]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/367755?rss=1">
<title>
<![CDATA[
NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/367755?rss=1</link>
<description><![CDATA[
NGLess is a domain specific language for describing next-generation sequence processing pipelines. It was developed with the goal of enabling user-friendly computational reproducibility.nnUsing this framework, we developed NG-meta-profiler, a fast profiler for metagenomes which performs sequence preprocessing, mapping to bundled databases, filtering of the mapping results, and profiling (taxonomic and functional). It is significantly faster than either MOCAT2 or htseq-count and (as it builds on NGLess) its results are perfectly reproducible. These pipelines can easily be customized and extended with other tools.nnNGLess and NG-meta-profiler are open source software (under the liberal MIT licence) and can be downloaded from http://ngless.embl.de or installed through bioconda.
]]></description>
<dc:creator>Coelho, L. P.</dc:creator>
<dc:creator>Alves, R.</dc:creator>
<dc:creator>Monteiro, P.</dc:creator>
<dc:creator>Huerta-Cepas, J.</dc:creator>
<dc:creator>Freitas, A. T.</dc:creator>
<dc:creator>Bork, P.</dc:creator>
<dc:date>2018-07-13</dc:date>
<dc:identifier>doi:10.1101/367755</dc:identifier>
<dc:title><![CDATA[NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/368498?rss=1">
<title>
<![CDATA[
Quantification of differential transcription factor activity and multiomic-based classification into activators and repressors: diffTF 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/368498?rss=1</link>
<description><![CDATA[
Transcription factor (TF) activity is an important read-out of cellular signalling pathways and thus to assess regulatory differences across conditions. However, current technologies lack the ability to simultaneously assess activity changes for multiple TFs and in particular to determine whether a specific TF acts globally as transcriptional repressor or activator. To this end, we introduce a widely applicable genome-wide method diffTF to assess differential TF activity and to classify TFs as activator or repressor (available at https://git.embl.de/grp-zaugg/diffTF). This is done by integrating any type of genome-wide chromatin accessibility data with RNA-Seq data and in-silico predicted TF binding sites. We corroborated the classification of TFs into repressors and activators by three independent analyses based on enrichments of active/repressive chromatin states, correlation of TF activity with gene expression, and activator-and repressor-specific chromatin footprints. To show the power of diffTF, we present two case studies: First, we applied diffTF in to a large ATAC-Seq/RNA-Seq dataset comparing mutated and unmutated chronic lymphocytic leukemia samples, where we identified dozens of known (40%) and potentially novel (60%) TFs that are differentially active. We were also able to classify almost half of them as either repressor and activator. Second, we applied diffTF to a small ATAC-Seq/RNA-Seq data set comparing two cell types along the hematopoietic differentiation trajectory (multipotent progenitors - MPP - versus granulocyte-macrophage progenitors - GMP). Here we identified the known drivers of differentiation and found that the majority of the differentially active TFs are transcriptional activators. Overall, diffTF was able to recover the known TFs in both case studies, additionally identified TFs that have been less well characterized in the given condition, and provides a classification of the TFs into transcriptional activators and repressors.
]]></description>
<dc:creator>Berest, I.</dc:creator>
<dc:creator>Arnold, C.</dc:creator>
<dc:creator>Reyes-Palomares, A.</dc:creator>
<dc:creator>Palla, G.</dc:creator>
<dc:creator>Rasmussen, K. D.</dc:creator>
<dc:creator>Helin, K.</dc:creator>
<dc:creator>Zaugg, J.</dc:creator>
<dc:date>2018-07-13</dc:date>
<dc:identifier>doi:10.1101/368498</dc:identifier>
<dc:title><![CDATA[Quantification of differential transcription factor activity and multiomic-based classification into activators and repressors: diffTF]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/364117?rss=1">
<title>
<![CDATA[
Conserved SQ and QS motifs in bacterial effectors suggest pathogen interplay with the ATM kinase family during infection 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/364117?rss=1</link>
<description><![CDATA[
Understanding how bacteria hijack eukaryotic cells during infection is vital to develop better strategies to counter the pathologies that they cause. ATM kinase family members phosphorylate eukaryotic protein substrates on Ser or Thr residues followed by Gln. The kinases are active under oxidative stress conditions and/or the presence of ds-DNA breaks. While examining the protein sequences of well-known bacterial effector proteins such as CagA and Tir, we noticed that they often show conserved (S/TQ) motifs, even though the evidence for effector phosphorylation by ATM has not been reported. We undertook a bioinformatics analysis to examine effectors for their potential to mimic the eukaryotic substrates of the ATM kinase. The candidates we found could interfere with the hosts intracellular signaling network upon interaction, which might give an advantage to the pathogen inside the host. Further, the putative phosphorylation sites should be accessible, conserved across species and, in the vicinity to the phosphorylation sites, positively charged residues should be depleted. We also noticed that the reverse motif (QT/S) is often also conserved and located close to (S/TQ) sites, indicating its potential biological role in ATM kinase function. Our findings could suggest a mechanism of infection whereby many pathogens inactivate/modulate the host ATM signaling pathway.
]]></description>
<dc:creator>Sampietro, D.</dc:creator>
<dc:creator>Samano-Sanchez, H.</dc:creator>
<dc:creator>Davey, N. E.</dc:creator>
<dc:creator>Sharan, M.</dc:creator>
<dc:creator>Meszaros, B.</dc:creator>
<dc:creator>Gibson, T. J.</dc:creator>
<dc:creator>Kumar, M.</dc:creator>
<dc:date>2018-07-09</dc:date>
<dc:identifier>doi:10.1101/364117</dc:identifier>
<dc:title><![CDATA[Conserved SQ and QS motifs in bacterial effectors suggest pathogen interplay with the ATM kinase family during infection]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/363028?rss=1">
<title>
<![CDATA[
Transposon silencing in the Drosophila female germline ensures genome stability in progeny embryos 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/363028?rss=1</link>
<description><![CDATA[
The piRNA pathway functions in transposon control in the germ line of metazoans. The conserved RNA helicase Vasa is an essential piRNA pathway component, but has additional important developmental functions. Here we address the importance of Vasa-dependent transposon control in the Drosophila female germline and early embryos. We find that transient loss of vasa expression during early oogenesis leads to transposon up-regulation in supporting nurse cells of the fly egg-chamber. We show that elevated transposon levels have dramatic consequences, as de-repressed transposons accumulate in the oocyte where they cause DNA damage. We find that suppression of Chk2-mediated DNA damage signaling in vasa mutant females restores oogenesis and egg production. Damaged DNA and up-regulated transposons are transmitted from the mother to the embryos, which sustain severe nuclear defects and arrest development. Our findings reveal that the Vasa-dependent protection against selfish genetic elements in the nuage of nurse cell is essential to prevent DNA damage-induced arrest of embryonic development.
]]></description>
<dc:creator>Ephrussi, A.</dc:creator>
<dc:creator>Durdevic, Z.</dc:creator>
<dc:creator>Pillai, R. S.</dc:creator>
<dc:date>2018-07-05</dc:date>
<dc:identifier>doi:10.1101/363028</dc:identifier>
<dc:title><![CDATA[Transposon silencing in the Drosophila female germline ensures genome stability in progeny embryos]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/362517?rss=1">
<title>
<![CDATA[
Super-resolution fight club: A broad assessment of 2D & 3D single-molecule localization microscopy software 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/362517?rss=1</link>
<description><![CDATA[
With the widespread uptake of 2D and 3D single molecule localization microscopy, a large set of different data analysis packages have been developed to generate super-resolution images. To guide researchers on the optimal analytical software for their experiments, we have designed, in a large community effort, a competition to extensively characterise and rank these options. We generated realistic simulated datasets for popular imaging modalities - 2D, astigmatic 3D, biplane 3D, and double helix 3D - and evaluated 36 participant packages against these data. This provides the first broad assessment of 3D single molecule localization microscopy software, provides a holistic view of how the latest 2D and 3D single molecule localization software perform in realistic conditions, and ultimately provides insight into the current limits of the field.
]]></description>
<dc:creator>Sage, D.</dc:creator>
<dc:creator>Pham, T.-A.</dc:creator>
<dc:creator>Babcock, H.</dc:creator>
<dc:creator>Lukes, T.</dc:creator>
<dc:creator>Pengo, T.</dc:creator>
<dc:creator>Velmurugan, R.</dc:creator>
<dc:creator>Herbert, A.</dc:creator>
<dc:creator>Agarwal, A.</dc:creator>
<dc:creator>Colabrese, S.</dc:creator>
<dc:creator>Wheeler, A.</dc:creator>
<dc:creator>Archetti, A.</dc:creator>
<dc:creator>Rieger, B.</dc:creator>
<dc:creator>Ober, R.</dc:creator>
<dc:creator>Hagen, G. M.</dc:creator>
<dc:creator>Sibarita, J.-B.</dc:creator>
<dc:creator>Ries, J.</dc:creator>
<dc:creator>Henriques, R.</dc:creator>
<dc:creator>Unser, M.</dc:creator>
<dc:creator>Holden, S.</dc:creator>
<dc:date>2018-07-04</dc:date>
<dc:identifier>doi:10.1101/362517</dc:identifier>
<dc:title><![CDATA[Super-resolution fight club: A broad assessment of 2D & 3D single-molecule localization microscopy software]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/353136?rss=1">
<title>
<![CDATA[
Structural rearrangement of TFIIS- and TFIIF/TFIIE-like subunits in RNA polymerase I transcription complexes 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/353136?rss=1</link>
<description><![CDATA[
RNA polymerase (Pol) I is a 14-subunit enzyme that solely transcribes pre-ribosomal RNA. Cryo-EM structures of Pol I initiation and elongation complexes have given first insights into the molecular mechanisms of Pol I transcription. Here, we present cryo-electron microscopy structures of yeast Pol I elongation complexes (ECs) bound to the nucleotide analog GMPCPP at 3.2 to 3.4 [A] resolution that provide additional insight into the functional interplay between the TFIIE/TFIIF-like A49-A34.5 heterodimer and the TFIIS-like subunit A12.2 present in Pol I. Strikingly, most of the nucleotide-bound ECs lack the A49-A34.5 heterodimer and adopt a Pol II-like conformation, in which the A12.2 C-terminal domain is bound in a previously unobserved position at the A135 surface. Our work suggests a regulatory mechanism of Pol I transcription where the association of the A49-A34.5 heterodimer to Pol I is regulated by subunit A12.2, thereby explaining in vitro biochemical and kinetic data.
]]></description>
<dc:creator>Tafur, L.</dc:creator>
<dc:creator>Sadian, Y.</dc:creator>
<dc:creator>Wetzel, R.</dc:creator>
<dc:creator>Weis, F.</dc:creator>
<dc:creator>Muller, C. W.</dc:creator>
<dc:date>2018-07-03</dc:date>
<dc:identifier>doi:10.1101/353136</dc:identifier>
<dc:title><![CDATA[Structural rearrangement of TFIIS- and TFIIF/TFIIE-like subunits in RNA polymerase I transcription complexes]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/360602?rss=1">
<title>
<![CDATA[
Nearly all new protein-coding predictions in the CHESS database are not protein-coding 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/360602?rss=1</link>
<description><![CDATA[
In a 2018 paper posted to bioRxiv, Pertea et al. presented the CHESS database, a new catalog of human gene annotations that includes 1,178 new protein-coding predictions. These are based on evidence of transcription in human tissues and homology to earlier annotations in human and other mammals. Here, we reanalyze the evidence used by CHESS, and find that nearly all protein-coding predictions are false positives. We find that 86% overlap transposons marked by RepeatMasker that are known to frequently result in false positive protein-coding predictions. More than half are homologous to only nine Alu-derived primate sequences corresponding to an erroneous and previously withdrawn Pfam protein domain. The entire set shows poor evolutionary conservation and PhyloCSF protein-coding evolutionary signatures indistinguishable from noncoding RNAs, indicating lack of protein-coding constraint. Only four predictions are supported by mass spectrometry evidence, and even those matches are inconclusive. Overall, the new protein-coding predictions are unsupported by any credible experimental or evolutionary evidence of function, result primarily from homology to genes incorrectly classified as protein-coding, and are unlikely to encode functional proteins.
]]></description>
<dc:creator>Jungreis, I.</dc:creator>
<dc:creator>Tress, M. L.</dc:creator>
<dc:creator>Mudge, J.</dc:creator>
<dc:creator>Sisu, C.</dc:creator>
<dc:creator>Hunt, T.</dc:creator>
<dc:creator>Johnson, R.</dc:creator>
<dc:creator>Uszczynska-Ratajczak, B.</dc:creator>
<dc:creator>Lagarde, J.</dc:creator>
<dc:creator>Wright, J.</dc:creator>
<dc:creator>Muir, P.</dc:creator>
<dc:creator>Gerstein, M.</dc:creator>
<dc:creator>Guigo, R.</dc:creator>
<dc:creator>Kellis, M.</dc:creator>
<dc:creator>Frankish, A.</dc:creator>
<dc:creator>Flicek, P.</dc:creator>
<dc:creator>The GENCODE Consortium,</dc:creator>
<dc:date>2018-07-02</dc:date>
<dc:identifier>doi:10.1101/360602</dc:identifier>
<dc:title><![CDATA[Nearly all new protein-coding predictions in the CHESS database are not protein-coding]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-07-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/354316?rss=1">
<title>
<![CDATA[
Systematic Characterization of RhoGEF/RhoGAP Regulatory Proteins Reveals Organization Principles of Rho GTPase Signaling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/354316?rss=1</link>
<description><![CDATA[
Rho GTPases control cell morphogenesis and thus fundamental processes in all eukaryotes. They are regulated by 145 RhoGEF and RhoGAP multi-domain proteins in humans. How the Rho signaling system is organized to generate localized responses in cells and prevent their spreading is not understood. Here, we systematically characterized the substrate specificities, localization and interactome of the RhoGEFs/RhoGAPs and revealed their critical role in contextualizing and spatially delimiting Rho signaling. They localize to multiple compartments providing positional information, are extensively interconnected to jointly coordinate their signaling networks and are widely autoinhibited to remain sensitive to local activation. RhoGAPs exhibit lower substrate specificity than RhoGEFs and may contribute to preserving Rho activity gradients. Our approach led us to uncover a multi-RhoGEF complex downstream of G-protein-coupled receptors controlling a Cdc42/RhoA crosstalk. The spatial organization of Rho signaling thus differs from other small GTPases and expands the repertoire of mechanisms governing localized signaling activity.
]]></description>
<dc:creator>Rocks, O.</dc:creator>
<dc:creator>Mueller, P. M.</dc:creator>
<dc:creator>Rademacher, J.</dc:creator>
<dc:creator>Bagshaw, R. D.</dc:creator>
<dc:creator>Alp, K. M.</dc:creator>
<dc:creator>Giudice, G.</dc:creator>
<dc:creator>Heinrich, L. E.</dc:creator>
<dc:creator>Barth, C.</dc:creator>
<dc:creator>Eccles, R. L.</dc:creator>
<dc:creator>Sanchez-Castro, M.</dc:creator>
<dc:creator>Mbamalu, G.</dc:creator>
<dc:creator>Tucholska, M.</dc:creator>
<dc:creator>Spatt, L.</dc:creator>
<dc:creator>Wortmann, C.</dc:creator>
<dc:creator>Czajkowski, M. T.</dc:creator>
<dc:creator>Welke, R. W.</dc:creator>
<dc:creator>Zhang, S.</dc:creator>
<dc:creator>Nguyen, V.</dc:creator>
<dc:creator>Brandeburg, L.</dc:creator>
<dc:creator>Rrustemi, T.</dc:creator>
<dc:creator>Trnka, P.</dc:creator>
<dc:creator>Freitag, K.</dc:creator>
<dc:creator>Larsen, B.</dc:creator>
<dc:creator>Popp, O.</dc:creator>
<dc:creator>Colwill, K.</dc:creator>
<dc:creator>Mertins, P.</dc:creator>
<dc:creator>Gingras, A.-C.</dc:creator>
<dc:creator>Bakal, C.</dc:creator>
<dc:creator>Pertz, O.</dc:creator>
<dc:creator>Roth, F. P.</dc:creator>
<dc:creator>Pawson, T.</dc:creator>
<dc:creator>Petsalaki, E.</dc:creator>
<dc:date>2018-06-24</dc:date>
<dc:identifier>doi:10.1101/354316</dc:identifier>
<dc:title><![CDATA[Systematic Characterization of RhoGEF/RhoGAP Regulatory Proteins Reveals Organization Principles of Rho GTPase Signaling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-24</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/350991?rss=1">
<title>
<![CDATA[
Memote: A community-driven effort towards a standardized genome-scale metabolic model test suite 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/350991?rss=1</link>
<description><![CDATA[
Several studies have shown that neither the formal representation nor the functional requirements of genome-scale metabolic models (GEMs) are precisely defined. Without a consistent standard, comparability, reproducibility, and interoperability of models across groups and software tools cannot be guaranteed.nnHere, we present memote (https://github.com/opencobra/memote) an open-source software containing a community-maintained, standardized set of metabolic model tests. The tests cover a range of aspects from annotations to conceptual integrity and can be extended to include experimental datasets for automatic model validation. In addition to testing a model once, memote can be configured to do so automatically, i.e., while building a GEM. A comprehensive report displays the models performance parameters, which supports informed model development and facilitates error detection.nnMemote provides a measure for model quality that is consistent across reconstruction platforms and analysis software and simplifies collaboration within the community by establishing workflows for publicly hosted and version controlled models.
]]></description>
<dc:creator>Lieven, C.</dc:creator>
<dc:creator>Beber, M. E.</dc:creator>
<dc:creator>Olivier, B. G.</dc:creator>
<dc:creator>Bergmann, F. T.</dc:creator>
<dc:creator>Babaei, P.</dc:creator>
<dc:creator>Bartell, J. A.</dc:creator>
<dc:creator>Blank, L. M.</dc:creator>
<dc:creator>Chauhan, S.</dc:creator>
<dc:creator>Correia, K.</dc:creator>
<dc:creator>Diener, C.</dc:creator>
<dc:creator>Dräger, A.</dc:creator>
<dc:creator>Ebert, B. E.</dc:creator>
<dc:creator>Edirisinghe, J. N.</dc:creator>
<dc:creator>Fleming, R. M. T.</dc:creator>
<dc:creator>Garcia-Jimenez, B.</dc:creator>
<dc:creator>van Helvoirt, W.</dc:creator>
<dc:creator>Henry, C.</dc:creator>
<dc:creator>Hermjakob, H.</dc:creator>
<dc:creator>Herrgard, M. J.</dc:creator>
<dc:creator>Kim, H. U.</dc:creator>
<dc:creator>King, Z.</dc:creator>
<dc:creator>Koehorst, J. J.</dc:creator>
<dc:creator>Klamt, S.</dc:creator>
<dc:creator>Klipp, E.</dc:creator>
<dc:creator>Lakshmanan, M.</dc:creator>
<dc:creator>Le Novere, N.</dc:creator>
<dc:creator>Lee, D.-Y.</dc:creator>
<dc:creator>Lee, S. Y.</dc:creator>
<dc:creator>Lee, S.</dc:creator>
<dc:creator>Lewis, N. E.</dc:creator>
<dc:creator>Ma, H.</dc:creator>
<dc:creator>Machado, D.</dc:creator>
<dc:creator>Mahadevan, R.</dc:creator>
<dc:creator>Maia, P.</dc:creator>
<dc:creator>Mardinoglu, A.</dc:creator>
<dc:creator>Medlock, G. L.</dc:creator>
<dc:creator>Monk, J.</dc:creator>
<dc:creator>Nielsen, J.</dc:creator>
<dc:creator>Nielsen, L. K.</dc:creator>
<dc:creator>Nogales, J.</dc:creator>
<dc:creator>Nookaew, I.</dc:creator>
<dc:creator>Resendis, O.</dc:creator>
<dc:creator>Palsson, B.</dc:creator>
<dc:date>2018-06-21</dc:date>
<dc:identifier>doi:10.1101/350991</dc:identifier>
<dc:title><![CDATA[Memote: A community-driven effort towards a standardized genome-scale metabolic model test suite]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-21</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/350868?rss=1">
<title>
<![CDATA[
Staged developmental mapping and X chromosome transcriptional dynamics during mouse spermatogenesis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/350868?rss=1</link>
<description><![CDATA[
Understanding male fertility requires an in-depth characterisation of spermatogenesis, the developmental process by which male gametes are generated. Spermatogenesis occurs continuously throughout a males reproductive window and involves a complex sequence of developmental steps, both of which make this process difficult to decipher at the molecular level. To overcome this, we transcriptionally profiled single cells from multiple distinct stages during the first wave of spermatogenesis, where the most mature germ cell type is known. This naturally enriches for spermatogonia and somatic cell types present at very low frequencies in adult testes. Our atlas, available as a shiny app (https://marionilab.cruk.cam.ac.uk/SpermatoShiny), allowed us to reconstruct the three main processes of spermatogenesis: spermatogonial differentiation, meiosis, and spermiogenesis. Additionally, we profiled the chromatin changes associated with meiotic silencing of the X chromosome, revealing a set of genes specifically and strongly repressed by H3K9me3 in the spermatocyte stage, but which escape post-meiotic silencing in spermatids.
]]></description>
<dc:creator>Ernst, C.</dc:creator>
<dc:creator>Eling, N.</dc:creator>
<dc:creator>Martinez-Jimenez, C. P.</dc:creator>
<dc:creator>Marioni, J. C.</dc:creator>
<dc:creator>Odom, D. T.</dc:creator>
<dc:date>2018-06-20</dc:date>
<dc:identifier>doi:10.1101/350868</dc:identifier>
<dc:title><![CDATA[Staged developmental mapping and X chromosome transcriptional dynamics during mouse spermatogenesis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/351015?rss=1">
<title>
<![CDATA[
Xist lncRNA forms silencing granules that induce heterochromatin formation and repressive complexes recruitment by phase separation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/351015?rss=1</link>
<description><![CDATA[
Main text Main text Microscopy RNA Structure Protein-RNA interactions Granule propensity Material and methods in... References Long non-coding RNAs (lncRNAs) are RNA molecules longer than 200 bases that lack coding potential1,2. They represent a significant portion of the cell transcriptome3 and work as activators or repressors of gene transcription acting on different regulatory mechanisms4-6. Indeed, lncRNAs can act as macro-scaffolds for protein recruitment7-14 and behave as guides and sponges for titrating RNA and proteins, influencing transcription at regulatory regions or triggering transcriptional interfere ...
]]></description>
<dc:creator>Cerase, A.</dc:creator>
<dc:creator>Armaos, A.</dc:creator>
<dc:creator>Cid-Samper, F.</dc:creator>
<dc:creator>Avner, P.</dc:creator>
<dc:creator>Tartaglia, G. G.</dc:creator>
<dc:date>2018-06-20</dc:date>
<dc:identifier>doi:10.1101/351015</dc:identifier>
<dc:title><![CDATA[Xist lncRNA forms silencing granules that induce heterochromatin formation and repressive complexes recruitment by phase separation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-20</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/348433?rss=1">
<title>
<![CDATA[
Microbial adaptation to venom is common in snakes and spiders 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/348433?rss=1</link>
<description><![CDATA[
Animal venoms are considered sterile sources of antimicrobial compounds with strong membrane disrupting activity against multi-drug resistant bacteria. However, bite wound infections are common in developing nations. Investigating the oral and venom microbiome of five snake and two spider species, we evidence viable microorganisms potentially unique to venom for black-necked spitting cobras (Naja nigricollis). Among these are two venom-resistant novel sequence types of Enterococcus faecalis; the genome sequence data of these isolates feature an additional 45 genes, nearly half of which improve membrane integrity. Our findings challenge the dogma of venom sterility and indicate an increased primary infection risk in the clinical management of venomous animal bite wounds.

One Sentence SummaryIndependent bacterial colonization of cobra venom drives acquisition of genes antagonistic to venom antimicrobial peptides.
]]></description>
<dc:creator>Esmaeilishirazifard, E.</dc:creator>
<dc:creator>Usher, L.</dc:creator>
<dc:creator>Trim, C.</dc:creator>
<dc:creator>Denise, H.</dc:creator>
<dc:creator>Sangal, V.</dc:creator>
<dc:creator>Tyson, G. H.</dc:creator>
<dc:creator>Barlow, A.</dc:creator>
<dc:creator>Redway, K.</dc:creator>
<dc:creator>Taylor, J. D.</dc:creator>
<dc:creator>Kremmyda-Vlachou, M.</dc:creator>
<dc:creator>Loftus, T. D.</dc:creator>
<dc:creator>Lock, M. M. G.</dc:creator>
<dc:creator>Wright, K.</dc:creator>
<dc:creator>Dalby, A.</dc:creator>
<dc:creator>Snyder, L. A. S.</dc:creator>
<dc:creator>Wuster, W.</dc:creator>
<dc:creator>Trim, S.</dc:creator>
<dc:creator>Moschos, S. A.</dc:creator>
<dc:date>2018-06-16</dc:date>
<dc:identifier>doi:10.1101/348433</dc:identifier>
<dc:title><![CDATA[Microbial adaptation to venom is common in snakes and spiders]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/347625?rss=1">
<title>
<![CDATA[
Understanding trivial challenges of microbial genomics: An assembly example 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/347625?rss=1</link>
<description><![CDATA[
The perceived "simplicity" of bacterial genomics (these genomes are small and easy to assemble) feeds the decentralized state of the field where computational analysis standards have been slow to evolve. This situation has a historical explanation. In cases of human, mouse, fly, worm and other model organisms there have been large sustained multinational genome sequencing efforts and analysis consortia such as the 1,000 genomes, ENCODE, modENCODE, GTEx and others. These resulted in development and proliferation of common tools, workflows, and data standards. This is not the case in microbiology. After the development of highly parallel sequencing methodologies in mid-2000s bacterial genomes no longer required initiatives of such scale. The flipside of this is the extreme heterogeneity of approaches to many well established microbial genomic analysis problems such as genome assembly. While competition amongst different methods is good, we argue that the quality of data analyses will improve if cutting edge tools are more accessible and microbiologists become more computationally savvy. Here we use genome assembly as an example to highlight current challenges and to provide a possible solution.
]]></description>
<dc:creator>Lariviere, D.</dc:creator>
<dc:creator>Mei, H.</dc:creator>
<dc:creator>Freeberg, M.</dc:creator>
<dc:creator>Taylor, J.</dc:creator>
<dc:creator>Nekrutenko, A.</dc:creator>
<dc:date>2018-06-14</dc:date>
<dc:identifier>doi:10.1101/347625</dc:identifier>
<dc:title><![CDATA[Understanding trivial challenges of microbial genomics: An assembly example]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/346833?rss=1">
<title>
<![CDATA[
Capturing variation impact on molecular interactions: the IMEx Consortium mutations data set 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/346833?rss=1</link>
<description><![CDATA[
The current wealth of genomic variation data identified at the nucleotide level has provided us with the challenge of understanding by which mechanisms amino acid variation affects cellular processes. These effects may manifest as distinct phenotypic differences between individuals or result in the development of disease. Physical interactions between molecules are the linking steps underlying most, if not all, cellular processes. Understanding the effects that amino acid variation of a molecules sequence has on its molecular interactions is a key step towards connecting a full mechanistic characterization of nonsynonymous variation to cellular phenotype. Here we present an open access resource created by IMEx database curators over 14 years, featuring 28,000 annotations fully describing the effect of individual point sequence changes on physical protein interactions. We describe how this resource was built, the formats in which the data content is provided and offer a descriptive analysis of the data set. The data set is publicly available through the IntAct website at www.ebi.ac.uk/intact/resources/datasets#mutationDs and is being enhanced with every monthly release.
]]></description>
<dc:creator>The IMEx Consortium curators,</dc:creator>
<dc:creator>del-Toro, N.</dc:creator>
<dc:creator>Duesbury, M.</dc:creator>
<dc:creator>Koch, M.</dc:creator>
<dc:creator>Perfetto, L.</dc:creator>
<dc:creator>Shrivastava, A.</dc:creator>
<dc:creator>Ochoa, D.</dc:creator>
<dc:creator>Wagih, O.</dc:creator>
<dc:creator>Pinero, J.</dc:creator>
<dc:creator>Kotlyar, M.</dc:creator>
<dc:creator>Chiara, P.</dc:creator>
<dc:creator>Beltrao, P.</dc:creator>
<dc:creator>Furlong, L. I.</dc:creator>
<dc:creator>Jurisica, I.</dc:creator>
<dc:creator>Hermjakob, H.</dc:creator>
<dc:creator>Orchard, S.</dc:creator>
<dc:creator>Porras Millan, P.</dc:creator>
<dc:date>2018-06-14</dc:date>
<dc:identifier>doi:10.1101/346833</dc:identifier>
<dc:title><![CDATA[Capturing variation impact on molecular interactions: the IMEx Consortium mutations data set]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/346957?rss=1">
<title>
<![CDATA[
A combinatorial extracellular code tunes the intracellular signaling network activity to distinct cellular responses 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/346957?rss=1</link>
<description><![CDATA[
Cells constantly survey a complex set of inputs that is processed by the intracellular signaling network, but little is known of how cells integrate input information from more than one cue. We employed a FRET biosensor-based imaging platform to study the effect of combinatorial growth factor levels on the signaling network in human cells. We found that pairwise stimuli caused distinct concentration- and ratio-dependent signaling states through signaling signatures such as antagonism, additivity and synergy. The unique signaling states correlated with differential gene expression and non-additive transcription patterns. We further elucidated how a signal-rich environment can fine-tune the signaling network and adjust physiological outcomes, by kinase and phosphatase activity profiling. We describe how complex extracellular conditions affect phospho-turnover and the basal phosphorylation status. Thus, we provide mechanistic insights into cellular processing of multiple cues and explain part of the complexity of cellular adaptation to changes in the extracellular environment.
]]></description>
<dc:creator>Kuchenov, D.</dc:creator>
<dc:creator>Ziebell, F.</dc:creator>
<dc:creator>Salopiata, F.</dc:creator>
<dc:creator>Citir, M.</dc:creator>
<dc:creator>Klingmueller, U.</dc:creator>
<dc:creator>Huber, W.</dc:creator>
<dc:creator>Schultz, C.</dc:creator>
<dc:date>2018-06-14</dc:date>
<dc:identifier>doi:10.1101/346957</dc:identifier>
<dc:title><![CDATA[A combinatorial extracellular code tunes the intracellular signaling network activity to distinct cellular responses]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/341735?rss=1">
<title>
<![CDATA[
SKEMPI 2.0: An updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/341735?rss=1</link>
<description><![CDATA[
MotivationUnderstanding the relationship between the sequence, structure, binding energy, binding kinetics and binding thermodynamics of protein-protein interactions is crucial to understanding cellular signaling, the assembly and regulation of molecular complexes, the mechanisms through which mutations lead to disease, and protein engineering.nnResultsWe present SKEMPI 2.0, a major update to our database of binding free energy changes upon mutation for structurally resolved protein-protein interactions. This version now contains manually curated binding data for 7085 mutations, an increase of 133%, including changes in kinetics for 1844 mutations, enthalpy and entropy changes for 443 mutations, and 440 mutations which abolish detectable binding.nnAvailabilityThe database is available at https://life.bsc.es/pid/skempi2/
]]></description>
<dc:creator>Jankauskaite, J.</dc:creator>
<dc:creator>Jimenez-Garcia, B.</dc:creator>
<dc:creator>Dapkunas, J.</dc:creator>
<dc:creator>Fernandez-Recio, J.</dc:creator>
<dc:creator>Moal, I. H.</dc:creator>
<dc:date>2018-06-07</dc:date>
<dc:identifier>doi:10.1101/341735</dc:identifier>
<dc:title><![CDATA[SKEMPI 2.0: An updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/338178?rss=1">
<title>
<![CDATA[
Single-cell transcriptomics identifies CD44 as a new marker and regulator of haematopoietic stem cells development 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/338178?rss=1</link>
<description><![CDATA[
The endothelial to haematopoietic transition (EHT) is the process whereby haemogenic endothelium differentiates into haematopoietic stem and progenitor cells (HSPCs). The intermediary steps of this process are unclear, in particular the identity of endothelial cells that give rise to HSPCs is unknown. Using single-cell transcriptome analysis and antibody screening we identified CD44 as a new marker of EHT enabling us to isolate robustly the different stages of EHT in the aorta gonad mesonephros (AGM) region. This allowed us to provide a very detailed phenotypical and transcriptional profile for haemogenic endothelial cells, characterising them with high expression of genes related to Notch signalling, TGFbeta/BMP antagonists (Smad6, Smad7 and Bmper) and a downregulation of genes related to glycolysis and the TCA cycle. Moreover, we demonstrated that by inhibiting the interaction between CD44 and its ligand hyaluronan we could block EHT, identifying a new regulator of HSPC development.
]]></description>
<dc:creator>Oatley, M.</dc:creator>
<dc:creator>Vargel Bolukbasi, O.</dc:creator>
<dc:creator>Svensson, V.</dc:creator>
<dc:creator>Shvartsman, M.</dc:creator>
<dc:creator>Ganter, K.</dc:creator>
<dc:creator>Zirngibl, K.</dc:creator>
<dc:creator>Pavlovich, P. V.</dc:creator>
<dc:creator>Milchevskaya, V.</dc:creator>
<dc:creator>Foteva, V.</dc:creator>
<dc:creator>Natarajan, K. N.</dc:creator>
<dc:creator>Baying, B.</dc:creator>
<dc:creator>Benes, V.</dc:creator>
<dc:creator>Patil, K. R.</dc:creator>
<dc:creator>Teichmann, S. A.</dc:creator>
<dc:creator>Lancrin, C.</dc:creator>
<dc:date>2018-06-06</dc:date>
<dc:identifier>doi:10.1101/338178</dc:identifier>
<dc:title><![CDATA[Single-cell transcriptomics identifies CD44 as a new marker and regulator of haematopoietic stem cells development]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-06</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/338822?rss=1">
<title>
<![CDATA[
Genome-scale oscillations in DNA methylation during exit from pluripotency 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/338822?rss=1</link>
<description><![CDATA[
Pluripotency is accompanied by the erasure of parental epigenetic memory with naive pluripotent cells exhibiting global DNA hypomethylation both in vitro and in vivo. Exit from pluripotency and priming for differentiation into somatic lineages is associated with genome-wide de novo DNA methylation. We show that during this phase, coexpression of enzymes required for DNA methylation turnover, DNMT3s and TETs, promotes cell-to-cell variability in this epigenetic mark. Using a combination of single-cell sequencing and quantitative biophysical modelling, we show that this variability is associated with coherent, genome-scale, oscillations in DNA methylation with an amplitude dependent on CpG density. Analysis of parallel single-cell transcriptional and epigenetic profiling provides evidence for oscillatory dynamics both in vitro and in vivo. These observations provide fresh insights into the emergence of epigenetic heterogeneity during early embryo development, indicating that dynamic changes in DNA methylation might influence early cell fate decisions.nnHighlightsO_LICo-expression of DNMT3s and TETs drive genome-scale oscillations of DNA methylationnC_LIO_LIOscillation amplitude is greatest at a CpG density characteristic of enhancersnC_LIO_LICell synchronisation reveals oscillation period and link with primary transcriptsnC_LIO_LIMultiomic single-cell profiling provides evidence for oscillatory dynamics in vivonC_LI
]]></description>
<dc:creator>Rulands, S.</dc:creator>
<dc:creator>Lee, H. J.</dc:creator>
<dc:creator>Clark, S. J.</dc:creator>
<dc:creator>Angermueller, C.</dc:creator>
<dc:creator>Smallwood, S. A.</dc:creator>
<dc:creator>Krueger, F.</dc:creator>
<dc:creator>Mohammed, H.</dc:creator>
<dc:creator>Dean, W.</dc:creator>
<dc:creator>Nichols, J.</dc:creator>
<dc:creator>Rugg-Gunn, P.</dc:creator>
<dc:creator>Kelsey, G.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Simons, B. D.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:date>2018-06-05</dc:date>
<dc:identifier>doi:10.1101/338822</dc:identifier>
<dc:title><![CDATA[Genome-scale oscillations in DNA methylation during exit from pluripotency]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/337915?rss=1">
<title>
<![CDATA[
Benchmark and integration of resources for the estimation of human transcription factor activities 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/337915?rss=1</link>
<description><![CDATA[
Prediction of transcription factor (TF) activities from the gene expression of their targets (i.e. TF regulon) is becoming a widely-used approach to characterize the functional status of transcriptional regulatory circuits. Several strategies and datasets have been proposed to link the target genes likely regulated by a TF, each one providing a different level of evidence. The most established ones are: (i) manually curated repositories, (ii) interactions derived from ChIP-seq binding data, (iii) in silico prediction of TF binding on gene promoters, and (iv) reverse-engineered regulons from large gene expression datasets. However, it is not known how these different sources of regulons affect the TF activity estimations, and thereby downstream analysis and interpretation. Here we compared the accuracy and biases of these strategies to define human TF regulons by means of their ability to predict changes in TF activities in three reference benchmark datasets. We assembled a collection of TF-target interactions among 1,541 TFs, and evaluated how the different molecular and regulatory properties of the TFs, such as the DNA-binding domain, specificities or mode of interaction with the chromatin, affect the predictions of TF activity changes. We assessed their coverage and found little overlap on the regulons derived from each strategy and better performance by literature-curated information followed by ChIP-seq data. We provide an integrated resource of all TF-target interactions derived through these strategies with a confidence score, as a resource for enhanced prediction of TF activities.
]]></description>
<dc:creator>Garcia-Alonso, L.</dc:creator>
<dc:creator>Ibrahim, M. M.</dc:creator>
<dc:creator>Turei, D.</dc:creator>
<dc:creator>Saez-Rodriguez, J.</dc:creator>
<dc:date>2018-06-03</dc:date>
<dc:identifier>doi:10.1101/337915</dc:identifier>
<dc:title><![CDATA[Benchmark and integration of resources for the estimation of human transcription factor activities]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-06-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/336008?rss=1">
<title>
<![CDATA[
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/336008?rss=1</link>
<description><![CDATA[
The epigenetic regulator TET2 is frequently mutated in hematological diseases. Mutations have been shown to arise in hematopoietic stem cells early in disease development, lead to altered DNA methylation landscapes and to an increased risk of hematopoietic malignancy. Here, we show by genome-wide mapping of TET2 binding sites in different cell types that TET2 localizes to regions of open chromatin and cell-type specific enhancers. We find that deletion of Tet2 in native hematopoiesis as well as fully transformed Acute Myeloid Leukemia (AML) results in changes in transcription factor (TF) activity within these regions, and we demonstrate that loss of TET2 leads to enzymatic activity-dependent attenuation of chromatin binding of the hematopoietic TF CDX4. Together, these findings demonstrate that TET2 activity shapes the local chromatin environment at enhancers to facilitate TF binding and provide a compelling example of how epigenetic dysregulation can affect gene expression patterns and drive disease development.
]]></description>
<dc:creator>Rasmussen, K.</dc:creator>
<dc:creator>Berest, I.</dc:creator>
<dc:creator>Kessler, S.</dc:creator>
<dc:creator>Nishimura, K.</dc:creator>
<dc:creator>Simon-Carrasco, L.</dc:creator>
<dc:creator>Vassilou, G. S.</dc:creator>
<dc:creator>Pedersen, M. T.</dc:creator>
<dc:creator>Christensen, J.</dc:creator>
<dc:creator>Zaugg, J.</dc:creator>
<dc:creator>Helin, K.</dc:creator>
<dc:date>2018-05-31</dc:date>
<dc:identifier>doi:10.1101/336008</dc:identifier>
<dc:title><![CDATA[TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-31</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/329995?rss=1">
<title>
<![CDATA[
The Human RNA-Binding Proteome and Its Dynamics During Arsenite-Induced Translational Arrest 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/329995?rss=1</link>
<description><![CDATA[
Proteins and RNA functionally and physically intersect in multiple biological processes, however, currently no universal method is available to purify protein-RNA complexes. Here we introduce XRNAX, a method for the generic purification of protein-crosslinked RNA, and demonstrate its versatility to study the composition and dynamics of protein-RNA interactions by various transcriptomic and proteomic approaches. We show that XRNAX captures all RNA biotypes, and use this to characterize the sub-proteomes that interact with coding and non-coding RNAs (ncRNAs), and to identify hundreds of protein-RNA interfaces. Exploiting the quantitative nature of XRNAX, we observe drastic remodeling of the RNA-bound proteome during arsenite-induced stress, distinct from autophagy-induced changes in the total proteome. In addition, we combine XRNAX with CLIP-seq to validate the interaction of ncRNA with Lamin B and EXOSC2. Thus, XRNAX is a resourceful approach to study structural and compositional aspects of protein-RNA interactions to address fundamental questions in RNA-biology.
]]></description>
<dc:creator>Trendel, J.</dc:creator>
<dc:creator>Schwarzl, T.</dc:creator>
<dc:creator>Prakash, A.</dc:creator>
<dc:creator>Bateman, A.</dc:creator>
<dc:creator>Hentze, M. W.</dc:creator>
<dc:creator>Krijgsveld, J.</dc:creator>
<dc:date>2018-05-30</dc:date>
<dc:identifier>doi:10.1101/329995</dc:identifier>
<dc:title><![CDATA[The Human RNA-Binding Proteome and Its Dynamics During Arsenite-Induced Translational Arrest]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/334110?rss=1">
<title>
<![CDATA[
Depolymerized lamins link nuclear envelope breakdown to mitotic transcriptional quiescence 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/334110?rss=1</link>
<description><![CDATA[
The nuclear envelope, a defining feature of eukaryotic cells, restricts DNA-dependent processes including gene transcription to the nucleus. The nuclear lamina is an integral component of the animal nuclear envelope, composed of polymers of nuclear lamin proteins1,2. Upon mitosis, the nuclear lamina disassembles, the nuclear envelope breaks down, and transcription becomes quiescent3,4. We report here a direct molecular link between nuclear lamina disassembly and mitotic transcriptional quiescence. We found that, at the G2 cell-cycle phase immediately preceding mitosis, nuclear lamin A/C (LMNA) became phosphorylated at Ser22 and depolymerized from the nuclear lamina. Depolymerized LMNA accumulated in the nuclear interior and physically associated with active cis-regulatory elements genome-wide. Depolymerized LMNA-associated sites were overrepresented near genes repressed by LMNA, suggesting that depolymerized LMNA participates in transcriptional repression at G2. Consistently, depolymerized LMNA-target genes underwent a steep expression decline from S to G2/M. Furthermore, LMNA deletion caused inappropriate RNA Polymerase II (Pol II) accumulation downstream of Pol II pause sites at promoters and enhancers genome-wide, leading to inappropriate and excessive transcriptional elongation. A subset of depolymerized LMNA-target genes were upregulated in fibroblasts of patients with Hutchinson-Gilford progeria, a premature aging disorder caused by LMNA mutations5, raising the possibility that defects in depolymerized LMNA-mediated mitotic transcriptional quiescence contribute to progeria pathogenesis. These observations support a model in which depolymerized LMNA targets active regulatory elements to promote RNA Pol II pausing preceding mitosis, coupling nuclear envelope breakdown to mitotic transcriptional quiescence.
]]></description>
<dc:creator>Ikegami, K.</dc:creator>
<dc:creator>Secchia, S.</dc:creator>
<dc:creator>Lieb, J. D.</dc:creator>
<dc:creator>Moskowitz, I. P.</dc:creator>
<dc:date>2018-05-30</dc:date>
<dc:identifier>doi:10.1101/334110</dc:identifier>
<dc:title><![CDATA[Depolymerized lamins link nuclear envelope breakdown to mitotic transcriptional quiescence]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-30</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/330654?rss=1">
<title>
<![CDATA[
Condensin controls cellular RNA levels through the accurate segregation of chromosomes instead of directly regulating transcription 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/330654?rss=1</link>
<description><![CDATA[
Condensins are genome organisers that shape chromosomes and promote their accurate transmission. Several studies have also implicated condensins in gene expression, although the mechanisms have remained enigmatic. Here, we report on the role of condensin in gene expression in fission and budding yeasts. In contrast to previous studies, we provide compelling evidence that condensin plays no direct role in the maintenance of the transcriptome, neither during interphase nor during mitosis. We further show that the changes in gene expression in post-mitotic fission yeast cells that result from condensin inactivation are largely a consequence of chromosome missegregation during anaphase, which notably depletes the RNA-exosome from daughter cells. Crucially, preventing karyotype abnormalities in daughter cells restores a normal transcriptome despite condensin inactivation. Thus, chromosome instability, rather than a direct role of condensin in the transcription process, changes gene expression. This knowledge challenges the concept of gene regulation by canonical condensin complexes.
]]></description>
<dc:creator>Hocquet, C.</dc:creator>
<dc:creator>Robellet, X.</dc:creator>
<dc:creator>Modolo, L.</dc:creator>
<dc:creator>Sun, X.-M.</dc:creator>
<dc:creator>Burny, C.</dc:creator>
<dc:creator>Cuylen-Haering, S.</dc:creator>
<dc:creator>Toselli, E.</dc:creator>
<dc:creator>Clauder-Münster, S.</dc:creator>
<dc:creator>Steinmetz, L.</dc:creator>
<dc:creator>Haering, C. H.</dc:creator>
<dc:creator>Marguerat, S.</dc:creator>
<dc:creator>Bernard, P.</dc:creator>
<dc:date>2018-05-25</dc:date>
<dc:identifier>doi:10.1101/330654</dc:identifier>
<dc:title><![CDATA[Condensin controls cellular RNA levels through the accurate segregation of chromosomes instead of directly regulating transcription]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/331587?rss=1">
<title>
<![CDATA[
A congenital pain insensitivity mutation in the nerve growth factor gene uncouples nociception from affective pain in heterozygous humans and mice 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/331587?rss=1</link>
<description><![CDATA[
Pain is an unpleasant but necessary sensory experience, which facilitates adaptive behaviours, such as fear. Despite recent advances, the question of how the pain experience influences learning of the fear response is still debated1,2. Genetic disorders rendering patients congenitally unable to feel pain have been described, and are usually explained by defects in peripheral nociceptors3-5. It is not known how growing up without pain affects central emotional and motivational responses to aversive stimuli. The rare autosomal recessive Hereditary Sensory and Autonomic Neuropathy type V (HSAN V) is caused by a mutation in the nerve growth factor (NGF) gene (R100W). HSAN V homozygous patients display a congenital indifference to painful events, with deficits in peripheral nociceptors but without overt cognitive impairment6. In contrast, heterozygous carriers do not present with pain-related deficits and have been identified only through pedigree and genetic screening7,8. We exploited this clinically silent population to dissociate nociceptive from affective features of pain. To address this we investigated both heterozygous knock-in mice bearing the R100W mutation (NGFR100W/m mice) and a cohort of HSAN V heterozygous human carriers. Surprisingly, we found that NGFR100W/m mice, despite normal responses to a noxious conditioning stimulus, show a deficit in learned fear while their social and innate fear responses are normal. The lack of pain-related fear response was linked to a reduced activation of anterior cingulate and motor cortices and of striatum, but not in primary somatosensory cortex. Likewise, human heterozygous R100W carriers, despite perceiving noxious stimuli and reporting subjective pain thresholds, show increased reaction latencies in response to painful stimulation, alongside a decreased subjective urgency to react. Functional magnetic resonance imaging (fMRI) revealed, comparably to the mouse data, an altered processing of painful stimuli in rostral anterior cingulate, medial premotor cortical regions and striatum. These findings from both human and mouse HSAN V carriers uncover behavioural and motivational consequences of a mild genetic pain insensitivity on the establishment of pain-dependent affective responses and memories.
]]></description>
<dc:creator>Testa, G.</dc:creator>
<dc:creator>Perini, I.</dc:creator>
<dc:creator>Mainardi, M.</dc:creator>
<dc:creator>Morelli, C.</dc:creator>
<dc:creator>Olimpico, F.</dc:creator>
<dc:creator>Pancrazi, L.</dc:creator>
<dc:creator>Petrella, C.</dc:creator>
<dc:creator>Severini, C.</dc:creator>
<dc:creator>Florio, R.</dc:creator>
<dc:creator>Malerba, F.</dc:creator>
<dc:creator>Heppenstall, P.</dc:creator>
<dc:creator>Costa, M.</dc:creator>
<dc:creator>Morrison, I.</dc:creator>
<dc:creator>Capsoni, S.</dc:creator>
<dc:creator>Cattaneo, A.</dc:creator>
<dc:date>2018-05-25</dc:date>
<dc:identifier>doi:10.1101/331587</dc:identifier>
<dc:title><![CDATA[A congenital pain insensitivity mutation in the nerve growth factor gene uncouples nociception from affective pain in heterozygous humans and mice]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/328138?rss=1">
<title>
<![CDATA[
Combined single cell profiling of expression and DNA methylation reveals splicing regulation and heterogeneity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/328138?rss=1</link>
<description><![CDATA[
BackgroundAlternative splicing is a key regulatory mechanism in eukaryotic cells and increases the effective number of functionally distinct gene products. Using bulk RNA sequencing, splicing variation has been studied across human tissues and in genetically diverse populations. This has identified disease-relevant splicing events, as well as associations between splicing and genomic variations, including sequence composition and conservation. However, variability in splicing between single cells from the same tissue or cell type and its determinants remain poorly understood.nnResultsWe applied parallel DNA methylation and transcriptome sequencing to differentiating human induced pluripotent stem cells to characterize splicing variation (exon skipping) and its determinants. Our results shows that variation in single-cell splicing can be accurately predicted based on local sequence composition and genomic features. We observe moderate but consistent contributions from local DNA methylation profiles to splicing variation across cells. A combined model that is built based on sequence as well as DNA methylation information accurately predicts different splicing modes of individual cassette exons (AUC=0.85). These categories include the conventional inclusion and exclusion patterns, but also more subtle modes of cell-to-cell variation in splicing. Finally, we identified and characterized associations between DNA methylation and splicing changes during cell differentiation.nnConclusionsOur study yields new insights into alternative splicing at the single-cell level and reveals a previously underappreciated link between DNA methylation variation and splicing.
]]></description>
<dc:creator>Linker, S. M.</dc:creator>
<dc:creator>Urban, L.</dc:creator>
<dc:creator>Clark, S.</dc:creator>
<dc:creator>Chhatriwala, M.</dc:creator>
<dc:creator>Amatya, S.</dc:creator>
<dc:creator>McCarthy, D.</dc:creator>
<dc:creator>Ebersberger, I.</dc:creator>
<dc:creator>Vallier, L.</dc:creator>
<dc:creator>Reik, W.</dc:creator>
<dc:creator>Stegle, O.</dc:creator>
<dc:creator>Bonder, M. J.</dc:creator>
<dc:date>2018-05-22</dc:date>
<dc:identifier>doi:10.1101/328138</dc:identifier>
<dc:title><![CDATA[Combined single cell profiling of expression and DNA methylation reveals splicing regulation and heterogeneity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/323956?rss=1">
<title>
<![CDATA[
An insulin, AMPK, and steroid hormone-mediated metabolic switch regulates the transition between growth and diapause in C. elegans 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/323956?rss=1</link>
<description><![CDATA[
The balance between growth and quiescence depends on the global metabolic state. The dauer larva of C. elegans, a developmentally arrested stage for survival under adverse environment, undergoes a major metabolic transition. Here, we show that this switch involves the concerted activity of several regulatory pathways. Whereas the steroid hormone receptor DAF-12 controls dauer morphogenesis, the insulin pathway maintains low energy expenditure through DAF-16/FoxO, which also requires AAK-2/AMPK. DAF-12 and AAK-2 separately promote a shift in the molar ratios between competing enzymes at two key branch points within the central carbon metabolic pathway. This way, carbon atoms are diverted from the TCA cycle and directed to gluconeogenesis. When both AAK-2 and DAF-12 are suppressed, the TCA cycle is active and the developmental arrest is bypassed. Hence, the metabolic status of each developmental stage is defined by stoichiometric ratios within the constellation of metabolic enzymes and controls the transition between growth and quiescence.
]]></description>
<dc:creator>Penkov, S.</dc:creator>
<dc:creator>Erkut, C.</dc:creator>
<dc:creator>Oertel, J.</dc:creator>
<dc:creator>Galli, R.</dc:creator>
<dc:creator>Vorkel, D.</dc:creator>
<dc:creator>Verbavatz, J.-M.</dc:creator>
<dc:creator>Koch, E.</dc:creator>
<dc:creator>Fahmy, K.</dc:creator>
<dc:creator>Kurzchalia, T. V.</dc:creator>
<dc:date>2018-05-16</dc:date>
<dc:identifier>doi:10.1101/323956</dc:identifier>
<dc:title><![CDATA[An insulin, AMPK, and steroid hormone-mediated metabolic switch regulates the transition between growth and diapause in C. elegans]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/319046?rss=1">
<title>
<![CDATA[
Evolutionary changes in DNA accessibility and sequence predict divergence of transcription factor binding and enhancer activity 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/319046?rss=1</link>
<description><![CDATA[
Transcription factor (TF) binding is determined by sequence as well as chromatin accessibility. While the role of accessibility in shaping TF-binding landscapes is well recorded, its role in evolutionary divergence of TF binding, which in turn can alter cis-regulatory activities, is not well understood. In this work, we studied the evolution of genome-wide binding landscapes of five major transcription factors (TFs) in the core network of mesoderm specification, between D. melanogaster and D. virilis, and examined its relationship to accessibility and sequence-level changes. We generated chromatin accessibility data from three important stages of embryogenesis in both D. melanogaster and D. virilis, and recorded conservation and divergence patterns. We then used multi-variable models to correlate accessibility and sequence changes to TF binding divergence. We found that accessibility changes can in some cases, e.g., for the master regulator Twist and for earlier developmental stages, more accurately predict binding change than is possible using TF binding motif changes between orthologous enhancers. Accessibility changes also explain a significant portion of the co-divergence of TF pairs. We noted that accessibility and motif changes offer complementary views of the evolution of TF binding, and developed a combined model that captures the evolutionary data much more accurately than either view alone. Finally, we trained machine learning models to predict enhancer activity from TF binding, and used these functional models to argue that motif and accessibility-based predictors of TF binding change can substitute for experimentally measured binding change, for the purpose of predicting evolutionary changes in enhancer activity.
]]></description>
<dc:creator>Peng, P.-C.</dc:creator>
<dc:creator>Khoueiry, P.</dc:creator>
<dc:creator>Girardot, C.</dc:creator>
<dc:creator>Reddington, J. P.</dc:creator>
<dc:creator>Garfield, D. A.</dc:creator>
<dc:creator>Furlong, E. E. M.</dc:creator>
<dc:creator>Sinha, S.</dc:creator>
<dc:date>2018-05-10</dc:date>
<dc:identifier>doi:10.1101/319046</dc:identifier>
<dc:title><![CDATA[Evolutionary changes in DNA accessibility and sequence predict divergence of transcription factor binding and enhancer activity]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-10</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/314716?rss=1">
<title>
<![CDATA[
Analysis of the human kinome and phosphatome reveals diseased signaling networks induced by overexpression 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/314716?rss=1</link>
<description><![CDATA[
Kinase and phosphatase overexpression drives tumorigenesis and drug resistance in many cancer types. Signaling networks reprogrammed by protein overexpression remain largely uncharacterized, hindering discovery of paths to therapeutic intervention. We previously developed a single cell proteomics approach based on mass cytometry that enables quantitative assessment of overexpression effects on the signaling network. Here we applied this approach in a human kinome- and phosphatome-wide study to assess how 649 individually overexpressed proteins modulate the cancer-related signaling network in HEK293T cells. Based on these data we expanded the functional classification of human kinases and phosphatases and detected 208 novel signaling relationships. In the signaling dynamics analysis, we showed that increased ERK-specific phosphatases sustained proliferative signaling, and using a novel combinatorial overexpression approach, we confirmed this phosphatase-driven mechanism of cancer progression. Finally, we identified 54 proteins that caused ligand-independent ERK activation with potential as biomarkers for drug resistance in cells carrying BRAF mutations.
]]></description>
<dc:creator>Lun, X.-K.</dc:creator>
<dc:creator>Szklarczyk, D.</dc:creator>
<dc:creator>Gabor, A.</dc:creator>
<dc:creator>Dobberstein, N.</dc:creator>
<dc:creator>Zanotelli, V. R. T.</dc:creator>
<dc:creator>Saez-Rodriguez, J.</dc:creator>
<dc:creator>von Mering, C.</dc:creator>
<dc:creator>Bodenmiller, B.</dc:creator>
<dc:date>2018-05-04</dc:date>
<dc:identifier>doi:10.1101/314716</dc:identifier>
<dc:title><![CDATA[Analysis of the human kinome and phosphatome reveals diseased signaling networks induced by overexpression]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/314484?rss=1">
<title>
<![CDATA[
Polarity sorting drives remodeling of actin-myosin networks 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/314484?rss=1</link>
<description><![CDATA[
Cytoskeletal networks of actin filaments and myosin motors drive many dynamic cell processes. A key characteristic of these networks is their contractility. Despite intense experimental and theoretical efforts, it is not clear what mechanism favors network contraction over expansion. Recent work points to a dominant role for the nonlinear mechanical response of actin filaments, which can withstand stretching but buckle upon compression. Here we present an alternative mechanism. We study how interactions between actin and myosin-2 at the single filament level translate into contraction at the network scale by performing time-lapse imaging on reconstituted quasi-2D-networks mimicking the cell cortex. We observe myosin end-dwelling after it runs processively along actin filaments. This leads to transport and clustering of actin filament ends and the formation of transiently stable bipolar structures. Further we show that myosin-driven polarity sorting leads to polar actin aster formation, which act as contractile nodes that drive contraction in crosslinked networks. Computer simulations comparing the roles of the end-dwelling mechanism and a buckling-dependent mechanism show that the relative contribution of end-dwelling contraction increases as the network mesh-size decreases.
]]></description>
<dc:creator>Wollrab, V.</dc:creator>
<dc:creator>Belmonte, J. M.</dc:creator>
<dc:creator>Leptin, M.</dc:creator>
<dc:creator>Nedelec, F.</dc:creator>
<dc:creator>Koenderink, G. H.</dc:creator>
<dc:date>2018-05-04</dc:date>
<dc:identifier>doi:10.1101/314484</dc:identifier>
<dc:title><![CDATA[Polarity sorting drives remodeling of actin-myosin networks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/313031?rss=1">
<title>
<![CDATA[
Comprehensive variant effect predictions of single nucleotide variants in model organisms 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/313031?rss=1</link>
<description><![CDATA[
The effect of single nucleotide variants (SNVs) in coding and non-coding regions is of great interest in genetics. Although many computational methods aim to elucidate the effects of SNVs on cellular mechanisms, it is not straightforward to comprehensively cover different molecular effects. To address this we compiled and benchmarked sequence and structure-based variant effect predictors and we analyzed the impact of nearly all possible amino acid and nucleotide variants in the reference genomes of H. sapiens, S. cerevisiae and E. coli. Studied mechanisms include protein stability, interaction interfaces, post-translational modifications and transcription factor binding sites. We apply this resource to the study of natural and disease coding variants. We also show how variant effects can be aggregated to generate protein complex burden scores that uncover protein complex to phenotype associations based on a set of newly generated growth profiles of 93 sequenced S. cerevisiae strains in 43 conditions. This resource is available through mutfunc, a tool by which users can query precomputed predictions by providing amino acid or nucleotide-level variants.
]]></description>
<dc:creator>Wagih, O.</dc:creator>
<dc:creator>Busby, B.</dc:creator>
<dc:creator>Galardini, M.</dc:creator>
<dc:creator>Memon, D.</dc:creator>
<dc:creator>Typas, A.</dc:creator>
<dc:creator>Beltrao, P.</dc:creator>
<dc:date>2018-05-02</dc:date>
<dc:identifier>doi:10.1101/313031</dc:identifier>
<dc:title><![CDATA[Comprehensive variant effect predictions of single nucleotide variants in model organisms]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-05-02</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/309054?rss=1">
<title>
<![CDATA[
Discovery of a new path for red blood cell generation in the mouse embryo 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/309054?rss=1</link>
<description><![CDATA[
Erythropoiesis occurs through several waves during embryonic development. Although the source of the primitive wave is well characterized, the origin of erythrocytes later in embryogenesis is less clear due to overlaps between the different erythroid waves. Using the miR144/451-GFP mouse model to track cells expressing the erythroid microRNAs miR144/451, we identified cells co-expressing VE-Cadherin and GFP in the yolk sac between E9.5 and E12. This suggested the existence of hemogenic endothelial cells committed to erythropoiesis (Ery-HEC). We showed that these cells were capable of generating erythrocytes ex vivo and we demonstrated that the formation of Ery-HEC was independent of the Runx1 gene expression. Using transcriptome analysis, we demonstrated that these cells coexpressed endothelial and erythroid genes such as Hbb-bh1 and Gata1 but we were surprised to detect the primitive erythroid genes Aqp3 and Aqp8 suggesting the formation of primitive erythrocytes at a much later time point than initially thought. Finally, we showed that enforced expression of Gata1 in endothelial cells was enough to initiate the erythroid transcriptional program.
]]></description>
<dc:creator>Pinheiro, I.</dc:creator>
<dc:creator>Vargel Bolukbasi, O.</dc:creator>
<dc:creator>Ganter, K.</dc:creator>
<dc:creator>Sabou, L. A.</dc:creator>
<dc:creator>Tew, V. K.</dc:creator>
<dc:creator>Bolasco, G.</dc:creator>
<dc:creator>Shvartsman, M.</dc:creator>
<dc:creator>Pavlovich, P. V.</dc:creator>
<dc:creator>Buness, A.</dc:creator>
<dc:creator>Nikolakopoulou, C.</dc:creator>
<dc:creator>Bergiers, I.</dc:creator>
<dc:creator>Kouskoff, V.</dc:creator>
<dc:creator>Lacaud, G.</dc:creator>
<dc:creator>Lancrin, C.</dc:creator>
<dc:date>2018-04-28</dc:date>
<dc:identifier>doi:10.1101/309054</dc:identifier>
<dc:title><![CDATA[Discovery of a new path for red blood cell generation in the mouse embryo]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/310029?rss=1">
<title>
<![CDATA[
The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/310029?rss=1</link>
<description><![CDATA[
Esophageal Adenocarcinoma (EAC) is a poor prognosis cancer type with rapidly rising incidence. Our understanding of genetic events which drive EAC development is limited and there are few molecular biomarkers for prognostication or therapeutics. We have accumulated a cohort of 551 genomically characterised EACs (73% WGS and 27% WES) with clinical annotation and matched RNA-seq. Using a variety of driver gene detection methods, we discover 77 EAC driver genes (73% novel) and 21 non-coding driver elements (95% novel), and describe mutation and CNV types with specific functional impact. We identify a mean of 4.4 driver events per case derived from both copy number events and mutations. We compare driver mutation rates to the exome-wide mutational excess calculated using Non-synonymous vs Synonymous mutation rates (dNdS). We observe mutual exclusivity or co-occurrence of events within and between a number of EAC pathways (GATA factors, Core Cell cycle genes, TP53 regulators and the SWI/SNF complex) suggestive of important functional relationships. These driver variants correlate with tumour differentiation, sex and prognosis. Poor prognostic indicators (SMAD4, GATA4) are verified in independent cohorts with significant predictive value. Over 50% of EACs contain sensitising events for CDK4/6 inhibitors which are highly correlated with clinically relevant sensitivity in a panel EAC cell lines and organoids.
]]></description>
<dc:creator>Frankell, A. M.</dc:creator>
<dc:creator>Jammula, S.</dc:creator>
<dc:creator>Contino, G.</dc:creator>
<dc:creator>Killcoyne, S. S.</dc:creator>
<dc:creator>Abbas, S.</dc:creator>
<dc:creator>Perner, J.</dc:creator>
<dc:creator>Bower, L.</dc:creator>
<dc:creator>Devonshire, G.</dc:creator>
<dc:creator>Grehan, N.</dc:creator>
<dc:creator>Mok, J.</dc:creator>
<dc:creator>O'Donovan, M.</dc:creator>
<dc:creator>Macrae, S.</dc:creator>
<dc:creator>Tavare, S.</dc:creator>
<dc:creator>Fitzgerald, R. C.</dc:creator>
<dc:creator>the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium,</dc:creator>
<dc:date>2018-04-28</dc:date>
<dc:identifier>doi:10.1101/310029</dc:identifier>
<dc:title><![CDATA[The landscape of selection in 551 Esophageal Adenocarcinomas defines genomic biomarkers for the clinic]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-28</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/309831?rss=1">
<title>
<![CDATA[
A rapid and robust method for single cell chromatin accessibility profiling 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/309831?rss=1</link>
<description><![CDATA[
The assay for transposase-accessible chromatin using sequencing (ATAC-seq) is widely used to identify regulatory regions throughout the genome. However, very few studies have been performed at the single cell level (scATAC-seq) due to technical challenges. Here we developed a simple and robust plate-based scATAC-seq method, combining upfront bulk Tn5 tagging with single-nuclei sorting. We demonstrated that our method worked robustly across various systems, including fresh and cryopreserved cells from primary tissues. By profiling over 3,000 splenocytes, we identify distinct immune cell types and reveal cell type-specific regulatory regions and related transcription factors.
]]></description>
<dc:creator>Chen, X.</dc:creator>
<dc:creator>Natarajan, K. N.</dc:creator>
<dc:creator>Teichmann, S. A.</dc:creator>
<dc:date>2018-04-27</dc:date>
<dc:identifier>doi:10.1101/309831</dc:identifier>
<dc:title><![CDATA[A rapid and robust method for single cell chromatin accessibility profiling]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/307629?rss=1">
<title>
<![CDATA[
Patterning of a telencephalon-like region in the adult brain of amphioxus 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/307629?rss=1</link>
<description><![CDATA[
The evolutionary origin of the vertebrate telencephalon remains unsolved. A major challenge has been the identification of homologous brain parts in invertebrate chordates. Here we report evidence for a telencephalic region in the brain of amphioxus, the most basally branching invertebrate chordate. This region is characterised, like its vertebrate counterpart, by the combined expression of the telencephalic markers FoxG1, Emx and Lhx2/9. It is located at the anterior neural border and dorsal-ventrally patterned, as in vertebrates, by the antagonistic expression of Pax4/6 and Nkx2.1, and a ventral Hh signal. This part of the brain develops only after metamorphosis via sustained proliferation of neuronal progenitors at the ventricular zone. This is concomitant with a massive expansion of late differentiating neuronal types as revealed by neuropeptide and neurotransmitter profiling. Overall, our results suggest that the adult amphioxus brain shows remarkable similarities to the vertebrate embryonic brain, thus providing a key missing link in understanding the invertebrate-to-vertebrate transition in chordate brain evolution.
]]></description>
<dc:creator>Benito Gutierrez, E.</dc:creator>
<dc:creator>Stemmer, M.</dc:creator>
<dc:creator>Rohr, S. D.</dc:creator>
<dc:creator>Schumacher, L. N.</dc:creator>
<dc:creator>Tang, J.</dc:creator>
<dc:creator>Marconi, A.</dc:creator>
<dc:creator>Jekely, G.</dc:creator>
<dc:creator>Arendt, D.</dc:creator>
<dc:date>2018-04-25</dc:date>
<dc:identifier>doi:10.1101/307629</dc:identifier>
<dc:title><![CDATA[Patterning of a telencephalon-like region in the adult brain of amphioxus]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-25</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/303842?rss=1">
<title>
<![CDATA[
Highly dynamic chromatin interactions drive neurogenesis through gene regulatory networks 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/303842?rss=1</link>
<description><![CDATA[
Lineage commitment is a fundamental process that enables the morphogenesis of multicellular organisms from a single pluripotent cell. While many genes involved in the commitment to specific lineages are known, the logic of their joint action is incompletely understood, and predicting the effects of genetic perturbations on lineage commitment is still challenging. Here, we devised a gene regulatory network analysis approach, GRN-loop, to identify key cis-regulatory DNA elements and transcription factors that drive lineage commitment. GRN-loop is based on signal propagation and combines transcription factor binding data with the temporal profiles of gene expression, chromatin state and 3D chromosomal architecture. Applying GRN-loop to a model of morphogen-induced early neural lineage commitment, we discovered a set of driver transcription factors and enhancers, some of them validated in recent data and others hitherto unknown. Our work provides the basis for an integrated understanding of neural lineage commitment, and demonstrates the potential of gene regulatory network analyses informed by 3D chromatin architecture to uncover the key genes and regulatory elements driving developmental processes.
]]></description>
<dc:creator>Malysheva, V.</dc:creator>
<dc:creator>Mendoza-Parra, M. A.</dc:creator>
<dc:creator>Blum, M.</dc:creator>
<dc:creator>Gronemeyer, H.</dc:creator>
<dc:date>2018-04-18</dc:date>
<dc:identifier>doi:10.1101/303842</dc:identifier>
<dc:title><![CDATA[Highly dynamic chromatin interactions drive neurogenesis through gene regulatory networks]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-18</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/302257?rss=1">
<title>
<![CDATA[
NAD(P)HX repair deficiency causes central metabolic perturbations in yeast and human cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/302257?rss=1</link>
<description><![CDATA[
NADHX and NADPHX are hydrated and redox inactive forms of the NADH and NADPH cofactors, known to inhibit several dehydrogenases in vitro. A metabolite repair system that is conserved in all domains of life and that comprises the two enzymes NAD(P)HX dehydratase and NAD(P)HX epimerase, allows reconversion of both the S- and R-epimers of NADHX and NADPHX to the normal cofactors. An inherited deficiency in this system has recently been shown to cause severe neurometabolic disease in children. Although evidence for the presence of NAD(P)HX has been obtained in plant and human cells, little is known about the mechanism of formation of these derivatives in vivo and their potential effects on cell metabolism. Here, we show that NAD(P)HX dehydratase deficiency in yeast leads to an important, temperature-dependent NADHX accumulation in quiescent cells with a concomitant depletion of intracellular NAD+ and serine pools. We demonstrate that NADHX potently inhibits the first step of the serine synthesis pathway in yeast. Human cells deficient in the NAD(P)HX dehydratase also accumulated NADHX and showed decreased viability. In addition, those cells consumed more glucose and produced more lactate, potentially indicating impaired mitochondrial function. Our results provide first insights into how NADHX accumulation affects cellular functions and pave the way for a better understanding of the mechanism(s) underlying the rapid and severe neurodegeneration leading to early death in NADHX repair deficient children.
]]></description>
<dc:creator>Becker-Kettern, J.</dc:creator>
<dc:creator>Paczia, N.</dc:creator>
<dc:creator>Conrotte, J.-F.</dc:creator>
<dc:creator>Zhu, C.</dc:creator>
<dc:creator>Fiehn, O.</dc:creator>
<dc:creator>Jung, P. P.</dc:creator>
<dc:creator>Steinmetz, L. M.</dc:creator>
<dc:creator>Linster, C. L.</dc:creator>
<dc:date>2018-04-16</dc:date>
<dc:identifier>doi:10.1101/302257</dc:identifier>
<dc:title><![CDATA[NAD(P)HX repair deficiency causes central metabolic perturbations in yeast and human cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-16</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/297960?rss=1">
<title>
<![CDATA[
Analyzing the symmetrical arrangement of structural repeats in proteins with CE-Symm 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/297960?rss=1</link>
<description><![CDATA[
Many proteins fold into highly regular and repetitive three dimensional structures. The analysis of structural patterns and repeated elements is fundamental to understand protein function and evolution. We present recent improvements to the CE-Symm tool for systematically detecting and analyzing the internal symmetry and structural repeats in proteins. In addition to the accurate detection of internal symmetry, the tool is now capable of i) reporting the type of symmetry, ii) identifying the smallest repeating unit, iii) describing the arrangement of repeats with transformation operations and symmetry axes, and iv) comparing the similarity of all the internal repeats at the residue level. CE-Symm 2.0 helps the user investigate proteins with a robust and intuitive sequence-to-structure analysis, with many applications in protein classification, functional annotation and evolutionary studies. We describe the algorithmic extensions of the method and demonstrate its applications to the study of interesting cases of protein evolution.nnAvailabilit: CE-Symm is an open source tool integrated into the BioJava library(www.biojava.org)and freely available at https://github.com/rcsb/symmetry.
]]></description>
<dc:creator>Bliven, S. E.</dc:creator>
<dc:creator>Lafita, A.</dc:creator>
<dc:creator>Rose, P. W.</dc:creator>
<dc:creator>Capitani, G.</dc:creator>
<dc:creator>Prlic, A.</dc:creator>
<dc:creator>Bourne, P.</dc:creator>
<dc:date>2018-04-09</dc:date>
<dc:identifier>doi:10.1101/297960</dc:identifier>
<dc:title><![CDATA[Analyzing the symmetrical arrangement of structural repeats in proteins with CE-Symm]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/289363?rss=1">
<title>
<![CDATA[
MDM4 is an essential disease driver targeted by 1q gain in Burkitt lymphoma 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/289363?rss=1</link>
<description><![CDATA[
Oncogenic MYC activation promotes cellular proliferation in Burkitt lymphoma (BL), but also induces cell cycle arrest and apoptosis mediated by TP53, a tumor suppressor gene that is mutated in 40% of BL cases. To identify therapeutic targets in BL, we investigated molecular dependencies in BL cell lines using RNAi-based, loss-of-function screening. By integrating genotypic and RNAi data, we identified a number of genotype-specific dependencies including the dependence of TCF3/ID3 mutant cell lines on TCF3 and of MYD88 mutant cell lines on TLR signaling. TP53 wild-type (TP53wt) BL were dependent on MDM4, a negative regulator of TP53. In BL cell lines, MDM4 knockdown induced cell cycle arrest and decreased tumor growth in a xenograft model in a p53-dependent manner, while small molecule inhibition of the MDM4-p53 interaction restored p53 activity resulting in cell cycle arrest. Consistent with the pathogenic effect of MDM4 upregulation in BL, we found that TP53wt BL samples were enriched for gain of chromosome 1q which includes the MDM4 locus. 1q gain was also enriched across non-BL cancer cell lines (n=789) without TP53 mutation (23% in TP53wt and 12% in TP53mut, p<0.001). In a set of 216 cell lines representing 19 cancer entities from the Achilles project, MDM4 was the strongest genetic dependency in TP53wt cell lines (p<0.001).nnOur findings show that in TP53wt BL, MDM4-mediated inhibition of p53 is a mechanism to evade cell cycle arrest. The data highlight the critical role of p53 as a tumor suppressor in BL, and identifies MDM4 as a key functional target of 1q gain in a wide range of cancers, which is therapeutically targetable.
]]></description>
<dc:creator>Huellein, J.</dc:creator>
<dc:creator>Slabicki, M.</dc:creator>
<dc:creator>Rosolowski, M.</dc:creator>
<dc:creator>Jethwa, A.</dc:creator>
<dc:creator>Habringer, S.</dc:creator>
<dc:creator>Tomska, K.</dc:creator>
<dc:creator>Kurilov, R.</dc:creator>
<dc:creator>Lu, J.</dc:creator>
<dc:creator>Scheinost, S.</dc:creator>
<dc:creator>Wagener, R.</dc:creator>
<dc:creator>Huang, Z.</dc:creator>
<dc:creator>Lukas, M.</dc:creator>
<dc:creator>Yavorska, O.</dc:creator>
<dc:creator>Helferich, H.</dc:creator>
<dc:creator>Scholtysik, R.</dc:creator>
<dc:creator>Bonneau, K.</dc:creator>
<dc:creator>Tedesco, D.</dc:creator>
<dc:creator>Kueppers, R.</dc:creator>
<dc:creator>Klapper, W.</dc:creator>
<dc:creator>Pott, C.</dc:creator>
<dc:creator>Stilgenbauer, S.</dc:creator>
<dc:creator>Burkhardt, B.</dc:creator>
<dc:creator>Loeffler, M.</dc:creator>
<dc:creator>Truemper, L.</dc:creator>
<dc:creator>Hummel, M.</dc:creator>
<dc:creator>Brors, B.</dc:creator>
<dc:creator>Zapatka, M.</dc:creator>
<dc:creator>Siebert, R.</dc:creator>
<dc:creator>Keller, U.</dc:creator>
<dc:creator>Huber, W.</dc:creator>
<dc:creator>Kreuz, M.</dc:creator>
<dc:creator>Zenz, T.</dc:creator>
<dc:creator>MMML consortium,</dc:creator>
<dc:date>2018-04-09</dc:date>
<dc:identifier>doi:10.1101/289363</dc:identifier>
<dc:title><![CDATA[MDM4 is an essential disease driver targeted by 1q gain in Burkitt lymphoma]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-09</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/234872?rss=1">
<title>
<![CDATA[
Distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/234872?rss=1</link>
<description><![CDATA[
Droplet-based single-cell RNA sequencing protocols have dramatically increased the throughput and efficiency of single-cell transcriptomics studies. A key computational challenge when processing these data is to distinguish libraries for real cells from empty droplets. Existing methods for cell calling set a minimum threshold on the total unique molecular identifier (UMI) count for each library, which indiscriminately discards cell libraries with low UMI counts. Here, we describe a new statistical method for calling cells from droplet-based data, based on detecting significant deviations from the expression profile of the ambient solution. Using simulations, we demonstrate that our method has greater power than existing approaches for detecting cell libraries with low UMI counts, while controlling the false discovery rate among detected cells. We also apply our method to real data, where we show that the use of our method results in the retention of distinct cell types that would otherwise have been discarded.
]]></description>
<dc:creator>Lun, A.</dc:creator>
<dc:creator>Riesenfeld, S.</dc:creator>
<dc:creator>Andrews, T.</dc:creator>
<dc:creator>Dao, T. P.</dc:creator>
<dc:creator>Gomes, T.</dc:creator>
<dc:creator>participants in the 1st Human Cell Atlas Jamboree,</dc:creator>
<dc:creator>Marioni, J.</dc:creator>
<dc:date>2018-04-04</dc:date>
<dc:identifier>doi:10.1101/234872</dc:identifier>
<dc:title><![CDATA[Distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/287862?rss=1">
<title>
<![CDATA[
Circadian protein regulation in the green lineage I. A phospho-dawn anticipates light onset before proteins peak in daytime. 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/287862?rss=1</link>
<description><![CDATA[
Diel regulation of protein levels and protein modification had been less studied than transcript rhythms. Here, we compare transcriptome data under light-dark cycles to partial proteome and phosphoproteome data, assayed using shotgun mass-spectrometry, from the alga Ostreococcus tauri, the smallest free-living eukaryote. 10% of quantified proteins but two-thirds of phosphoproteins were rhythmic. Mathematical modelling showed that light-stimulated protein synthesis can account for the observed clustering of protein peaks in the daytime. Prompted by night-peaking and apparently dark-stable proteins, we also tested cultures under prolonged darkness, where the proteome changed less than under the diel cycle. The dark-stable, prasinophyte-specific proteins were also reported to accumulate when O. tauri formed lipid droplets. In the phosphoproteome, 39% of rhythmic phospho-sites reached peak levels just before dawn. This anticipatory phosphorylation suggests that a clock-regulated phospho-dawn prepares green cells for daytime functions. Acid-directed and proline-directed protein phosphorylation sites were regulated in antiphase, implicating the clock-related, casein kinases 1 and 2 in phase-specific regulation, alternating with the CMGC protein kinase family. Understanding the dynamic phosphoprotein network should be facilitated by the minimal kinome and proteome of O. tauri. The data are available from ProteomeXchange, with identifiers PXD001734, PXD001735 and PXD002909. This submission updates a previous version, posted on bioRxiv on 4th April 2018, as https://www.biorxiv.org/content/10.1101/287862v1

HighlightThe phosphorylation of most protein sites was rhythmic under light-dark cycles, and suggested circadian control by particular kinases. Day-peaking, rhythmic proteins likely reflect light-stimulated protein synthesis in this microalga.
]]></description>
<dc:creator>Noordally, Z. B.</dc:creator>
<dc:creator>Hindle, M. M.</dc:creator>
<dc:creator>Martin, S. F.</dc:creator>
<dc:creator>Seaton, D. D.</dc:creator>
<dc:creator>Simpson, I.</dc:creator>
<dc:creator>Le Bihan, T.</dc:creator>
<dc:creator>Millar, A. J.</dc:creator>
<dc:date>2018-04-04</dc:date>
<dc:identifier>doi:10.1101/287862</dc:identifier>
<dc:title><![CDATA[Circadian protein regulation in the green lineage I. A phospho-dawn anticipates light onset before proteins peak in daytime.]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-04</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/291443?rss=1">
<title>
<![CDATA[
PDX Finder: A Portal for Patient-Derived tumor Xenograft Model Discovery 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/291443?rss=1</link>
<description><![CDATA[
Patient-derived tumor xenograft (PDX) mouse models are a versatile oncology research platform for studying tumor biology and for testing chemotherapeutic approaches tailored to genomic characteristics of individual patients tumors. PDX models are generated and distributed by a diverse group of academic labs, research organizations, multi-institution consortia, and contract research organizations. The distributed nature of PDX repositories and the use of different standards in the associated metadata presents a significant challenge to finding PDX models relevant to specific cancer research questions. The Jackson Laboratory and EMBL-EBI are addressing these challenges by co-developing PDX Finder, a comprehensive open global catalog of PDX models and their associated datasets. Within PDX Finder, model attributes are harmonized and integrated using a previously developed community minimal information standard to support consistent searching across the originating resources. Links to repositories are provided from the PDX Finder search results to facilitate model acquisition and/or collaboration. The PDX Finder resource currently contains information for more than 1900 PDX models of diverse cancers including those from large resources such as the Patient-Derived Models Repository, PDXNet, and EurOPDX. Individuals or organizations that generate and distribute PDXs are invited to increase the "findability" of their models by participating in the PDX Finder initiative at www.pdxfinder.org.
]]></description>
<dc:creator>Conte, N.</dc:creator>
<dc:creator>Mason, J.</dc:creator>
<dc:creator>Halmagyi, C.</dc:creator>
<dc:creator>Neuhauser, S.</dc:creator>
<dc:creator>Mosaku, A.</dc:creator>
<dc:creator>Begley, D. A.</dc:creator>
<dc:creator>Kupkre, D. M.</dc:creator>
<dc:creator>Parkinson, H.</dc:creator>
<dc:creator>Meehan, T.</dc:creator>
<dc:creator>Bult, C. J.</dc:creator>
<dc:date>2018-04-03</dc:date>
<dc:identifier>doi:10.1101/291443</dc:identifier>
<dc:title><![CDATA[PDX Finder: A Portal for Patient-Derived tumor Xenograft Model Discovery]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-04-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/289868?rss=1">
<title>
<![CDATA[
Onset of differentiation is posttranscriptionally controlled in adult neural stem cells 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/289868?rss=1</link>
<description><![CDATA[
The contribution of posttranscriptional regulation of gene expression to neural stem cell differentiation during tissue homeostasis remains elusive. Here we show highly dynamic changes in protein synthesis along differentiation of stem cells to neurons in vivo. Examination of individual transcripts using RiboTag mouse models reveals that neural stem cells efficiently translate abundant transcripts, whereas translation becomes increasingly controlled with the onset of differentiation. Stem cell generation of early neuroblasts involves translational repression of a subset of mRNAs including the stem cell-identity factors Sox2 and Pax6 as well as translation machinery components. In silico motif analysis identifies a pyrimidine-rich motif (PRM) in this repressed subset. A drop in mTORC1 activity at the onset of differentiation selectively blocks translation of PRM-containing transcripts. Our data uncovers how a drop in mTORC1 allows robust simultaneous posttranscriptional repression of key stem cell identity-factors and translation-components and thereby stemness exit and migration.
]]></description>
<dc:creator>Baser, A.</dc:creator>
<dc:creator>Dang, Y.</dc:creator>
<dc:creator>Skabkin, M.</dc:creator>
<dc:creator>Guelcueler Balta, G.</dc:creator>
<dc:creator>Kalamakis, G.</dc:creator>
<dc:creator>Kleber, S.</dc:creator>
<dc:creator>Goepferich, M.</dc:creator>
<dc:creator>Schefzik, R.</dc:creator>
<dc:creator>Santos Lopez, A.</dc:creator>
<dc:creator>Llorens Bobadilla, E.</dc:creator>
<dc:creator>Schultz, C.</dc:creator>
<dc:creator>Fischer, B.</dc:creator>
<dc:creator>Martin-Villalba, A.</dc:creator>
<dc:date>2018-03-27</dc:date>
<dc:identifier>doi:10.1101/289868</dc:identifier>
<dc:title><![CDATA[Onset of differentiation is posttranscriptionally controlled in adult neural stem cells]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-27</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/287045?rss=1">
<title>
<![CDATA[
The Drosophila microbiome has a limited influence on sleep, activity, and courtship behaviors 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/287045?rss=1</link>
<description><![CDATA[
In animals, commensal microbes modulate various physiological functions, including behavior. While microbiota exposure is required for normal behavior in mammals, it is not known how widely this dependency is present in other animal species. We proposed the hypothesis that the microbiome has a major influence on the behavior of the vinegar fly (Drosophila melanogaster), a major invertebrate model organism. Several assays were used to test the contribution of the microbiome on some well-characterized behaviors: defensive behavior, sleep, locomotion, and courtship in microbe-bearing, control flies and two generations of germ-free animals. None of the behaviors were largely influenced by the absence of a microbiome, and the small or moderate effects were not generalizable between replicates and/or generations. These results refute the hypothesis, indicating that the Drosophila microbiome does not have a major influence over several behaviors fundamental to the animals survival and reproduction. The impact of commensal microbes on animal behaviour may not be broadly conserved.
]]></description>
<dc:creator>Selkrig, J.</dc:creator>
<dc:creator>Mohammad, F.</dc:creator>
<dc:creator>Ng, S. H.</dc:creator>
<dc:creator>Chua, J. Y.</dc:creator>
<dc:creator>Tumkaya, T.</dc:creator>
<dc:creator>Ho, J.</dc:creator>
<dc:creator>Chiang, Y. N.</dc:creator>
<dc:creator>Rieger, D.</dc:creator>
<dc:creator>Pettersson, S.</dc:creator>
<dc:creator>Helfrich-Foerster, C.</dc:creator>
<dc:creator>Yew, J.</dc:creator>
<dc:creator>Claridge-Chang, A.</dc:creator>
<dc:date>2018-03-22</dc:date>
<dc:identifier>doi:10.1101/287045</dc:identifier>
<dc:title><![CDATA[The Drosophila microbiome has a limited influence on sleep, activity, and courtship behaviors]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/283820?rss=1">
<title>
<![CDATA[
Differential encoding of predator fear in the ventromedial hypothalamus and periaqueductal grey 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/283820?rss=1</link>
<description><![CDATA[
The ventromedial hypothalamus is a central node of the mammalian predator defense network. Stimulation of this structure in rodents and primates elicits abrupt defensive responses, including flight, freezing, sympathetic activation, and panic, while inhibition reduces defensive responses to predators. The major efferent target of the ventromedial hypothalamus is the dorsal periaqueductal grey, and stimulation of this structure also elicits flight, freezing, and sympathetic activation. However, reversible inhibition experiments suggest that the ventromedial hypothalamus and periaqueductal grey play distinct roles in the control of defensive behavior, with the former proposed to encode an internal state necessary for the motivation of defensive responses, while the latter serves as a motor pattern initiator. Here we used electrophysiological recordings of single units in behaving mice exposed to a rat to investigate the encoding of predator fear in the dorsomedial division of the ventromedial hypothalamus and the dorsal periaqueductal grey. Distinct correlates of threat intensity and motor responses were found in both structures, suggesting a distributed encoding of sensory and motor features in the medial hypothalamic-brainstem instinctive network.
]]></description>
<dc:creator>Esteban Masferrer, M.</dc:creator>
<dc:creator>Silva, B. A.</dc:creator>
<dc:creator>Nomoto, K.</dc:creator>
<dc:creator>Lima, S. Q.</dc:creator>
<dc:creator>Gross, C. T.</dc:creator>
<dc:date>2018-03-17</dc:date>
<dc:identifier>doi:10.1101/283820</dc:identifier>
<dc:title><![CDATA[Differential encoding of predator fear in the ventromedial hypothalamus and periaqueductal grey]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-17</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/282517?rss=1">
<title>
<![CDATA[
Quantifying the impact of public omics data 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/282517?rss=1</link>
<description><![CDATA[
The amount of omics data in the public domain is increasing every year [1, 2]. Public availability of datasets is growing in all disciplines, because it is considered to be a good scientific practice (e.g. to enable reproducibility), and/or it is mandated by funding agencies, scientific journals, etc. Science is now a data intensive discipline and therefore, new and innovative ways for data management, data sharing, and for discovering novel datasets are increasingly required [3, 4]. However, as data volumes grow, quantifying its impact becomes more and more important. In this context, the FAIR (Findable, Accessible, Interoperable, Reusable) principles have been developed to promote good scientific practises for scientific data and data resources [5]. In fact, recently, several resources [1, 2, 6] have been created to facilitate the Findability (F) and Accessibility (A) of biomedical datasets. These principles put a specific emphasis on enhancing the ability of both individuals and software to discover and re-use digital objects in an automated fashion throughout their entire life cycle [5]. While data resources typically assign an equal relevance to all datasets (e.g. as results of a query), the usage patterns of the data can vary enormously, similarly to other "research products" such as publications. How do we know which datasets are getting more attention? More generally, how can we quantify the scientific impact of datasets?
]]></description>
<dc:creator>Perez-Riverol, Y.</dc:creator>
<dc:creator>Zorin, A.</dc:creator>
<dc:creator>Dass, G.</dc:creator>
<dc:creator>Glont, M.</dc:creator>
<dc:creator>Vizcaino, J. A.</dc:creator>
<dc:creator>Jarnuczak, A.</dc:creator>
<dc:creator>Petryszak, R.</dc:creator>
<dc:creator>Ping, P.</dc:creator>
<dc:creator>Hermjakob, H.</dc:creator>
<dc:date>2018-03-14</dc:date>
<dc:identifier>doi:10.1101/282517</dc:identifier>
<dc:title><![CDATA[Quantifying the impact of public omics data]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-14</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/280834?rss=1">
<title>
<![CDATA[
Bicoid gradient formation mechanism and dynamics revealed by protein lifetime analysis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/280834?rss=1</link>
<description><![CDATA[
Embryogenesis relies on instructions provided by spatially organized signaling molecules known as morphogens. Understanding the principles behind morphogen distribution and how cells interpret locally this information remains a major challenge in developmental biology. Here we introduce morphogen-age measurements as a novel approach to retrieve key parameters in morphogen dynamics. Using a tandem fluorescent timer (tFT) as a protein-age sensor we find a gradient of increasing age of Bicoid (Bcd) along the anterior-posterior (AP) axis in the early Drosophila embryo. Quantitative analysis retrieves parameter that are most consistent with the synthesis-diffusion-degradation (SDD) model underlying Bcd-gradient formation, and rule out some other hypotheses for gradient formation. Moreover, we show that the timer can detect transitions in the dynamics associated with syncytial cellularization. Our results provide new insight into Bcd gradient formation, and demonstrate how morphogen age-information can complement knowledge about movement, abundance and distribution, which should be widely applicable for other systems.
]]></description>
<dc:creator>Durrieu, L.</dc:creator>
<dc:creator>Kirrmaier, D.</dc:creator>
<dc:creator>Schneidt, T.</dc:creator>
<dc:creator>Kats, I.</dc:creator>
<dc:creator>Raghavan, S.</dc:creator>
<dc:creator>Knop, M.</dc:creator>
<dc:creator>Saunders, T. E.</dc:creator>
<dc:creator>Hufnagel, L.</dc:creator>
<dc:date>2018-03-13</dc:date>
<dc:identifier>doi:10.1101/280834</dc:identifier>
<dc:title><![CDATA[Bicoid gradient formation mechanism and dynamics revealed by protein lifetime analysis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-13</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/277335?rss=1">
<title>
<![CDATA[
The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/277335?rss=1</link>
<description><![CDATA[
Chromatin looping controls gene expression by regulating promoter-enhancer contacts, the spread of epigenetic modifications, and the segregation of the genome into transcriptionally active and inactive compartments. We studied the impact on the structure and expression of host chromatin by the human retrovirus HTLV-1. We show that HTLV-1 disrupts host chromatin structure by forming loops between the provirus and the host genome; certain loops depend on the critical chromatin architectural protein CTCF, which we recently showed binds to the HTLV-1 provirus. Finally, we show that the provirus causes two distinct patterns of abnormal transcription of the host genome in cis: bidirectional transcription in the host genome immediately flanking the provirus, and clone-specific transcription in cis at non-contiguous loci up to >300 kb from the integration site. We conclude that HTLV-1 causes insertional mutagenesis up to the megabase range in the host genome in >104 persistently-maintained HTLV-1+ T-cell clones in vivo.
]]></description>
<dc:creator>Melamed, A.</dc:creator>
<dc:creator>Yaguchi, H.</dc:creator>
<dc:creator>Miura, M.</dc:creator>
<dc:creator>Witkover, A.</dc:creator>
<dc:creator>Fitzgerald, T. W.</dc:creator>
<dc:creator>Birney, E.</dc:creator>
<dc:creator>Bangham, C. R. M.</dc:creator>
<dc:date>2018-03-07</dc:date>
<dc:identifier>doi:10.1101/277335</dc:identifier>
<dc:title><![CDATA[The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/277491?rss=1">
<title>
<![CDATA[
VarQ: a tool for the structural analysis of Human Protein Variants 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/277491?rss=1</link>
<description><![CDATA[
Understanding the functional effect of Single Amino acid Substitutions (SAS), derived from the occurrence of single nucleotide variants (SNVs), and their relation to disease development is a major issue in clinical genomics. Even though there are several bioinformatic algorithms and servers that predict if a SAS can be pathogenic or not they give little or non-information on the actual effect on the protein function. Moreover, many of these algorithms are able to predict an effect that no necessarily translates directly into pathogenicity. VarQ Web Server is an online tool that given an UniProt id automatically analyzes known and user provided SAS for their effect on protein activity, folding, aggregation and protein interactions among others. VarQ assessment was performed over a set of previously manually curated variants, showing its ability to correctly predict the phenotypic outcome and its underlying cause. This resource is available online at http://varq.qb.fcen.uba.ar/.nnContact: lradusky@qb.fcen.uba.arnnSupporting Information & Tutorials may be found in the webpage of the tool.
]]></description>
<dc:creator>Radusky, L.</dc:creator>
<dc:creator>Modenutti, C. P.</dc:creator>
<dc:creator>Delgado, J.</dc:creator>
<dc:creator>Bustamante, J. P.</dc:creator>
<dc:creator>Vishnopolska, S.</dc:creator>
<dc:creator>Kiel, C.</dc:creator>
<dc:creator>Serrano, L.</dc:creator>
<dc:creator>Marti, M.</dc:creator>
<dc:creator>Turjanski, A. G.</dc:creator>
<dc:date>2018-03-07</dc:date>
<dc:identifier>doi:10.1101/277491</dc:identifier>
<dc:title><![CDATA[VarQ: a tool for the structural analysis of Human Protein Variants]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-07</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/276493?rss=1">
<title>
<![CDATA[
Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/276493?rss=1</link>
<description><![CDATA[
In Down syndrome (DS), the overall genetic imbalance caused by trisomy of chromosome 21 leads to a complex pleiotropic phenotype that involves a recognizable set of facial traits. Several studies have shown the potential of epigallocatechin-3-gallate (EGCG), a green tea flavanol, as a therapeutic tool for alleviating different developmental alterations associated with DS, such as cognitive impairment, skull dysmorphologies, and skeletal deficiencies. Here we provide for the first time experimental and clinical evidence of the potential benefits of EGCG treatment to facial morphology. Our results showed that mouse models treated with low dose of EGCG during pre- and postnatal development improved facial dysmorphology. However, the same treatment at high dose produced disparate facial morphology changes with an extremely wide and abnormal range of variation. Our observational study in humans revealed that EGCG treatment since early in development is associated with intermediate facial phenotypes and significant facial improvement scores. Overall, our findings suggest a potential beneficial effect of ECGC on facial development, which requires further research to pinpoint the optimal dosages of EGCG that reliably improve DS phenotypes. Current evidence warns against the non-prescribed intake of this supplement as a health-promoting measure.
]]></description>
<dc:creator>Starbuck, J.</dc:creator>
<dc:creator>Llambrich, S.</dc:creator>
<dc:creator>Gonzalez, R.</dc:creator>
<dc:creator>Albaiges, J.</dc:creator>
<dc:creator>Sarle, A.</dc:creator>
<dc:creator>Wouters, J.</dc:creator>
<dc:creator>Gonzalez, A.</dc:creator>
<dc:creator>Sevillano, X.</dc:creator>
<dc:creator>Sharpe, J.</dc:creator>
<dc:creator>de la Torre, R.</dc:creator>
<dc:creator>Dierssen, M.</dc:creator>
<dc:creator>Vande Velde, G.</dc:creator>
<dc:creator>Martinez-Abadias, N.</dc:creator>
<dc:date>2018-03-05</dc:date>
<dc:identifier>doi:10.1101/276493</dc:identifier>
<dc:title><![CDATA[Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-05</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/275032?rss=1">
<title>
<![CDATA[
CELLector: Genomics Guided Selection of Cancer in vitro Models 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/275032?rss=1</link>
<description><![CDATA[
The selection of appropriate cancer models is a key prerequisite for maximising translational potential and clinical relevance of in-vitro oncology studies.

We developed CELLector: a computational method (implemented in an open source R Shiny application and R package) allowing researchers to select the most relevant cancer cell lines in a patient-genomic guided fashion. CELLector leverages tumour genomics data to identify recurrent sub-types with associated genomic signatures. It then evaluates these signatures in cancer cell lines to rank them and prioritise their selection. This enables users to choose appropriate models for inclusion/exclusion in retrospective analyses and future studies. Moreover this allows bridging data from cancer cell line screens to precisely defined sub-cohorts of primary tumours. Here, we demonstrate usefulness and applicability of our method through example use cases, showing how it can be used to prioritise the development of new in-vitro models and to effectively unveil patient-derived multivariate prognostic and therapeutic markers.

Graphical Abstract

O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=161 SRC="FIGDIR/small/275032v3_ufig1.gif" ALT="Figure 1">
View larger version (41K):
org.highwire.dtl.DTLVardef@11f46b1org.highwire.dtl.DTLVardef@5a207aorg.highwire.dtl.DTLVardef@10a57edorg.highwire.dtl.DTLVardef@12b332_HPS_FORMAT_FIGEXP  M_FIG C_FIG
]]></description>
<dc:creator>Najgebauer, H.</dc:creator>
<dc:creator>Yang, M.</dc:creator>
<dc:creator>Francies, H.</dc:creator>
<dc:creator>Stronach, E. A.</dc:creator>
<dc:creator>Garnett, M. J.</dc:creator>
<dc:creator>Saez-Rodriguez, J.</dc:creator>
<dc:creator>Iorio, F.</dc:creator>
<dc:date>2018-03-03</dc:date>
<dc:identifier>doi:10.1101/275032</dc:identifier>
<dc:title><![CDATA[CELLector: Genomics Guided Selection of Cancer in vitro Models]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-03-03</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/271510?rss=1">
<title>
<![CDATA[
CONSTRUCTION OF WHOLE GENOMES FROM SCAFFOLDS USING SINGLE CELL STRAND-SEQ DATA 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/271510?rss=1</link>
<description><![CDATA[
Accurate reference genome sequences provide the foundation for modern molecular biology and genomics as the interpretation of sequence data to study evolution, gene expression and epigenetics depends heavily on the quality of the genome assembly used for its alignment. Correctly organising sequenced fragments such as contigs and scaffolds in relation to each other is a critical and often challenging step in the construction of robust genome references. We previously identified misoriented regions in the mouse and human reference assemblies using Strand-seq, a single cell sequencing technique that preserves DNA directionality1, 2. Here we demonstrate the ability of Strand-seq to build and correct full-length chromosomes, by identifying which scaffolds belong to the same chromosome and determining their correct order and orientation, without the need for overlapping sequences. We demonstrate that Strand-seq exquisitely maps assembly fragments into large related groups and chromosome-sized clusters without using new assembly data. Using template strand inheritance as a bi-allelic marker, we employ genetic mapping principles to cluster scaffolds that are derived from the same chromosome and order them within the chromosome based solely on directionality of DNA strand inheritance. We prove the utility of our approach by generating improved genome assemblies for several model organisms including the ferret, pig, Xenopus, zebrafish, Tasmanian devil and the Guinea pig.
]]></description>
<dc:creator>Hills, M.</dc:creator>
<dc:creator>Falconer, E.</dc:creator>
<dc:creator>O'Neil, K.</dc:creator>
<dc:creator>Sanders, A.</dc:creator>
<dc:creator>Howe, K.</dc:creator>
<dc:creator>Guryev, V.</dc:creator>
<dc:creator>Lansdorp, P. M.</dc:creator>
<dc:date>2018-02-26</dc:date>
<dc:identifier>doi:10.1101/271510</dc:identifier>
<dc:title><![CDATA[CONSTRUCTION OF WHOLE GENOMES FROM SCAFFOLDS USING SINGLE CELL STRAND-SEQ DATA]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-26</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/269811?rss=1">
<title>
<![CDATA[
Tracing the Transitions from Pluripotency to Germ Cell Fate with CRISPR Screening 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/269811?rss=1</link>
<description><![CDATA[
Early mammalian development entails a series of cell fate transitions that includes transit through naive pluripotency to post-implantation epiblast. This subsequently gives rise to primordial germ cells (PGC), the founding population of the germline lineage. To investigate the gene regulatory networks that control these critical cell fate decisions, we developed a compound-reporter system to track cellular identity in a model of PGC specification (PGC-like cells; PGCLC), and coupled it with unbiased genome-wide CRISPR screening. This enabled identification of key genes both for exit from pluripotency and for acquisition of PGC fate, with further characterisation revealing a central role for the transcription factors Nr5a2 and Zfp296 in germline ontogeny. Abrogation of these genes results in significantly impaired PGCLC development due to widespread activation (Nr5a2-/-) or inhibition (Zfp296-/-) of WNT pathway components. This leads to aberrant upregulation of the somatic programme or failure to appropriately activate germline genes in PGCLC, respectively, and consequently loss of germ cell identity. Overall our study places Zfp296 and Nr5a2 as key components of an expanded PGC gene regulatory network, and outlines a transferable strategy for identifying critical regulators of complex cell fate transitions.
]]></description>
<dc:creator>Hackett, J. A.</dc:creator>
<dc:creator>Huang, Y.</dc:creator>
<dc:creator>Gunesdogan, U.</dc:creator>
<dc:creator>Holm-Gretarsson, K.</dc:creator>
<dc:creator>Kobayashi, T.</dc:creator>
<dc:creator>Surani, A. M.</dc:creator>
<dc:date>2018-02-22</dc:date>
<dc:identifier>doi:10.1101/269811</dc:identifier>
<dc:title><![CDATA[Tracing the Transitions from Pluripotency to Germ Cell Fate with CRISPR Screening]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-22</prism:publicationDate>
<prism:section></prism:section>
</item>
<item rdf:about="https://biorxiv.org/content/10.1101/269068?rss=1">
<title>
<![CDATA[
Ubiquitous abundance distribution of non-dominant plankton across the world’s ocean 
]]>
</title>
<link>https://biorxiv.org/content/10.1101/269068?rss=1</link>
<description><![CDATA[
Species Abundance Distributions (SADs) bear the imprint of ecological processes that shape biological communities, and are therefore used to discriminate among different scenarios of community assembly. Even though empirical distributions appear to follow a handful of qualitative laws, it is still unclear if and how quantitative variation in SADs reflects peculiar features of the communities and their environmental context. Here, we use the extensive dataset generated by the Tara Oceans expedition for marine microbial eukaryotes (protists) and an adaptive algorithm to explore how SADs vary across plankton communities in the global ocean. We show that the decay in abundance of non-dominant OTUs, comprising over 99% of local richness, is commonly governed by a power-law. The power-law exponent varies by less than 10% across locations and shows no biogeographical signature, but is weakly modulated by cell size. Our findings suggest that large-scale ubiquitous ecological processes govern the assembly of non-dominant plankton throughout the global ocean.
]]></description>
<dc:creator>Ser-Giacomi, E.</dc:creator>
<dc:creator>Zinger, L.</dc:creator>
<dc:creator>Malviya, S.</dc:creator>
<dc:creator>De Vargas, C.</dc:creator>
<dc:creator>Karsenti, E.</dc:creator>
<dc:creator>Bowler, C.</dc:creator>
<dc:creator>De Monte, S.</dc:creator>
<dc:date>2018-02-21</dc:date>
<dc:identifier>doi:10.1101/269068</dc:identifier>
<dc:title><![CDATA[Ubiquitous abundance distribution of non-dominant plankton across the world’s ocean]]></dc:title>
<dc:publisher>Cold Spring Harbor Laboratory Press</dc:publisher>
<prism:publicationDate>2018-02-21</prism:publicationDate>
<prism:section></prism:section>
</item>
</rdf:RDF>
